<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://journal.uii.ac.id/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-05-26T18:18:43Z</responseDate>
	<request from="2020-12-10" metadataPrefix="oai_dc" verb="ListRecords">https://journal.uii.ac.id/JIF/oai</request>
	<ListRecords>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/2478</identifier>
				<datestamp>2025-07-23T07:26:48Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">PENGARUH PRAPERLAKUAN JUS PISANG AMBON ( Musa paradisiaca L. ) TERHADAP BIOAVAILABILITAS SULFAMEZATIN PADA TIKUS PUTIH JANTAN</dc:title>
	<dc:creator>Hayati, Farida</dc:creator>
	<dc:creator>Hakim, Arief Rahman</dc:creator>
	<dc:creator>Riptasari, Rhatna Dewi</dc:creator>
	<dc:subject xml:lang="en-US">Bioavailability</dc:subject>
	<dc:subject xml:lang="en-US">Sulfamezathin</dc:subject>
	<dc:subject xml:lang="en-US">Ambon banana</dc:subject>
	<dc:subject xml:lang="en-US">Musa paradisiaca L</dc:subject>
	<dc:description xml:lang="en-US">The influence of ambon banana’s fruit ( Musa paradisiaca L. ) juice on the bioavailability of sulfamezathin on the rat that aim to know there are interaction result from their consumption together has been studied. The study was using experiment’s animal is white rats Wistar’s spesies that have age around 3-4 months and their weight 200-300 g. This experimental was used completely randomized design with three group’s test, each group’s test is contain seven rats. The first group is pretreatment single dose sulfamezathin (60 mg/kg ww; peroral ), second is sullfamezathin and banana ( 12,6 g/kg ww; peroral ) together and third group is sulfamezathin after one hour dose banana like second group. Respectively blood samples take up from tail vein of rat at 15, 30, 45, 60, 90, 120, 150, 180, 240, 360, 480 and 600 minutes. Consentrations of Sulfamezatin were measured use Bratton Marshall methode with spektrofotometer instrument at 545 mn wavelength. Consentrations of sulfamezathin versus times by software of Stripe used to calculate pharmacokinetics parameters in each group’s test and the value parameters of pharmacokinetics have statistic analysis by ANOVA and if there are difference’s significant ( p &amp;lt; 0,05 ) from calculated value, statistic analysis continued by Tukey test. The results from experimental banana at second and third groups in compare with control at the first group can increased significant ( p &amp;lt; 0,05 ) parameters C maks, t maks, AUC0- .Bioavailability, Sulfamezathin, Ambon banana, Musa paradisiaca L.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2004-04-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/2478</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 1 No. 1 (2004); 1-6</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/2478/2265</dc:relation>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/2479</identifier>
				<datestamp>2025-07-22T06:59:29Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">EFEK ANTI PROLIFERATIF EKSTRAK ETANOL KULIT BATANG TANAMAN CANGKRING (Erythrina fusca Lour) TERHADAP SEL MYELOMA</dc:title>
	<dc:creator>Meiyanto, Edy</dc:creator>
	<dc:creator>Sismindari, Sismindari</dc:creator>
	<dc:creator>Triastuti, Asih</dc:creator>
	<dc:description xml:lang="en-US">ABSTRACTErythrina fusca Lour has been traditionally used to cure hepatosis, malaria, hematuria, andcancer. The bark of this plant contains  carotene, polifenol, thiamin, saponin, and alkaloiderythralin and erythramin. The aim of this research was to know the underlying mechanism of itseffect as antiproliferative against Myeloma cells. The bark powder was extracted using ethanol(70%) and was used for the experiment after freezed drying. Citotoxicity test of this extractperformed LC50 of 0,367 mg/ml. The rate of proliferation was observed by doubling time effectagainst proliferating cells. The cells were exposed with ethanolic extract in RPMI 1640 mediumcontaining 1) 0,25 mg/ml 2) 6,25x10-2mg/ml, and 3) 1,56x10-2mg/ml and every 0, 6, 12, 24, 48,and 72 hours cell were counted. The result showed that extract treated cells delayed proliferation atall concentration with doubling time dose 2) of 161, 38 hours, and dose 3) of 93,91 hours, whereasdoubling time of control cells were 69,86 hours. Ethidium bromide staining of extract treated cellsshowed apoptosis like profile. These results indicated that ethanolic extract of the bark of Erythrinafusca Lour has an antiproliverative effect on Myeloma cell line. Several mechanisms might accountfor this effect, like inhibiting cell cycle progression, signal transduction, causing delayed andapoptosisKeywords: Erythrina fusca Lour, atiproliferative, Myeloma</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2004-04-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/2479</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 1 No. 1 (2004); 7-12</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/2479/2266</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/2480</identifier>
				<datestamp>2025-07-22T06:59:29Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">POLA PENGGUNAAN OBAT UNTUK PENDERITAGAGAL GINJAL AKUT DI INSTALASI RAWAT INAP RUMAH SAKIT UMUM PUSAT (RSUP) DR. SARDJITO YOGYAKARTA TAHUN 1997-2001</dc:title>
	<dc:creator>Hanifah, Suci</dc:creator>
	<dc:description xml:lang="en-US">ABSTRACTDrug Utility Review for ARF’ patients of Internal Unit, Sardjito’s hospital was examed. Itinvolved 109 ARF’s patients. Medical Record Unit reported that this number was 0,12% of alldisese i.e. 93.445 case in 2001. The level was 93rdfrom 945 kind of disease. It was studied bynonanalitical descriptive design. using notes of Medical Record system. Collecting of data byretrospektive methode. This research was aimed to study the Drug Utility Review for ARF’spatients, especially to study ; drug variation included kind and class of drugs, route ofadministration, variation drug number, length of stay, and regimen dosage of drugs. To complete it,mortality persentaged was reported. The result of the study showed that ARF’s patients got somany variation of drugs. Using of antibiotic, diuretic, and electrolit was the most case. It conformedto Health Care Standard in Sardjito’s hospital. The others was aimed to simptomatical drugs i.e.antihypertensi, cardioasculer drugs, analgetic, antiemetic, multivitamin, laxan etc. It depended onsymptoms and complication of patients. Variation of number between 1-24. The average numberwas 7,7 drugs. It tended to use new generation of antibiotic and combinatins antibiotic, as indicatorof extravagant prescibing. Route of administratin by orally in most case and 38 % by injection.Injection route so indicate extravagant prescibing except on emergency care. The others used bysublingual and suppositoria. Length of stay averaged 12,52 days. Mortality persentaged was 22%.Key words : Drug Utility Review, ARF, Medical Record,Extravagant Prescribing</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2004-04-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/2480</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 1 No. 1 (2004); 13-22</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/2480/2267</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/2481</identifier>
				<datestamp>2025-07-22T06:59:29Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">SENYAWA INSEKTISIDA DARI TANAMAN</dc:title>
	<dc:creator>Hidayati, Atik</dc:creator>
	<dc:description xml:lang="en-US">ABSTRACTThe importance of insecticides in agricultural and economic aspects is undoubted. But thenegative impacts that arise lead to the discovery of new ones. A high number of insecticidal agentsare synthesized by plant species. They are of interest in that chemical modification of the naturalproduct can open the way to novel, synthetic insecticides.Key words: insecticides, Spodoptera litura</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2004-04-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/2481</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 1 No. 1 (2004); 23-27</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/2481/2268</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/2482</identifier>
				<datestamp>2025-07-22T06:59:29Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">SISTEM PENGHANTARAN OBAT MELEWATI BARRIER DARAH OTAK</dc:title>
	<dc:creator>Syukri, Yandi</dc:creator>
	<dc:subject xml:lang="en-US">acute toxicity</dc:subject>
	<dc:subject xml:lang="en-US">effervescent tablet</dc:subject>
	<dc:subject xml:lang="en-US">Piper betle</dc:subject>
	<dc:description xml:lang="en-US">ABSTRACTBrain barrier is effective barrier in drug delivery to brain. For effectiveness drug deliveryneed be desaigned a delivery with nanoparticle technology. Nanoparticles are solid colloidalparticles ranging in size from 1 to 1000 nm that are utilized as drug delivery agents. The primaryadvantages of nanoparticle carrier technology is that nanoparticles mask the blood – brain barrierlimiting characteristics of the therapeutic drug molecule. Furthermore, this system may slow drugrelease in the brain, decreasing peripheral toxicity. The method which elaboration in manufacturenanoparticles are emulsion polimerization, interfacial polimerization, desolvation evaporation andsolvent deposition. Currently, report evaluating nanoparticles for brain delivery have studiedanesthetic and chemoterapeutic agent. These studies are reviewed for efficacy and mechanisms oftransport. Physiological factors such as phagocytic activity of the reticuloendothelial system andprotein opsonization may limit the amount of brain delivered drug. Nanoparticle technology appearsto have significant promise in delivering therapeutic molecules across the blood-brain barrier.Key Word : Drug Delivery System, Nanoparticle, Blood-Brain Barrier</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2004-04-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/2482</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 1 No. 1 (2004); 28-35</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/2482/2269</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/12525</identifier>
				<datestamp>2022-01-31T13:22:52Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Determination of antioxidant active fraction from ethanol extract of benalu leaves (Scurrula atropurpurea (Bl.) Denser) which grows on rambutan trees</dc:title>
	<dc:creator>Werdyani, Sista</dc:creator>
	<dc:creator>Hartati, Denda Suli</dc:creator>
	<dc:creator>Jumaryatno, Pinus</dc:creator>
	<dc:description xml:lang="id-ID">IntisariLatar belakang: Aktivitas antioksidan benalu dapat berbeda apabila inang yang ditumbuhi berbeda. Penelusuran senyawa aktif antioksidan pada benalu rambutan belum pernah dilakukan, padahal pohon rambutan diketahui memiliki aktivitas antioksidan yang tinggi.Tujuan: Mengetahui golongan senyawa yang terkandung dalam fraksi aktif dengan aktivitas antioksidan tertinggi dan menghitung aktivitas antioksidannya menggunakan metode DPPH.Metode: Ekstraksi dilakukan dengan metode maserasi dan dilanjutkan dengan fraksinasi menggunakan kromatografi kolom vakum (KCV). Uji kualitatif kandungan senyawa ekstrak dan fraksi selanjutnya dilakukan dengan metode kromatografi lapis tipis (KLT) dengan bantuan reagen semprot. Aktivitas antioksidan ekstrak dan fraksi kemudian dihitung dengan metode DPPH.Hasil: Aktivitas antioksidan tertinggi adalah fraksi 5 dengan nilai IC50 7,211   ± 0,072. Kelompok senyawa pada fraksi 5 adalah flavonoid dan tannin. Kesimpulan: Senyawa aktif antioksidan dalam ekstrak etanol daun benalu rambutan terdapat dalam fraksi 5 dan diduga termasuk ke dalam golongan senyawa flavonoid dan atau tannin.  Kata kunci: Antioksidan, DPPH, benalu rambutan, Scurrula atropurpurea (Bl.) Denser Determination of Antioxidant Active Fraction from Ethanol Extract of Benalu Leaves (Scurrula atropurpurea (Bl.) Denser) which Grows on Rambutan TreesAbstractBackground: Antioxidant activity of benalu can be different if the overgrown host is different. The study for antioxidant active compounds in benalu which grows on rambutan trees has never been done, even though rambutan trees are known to have high antioxidant activity.Objective: to investigate the class of compounds contained in the active fraction with the highest antioxidant activity and to calculate their antioxidant activity using DPPH methods.Method: Extraction was carried out by maceration method and continued with fractionation using vacuum column chromatography (KCV). Qualitative tests of extract compound content and subsequent fractions were carried out by thin layer chromatography (TLC) method with the help of spray reagents. The antioxidant activity of extracts and fractions was then calculated using the DPPH method.Results: The highest antioxidant activity was fraction 5 with IC50 value 7.211 ± 0.072. The group of compounds in fraction 5 are flavonoids and tannins. Conclusion: The antioxidant active compounds in the ethanol extract of benalu which grows in rambutan were found in fraction 5 and were thought to belong to the class of flavonoids and or tannins. Keywords: antioxidant, DPPH, rambutan’s benalu, Scurrula atropurpurea (Bl.) Denser</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2019-11-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/12525</dc:identifier>
	<dc:identifier>10.20885/jif.vol15.iss2.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 15 No. 2 (2019): Jurnal Ilmiah Farmasi; 70-79</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/12525/9759</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/12998</identifier>
				<datestamp>2020-12-31T11:45:33Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The relationship between sosiodemographic factors and public knowledge of herbal medicines in two districts in Sleman Regency</dc:title>
	<dc:creator>Medisa, Dian</dc:creator>
	<dc:creator>Anshory, Hady</dc:creator>
	<dc:creator>Litapriani, Putri</dc:creator>
	<dc:creator>Fajriyati M, Rezky</dc:creator>
	<dc:description xml:lang="id-ID">AbstractIntroduction: The use of herbal medicines in the community is increasing, both in developing and developed countries.. Most people use herbal medicine for generations or based on experience. Therefore, it is necessary to analyze the public knowledge about herbal medicine to support the use of herbal medicines appropriately and correctlyObjective : To determine the relationship between sociodemographic characteristic with public knowledge level about  herbal medicine in Sleman Regency.Methods: Survey research conducted on the people of Minggir and Cangkringan districts, Sleman Regency. Sampling of 240 respondents was done by cluster sampling method. Data obtained from the distribution of questionnaires that have been validated to the public. The correct answer was counted and scored, then responden who score greater or equal to the mean were grouped into good knowledge, whereas those who score less than mean were grouped into poor knowledge. Data were analyzed by univariate and bivariate by chi-square test.Result : The majority of respondents were women (61.2%) and the most age was 26-45 years (46.7%). The respondents' knowledge is the best in the domain of how to use herbal medicine with an average percentage of correct answers 67.6%. In the domain of side effects, the average percentage of answers is only 47.7%. Overall respondents who had a good level of knowledge were 66.2% and respondents who were poorly knowledgeable were 33.8%. The results of the bivariate analysis showed no correlation between sociodemographic characteristics and knowledge level about herbal medicine (p&amp;gt; 0.05).Conclusion: Most people in Sleman Regency have good knowledge about herbal medicine. However, education still needs to be done about herbal medicines, especially the efficacy and side effects. Keyword: knowledge, herbal medicine, sleman regencyIntisariLatar Belakang: Penggunaan obat herbal (OH) di masyarakat semakin meningkat, baik di negara berkembang maupun negara maju. Sebagian besar masyarakat menggunakan obat herbal secara turun temurun atau berdasarkan pengalaman. Oleh karena itu, perlu dilakukan analisis terhadap pengetahuan masyarakat tentang obat herbal untuk mendukung penggunaan obat herbal dengan tepat dan benar.Tujuan: Untuk mengetahui hubungan sosiodemografi dengan tingkat pengetahuan masyarakat tentang obat herbal pada dua kecamatan di Kabupaten Sleman.Metode: Penelitian survey yang dilakukan pada masyarakat Kecamatan Minggir dan Cangkringan, Kabupaten Sleman. Pengambilan sampel sebanyak 240 responden dilakukan dengan metode cluster sampling. Data diperoleh dari pembagian kuesioner yang telah tervalidasi. Responden yang memiliki skor di atas nilai rata-rata termasuk dalam kategori berpengetahuan baik, sedangkan jika dibawah atau sama dengan rata-rata termasuk kategori berpengetahuan buruk. Data dianalisis menggunakan uji chi-square.Hasil: Mayoritas responden adalah wanita (61,2%) dan usia paling banyak 26-45 tahun (46,7%). Persentase pengetahuan yang paling baik yaitu pada domain efek samping obat herbal (78,3%), sedangkan pengetahuan yang terendah tentang cara penggunaan obat herbal (32,1%). Lima puluh lima persen responden memiliki pengetahuan yang baik tentang obat herbal secara keseluruhan. Hasil analisis bivariat menunjukkan faktor sosiodemografi tidak berhubungan secara signifikan dengan tingkat pengetahuan responden tentang obat herbal (p&amp;lt;0,05).Kesimpulan: Faktor sosiodemografi tidak berhubungan dengan tingkat pengetahuan tentang obat herbal. Pengetahuan tentang obat herbal dapat ditingkatkan melalui pemberian edukasi yang sesuai dengan kebutuhan dan kondisi sosiodemografi masyarakat.Kata kunci: pengetahuan, obat tradisional, Kabupaten Sleman</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-09-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/12998</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art1</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 96-104</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/12998/10505</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header status="deleted">
				<identifier>oai:ojs.jurnal.uii.ac.id:article/13173</identifier>
				<datestamp>2021-07-16T10:58:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/13278</identifier>
				<datestamp>2022-11-24T12:30:54Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">TINGKAT KEPUASAN PASIEN TERHADAP PELAYANAN RSUD X YOGYAKARTA 2015</dc:title>
	<dc:creator>Suryanegara, Fithria Dyah Ayu</dc:creator>
	<dc:creator>Medisa, Dian</dc:creator>
	<dc:creator>Aziz, Muiz Abdul</dc:creator>
	<dc:description xml:lang="en-US">Intisari Jaminan Kesehatan Nasional (JKN) dilaksanakan di Indonesia per 1 Januari 2014. JKN diselenggarakan oleh BPJS Kesehatan (Badan Penyelenggara Jaminan Sosial), sedangkan dalam melayani anggotanya, BPJS Kesehatan bekerja sama dengan beberapa fasilitas kesehatan, seperti rumah sakit daerah, rumah sakit swasta dan lain-lain. BPJS Kesehatan mengembangkan beberapa indicator yang digunakan untuk mengevaluasi kinerja dari fasilitas kesehatan yang nantinya akan digunakan dalam proses seleksi, salah satu indikator yang dikembangkan adalah kepuasan pasien. RSUD X Yogyakarta adalah salah satu rumah sakit daerah yang bekerja sama dengan BPJS Kesehatan dalam rangka memberikan pelayanan kesehatan kepada masyarakat, oleh sebab itu di rumah sakit tersebut perlu dilakukan evaluasi tingkat kepuasan pasien. Tujuan dari penelitian ini adalah untuk mengetahui tingkat kepuasan pasien terhadap pelayanan rumah sakit, yang terbagi ke dalam 4 (empat) bidang, yaitu pendaftaran, verifikasi asuransi, pelayanan poliklinik, dan pelayanan farmasi. Penelitian diselenggarakan pada bulan September-Oktober 2015 di RSUD X Yogyakarta. Desain penelitian menggunakan cross sectional dan teknik pengambilan sampel dengan accidental sampling. Data diperoleh dengan menyebarkan kuesioner yang telah divalidasi pada pasien rawat jalan RSUD X Yogyakarta. Total responden yang diperoleh dalam penelitian adalah 100. Hasil penelitian menunjukkan bahwa tingkat kepuasan pasien di RSUD X Yogyakarta pada bagian pendaftaran, verifikasi asuransi, pelayanan poliklinik, dan pelayanan farmasi sebesar 71.68%; 70.34%; 73.74%; 72.28% secara berturut-turut. Hal tersebut masih jauh dari target BPJS Kesehatan, yaitu 85%. Pasien di RSUD X Yogyakarta cukup puas terhadap pelayanan kesehatan yang diberikan, akan tetapi RSUD X Yogyakarta perlu melakukan perbaikan dalam pelayanan agar tingkat kepuasan pasien setidaknya sesuai dengan yang telah ditargetkan oleh BPJS Kesehatan.Kata kunci : JKN, kinerja, rumah sakit, kepuasan</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2019-08-07</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/13278</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 11 No. 2 (2015): Jurnal Ilmiah Farmasi; 45-54</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/13278/9340</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/13279</identifier>
				<datestamp>2022-11-24T12:30:54Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">IDENTIFIKASI pH OBAT-OBAT YANG DIGUNAKAN DI  PEDIATRIC INTENSIVE CARE UNIT (PICU) UNTUK PENCEGAHAN INKOMPATIBILITAS INTRAVENA</dc:title>
	<dc:creator>Hanifah, Suci</dc:creator>
	<dc:description xml:lang="en-US">Intisari Pasien anak-anak di unit perawatan intensif sering mendapatkan banyak obat dalam satu jalur infus. Presipitasi akibat perbedaan pH obat-obat yang bertemu i jalur intravena cenderung terjadi secara cepat sehingga menimbulkan masalah di jalur infus. Oleh karena itu, data pH sangat penting bagi praktisi untuk membuat panduan dalam menentukan jenis jalur yang tepat sehingga inkompatibilitas tidak terjadi. Penelitian ini bertujuan  untuk mengidentifikasi obat-obat yang sering digunakan di PICU dan mengukur pH dari obat-obat yang umum digunakan di ICU. Data obat dikumpulkan dari dokumen logistic farmasi selama tahun 2013. Keempat puluh obat injeksi yang siap diberikan, diuji nilai pHnya dengan pH meter. Berdasarkan nilai pH yang diperoleh, potensi inkompatibilitas banyak terjadi pada obat-obat pH asam seperti kardiotonik dan antikolinergik dan obat-obat yang memiliki pH tinggi (basa) misalnya misalnya Asiklovir, Ampisilin, Ampi-Sulbaktam, Fenobarbital, Fenitoin, Furosemid, dan Omeprazo. Berdasarkan hasil identifikasi pH masing-masing obat, untuk mencegah inkompatibilitas, sedikitnya diperlukan tiga jalur; jalur obat asam, jalur obat basa, dan jalur khusus. Jalur yang spesifik digunakan untuk cairan yang cenderung tidak bisa melalui jalur asam maupun basa, karena hiperosmolar atau sulit larut misalnya mannitol dan diazepam.  Kata Kunci : pH, intravena, pediatric intensive care unit, inkompatibilitas</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2019-08-07</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/13279</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 11 No. 2 (2015): Jurnal Ilmiah Farmasi; 55-64</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/13279/9341</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/13280</identifier>
				<datestamp>2022-11-24T12:30:54Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">AKTIVITAS ANTIBAKTERI SENYAWA ISOLAT DAUN MUNDU  (Garcinia dulcis) TERHADAP BAKTERI PATOGEN GRAM POSITIF</dc:title>
	<dc:creator>Tamhid, Hady Anshory</dc:creator>
	<dc:creator>Hertiani, Triana</dc:creator>
	<dc:creator>Wahyuono, Subagus</dc:creator>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2019-08-07</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/13280</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 11 No. 2 (2015): Jurnal Ilmiah Farmasi; 30-37</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/13280/9342</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/13281</identifier>
				<datestamp>2022-11-24T12:46:15Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Aktivitas antioksidan ekstrak etanol daun Sonchus arvensis L.</dc:title>
	<dc:creator>Istikharah, Rochmy</dc:creator>
	<dc:creator>Annisa, Khittah Dea Annisa</dc:creator>
	<dc:creator>Pratama, Nofran Putra </dc:creator>
	<dc:creator>Tamhid, Hady Anshory </dc:creator>
	<dc:description xml:lang="en-US">Intisari Penelitian terhadap ekstrak air dan ekstrak metanol daun Sonchus arvensis L. atau tempuyung telah terbukti mempunyai khasiat sebagai antioksidan. Salah satunya diduga karena kandungan flavonoidnya. Etanol merupakan pelarut yang paling sering digunakan dalam proses ekstraksi dan mempunyai kemampuan yang baik dalam mengekstraksi flavonoid. Penelitian ini bertujuan untuk mengetahui aktivitas ekstrak etanol daun S. arvensis sebagai antioksidan dengan metode DPPH (1,1-diphenyl-2-picrylhydrazyl) dan metode ABTS (2,2’-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid). Ekstrak daun S. arvensis diperoleh melalui proses maserasi dengan etanol 70%. Uji aktivitas antioksidan dilakukan dengan menggunakan DPPH dan ABTS sebagai sumber radikal bebas terhadap seri kadar ekstrak sehingga dapat dihitung nilai IC50 melalui perhitungan PROBIT. Seri kadar vitamin C digunakan sebagai kontrol positif. Hasil uji peredaman radikal bebas menunjukkan nilai IC50 S. arvensis sebesar 138,26 µg/mL terhadap ABTS dan 64,97 µg/mL terhadap DPPH. Ekstrak etanol daun S. arvensis yang diuji mempunyai aktivitas antioksidan. Kata kunci : Sonchus arvensis, antioksidan, ABTS, DPPH</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2019-08-07</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/13281</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 11 No. 2 (2015): Jurnal Ilmiah Farmasi; 38-44</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/13281/9343</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/14506</identifier>
				<datestamp>2020-12-31T11:46:28Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Confusion, difficulty concentrating, and slow response induced by ropinirole therapy in an elderly patient with secondary Parkinsonism: a case report</dc:title>
	<dc:creator>Sidharta, Emilia</dc:creator>
	<dc:creator>Wijaya, Ivon Sindu</dc:creator>
	<dc:creator>Cahyadi, Hanny</dc:creator>
	<dc:description xml:lang="en-US">Abstract  Background: Ropinirole is a therapy that is widely used in patients with Parkinson's disease or Restless Leg Syndrome (RLS). Some research journals show that the long-term use of ropinirole can cause side effects. But unfortunately, there are no published studies from Indonesia that show the side effects of ropinirole..Objective: To report a case of several side effects induced by ropinirole therapyMethod : Assessment methods used were time series data collection followed by causality analysis using Naranjo Scale. Results:  This case reports several side effects such as confusion, difficulty concentrating, and  slow response experienced by a 75-year-old elderly patient who consumed ropinirole 2 mg as a therapy for Secondary Parkinsonism. Before using ropinirole, the patient had used levodopa-benserazide, trihexyphenidyl, and pramipexole to overcome Parkinson's for more than 3 years. During the period no side effects occurred. Side effects occurred after ropinirole therapy was given to patients.  The analysis using Naranjo Scale shows a score of 6 which means Probable.  Conclusion: The aim of this study is to raise awareness for health workers, especially pharmacists in order to increase alertness in patients using long-term medications such as those with Parkinson's.Keywords: side effect, secondary parkinsonism, ropinirole, elderly</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-10-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/14506</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 112-117</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/14506/10592</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/14816</identifier>
				<datestamp>2020-12-31T11:47:28Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Stability studies of mefenamic acid Self-Nanoemulsifying Drug Delivery System (SNEEDS) preparation with oleic acid as the oil phase</dc:title>
	<dc:creator>Syukri, Yandi</dc:creator>
	<dc:creator>Cahyani, Septiani Eka</dc:creator>
	<dc:creator>Nugroho, Bambang Hernawan</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with low solubility in water.Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) play a role to improve the solubility and bioavailabilityof mefenamic acid.Objective: This study aimed to determine the stability of mefenamic acid in SNEDDS formulation throughvarious stability studies.Methods: The stability studies conducted consisted of centrifugation test, heating-cooling cycle test, freezethaw cycle test, robustness to dilution, accelerated storage test, and determination of drug content.Results: The centrifugation test, heating-cooling cycle test, and freeze-thaw cycle test showed no phaseseparation in the samples. The robustness to dilution and accelerated storage test resulted in 2 formulas ofmefenamic acid loaded SNEDDS having good stability with 10% oleic acid, 80% tween 80, 10% PEG 400 and10% oleic acid, 70% tween 80, 20% PEG 400. The determination of drug content in both of these formulationsshowed 98.20 ± 0.04% and 90.98 ± 0.06%.Conclusion: The SNEDDS formulation of mefenamic acid in this study had good stability.Keywords: SNEDDS, mefenamic acid, stability study, oleic acid IntisariLatar belakang: Asam mefenamat merupakan obat anti inflamasi non steroidal (AINS) dengan kelarutan yang rendah di dalam air. Salah satu cara untuk meningkatkan kelarutan dan bioavailabilitas asam mefenamat membuatnya dalam bentuk sediaan Self Nano-Emulsifying Delivery Drug System (SNEDDS)Tujuan: Penelitian ini bertujuan untuk menentukan stabilitas SNEDDS asam mefenamat terhadap berbagai studi stabilitas yang dilakukanMetode: Uji stabilitas dilakukan dengan uji sentrifugasi, uji siklus panas-dingin, uji siklus beku-cair, uji ketahanan, uji penyimpanan dipercepat, dan uji kadar.Hasil: Hasil dari evaluasi uji sentrifugasi yaitu tidak terjadi pemisahan, pada uji siklus panas-dingin dan uji siklus beku-cair tetap stabil dan tidak terjadi pemisahan fase. Hasil dari uji ketahanan dan uji penyimpanan dipercepat menunjukkan 2 formula SNEDDS asam mefenamat yang memiliki stabilitas yang baik dengan komponen Asam Oleat 10%, Tween 80 80%, PEG 400 10% dan Asam Oleat 10%, Tween 80 70%, PEG 400 20%. Pada uji kadar diperoleh kadar asam mefenamat selama penyimpanan pada formula diatas adalah 98,20 ± 0,04 % dan 90,98 ± 0,06 %.Kesimpulan: Dapat disimpulkan sediaan SNEDDS asam mefenamat memiliki stabilitas yang baik terhadap berbagai studi stabilitas yang dilakukan.Kata kunci : SNEDDS, asam mefenamat, studi stabilitas, asam oleat</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-12-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/14816</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art5</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 130-143</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/14816/10655</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/14843</identifier>
				<datestamp>2021-07-31T16:51:45Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Identification and activity of active compound of bamboo leaves  (Bambusa vulgaris Schrad ex.J.C) ethanolic extract against diabetic ulcers  gram-negative bacteria from diabetic ulcer’s patient</dc:title>
	<dc:creator>Apridamayanti, Pratiwi</dc:creator>
	<dc:description xml:lang="id-ID"> Abstract Background: Bamboo leaves (Bambusa vulgaris Schrad ex.J.C) are plants that are known to have pharmacological activity, one of which is to have antibacterial activity. Diabetic Foot Ulcers (DFU) is one chronic complication of diabetes mellitus. DFU is open sores on the surface of the skin that can be accompanied by local tissue death. Infection that is not appropriately treated in patients can cause amputation. Improper use of antibiotics can cause resistance events. A resistance that occurs in Proteus mirabilis, Pseudomonas aeruginosa, and Escherichia coli in isolates from DFU patients encourages researchers to look for alternative antibiotics from natural resources.Objective: Determine the profile of secondary metabolites by thin-layer chromatography, foam index, total phenols, total flavonoids and the antibacterial activity of bamboo (B. vulgaris) through the antibacterial with clear zone value of bamboo leaf ethanol extract against bacteria E. coli, P. aeruginosa, and P. mirabilis.Method: Phenol, flavonoid, and triterpenoid test using TLC method. Saponin tests were carried out using foam index, fish index, and hemolytic index test methods. Total flavonoid testing using Chang method and total phenol method using the Follin Ciocalteau reagent then proceed using a spectrophotometer. Test the antibacterial activity using the agar diffusion method.Results: Chromatographic profile, phenol, flavonoid, and triterpenoid compounds were obtained; saponin index obtained foam index of 333; fish index of 200; and the hemolytic index of 1,111. The total phenol test was 16.052 ± 3.12 % and the total flavonoid was 2.42 ± 0.44 %. Antibacterial activity test obtained MIC values of 60 mg/ml for E. coli bacteria; 100 mg/ml for the bacterium P. aeruginosa; and 30 mg/ml of P. mirabilis.Conclusion: The content of secondary metabolites found in the ethanol extract of bamboo leaves were flavonoid, phenol, saponin and triterpenoids. Ethanol extract of bamboo leaves has a the potential to produce antibacterial activity against gram-negative pathogenic bacteria isolated from diabetic wound patientsKeywords: Bambusa vulgaris Schrad ex.J.C, total phenol, total flavonoid, MIC Intisari  Latar belakang: Daun bambu (Bambusa vulgaris Schrad ex.J.C) merupakan tumbuhan yang diketahui memiliki aktivitas farmakologis, salah satunya adalah memiliki aktivitas antibakteri. Ulkus Kaki Diabetik (UKD) adalah salah satu bentuk komplikasi kronik diabetes melitus berupa luka terbuka pada permukaan kulit yang dapat disertai adanya kematian jaringan setempat. Infeksi yang tidak ditangani dengan baik pada penderita dapat menyebabkan terjadinya kasus amputasi. Penggunaan antibiotik yang tidak tepat dapat mendorong peristiwa resistensi. Resistensi yang terjadi pada Proteus mirabilis, Pseudomonas aeruginosa dan Escherichia coli pada isolat pasien UKD mendorong peneliti untuk mencari alternative antibiotik yang bersumber dari bahan alam.Tujuan: Mengetahui profil metabolit sekunder secara kromatografi lapis tipis, indeks busa, total fenol, total flavonoid dan aktivitas antibakteri bambu (B. vulgaris) melalui nilai  Kadar Hambat Minimum (KHM) ekstrak etanol daun bambu terhadap bakteri E. coli, P. aeruginosa dan P. mirabilis.Metode: Uji Fenol, Flavonoid dan Triterpenoid menggunakan metode KLT. Pengujian saponin dilakukan dengan metode uji indeks busa, indeks ikan, dan indeks hemolitik. Pengujian Flavonoid total menggunakan metode Chang dan Fenol total dengan menggunakan reagen Follin Ciocalteau kemudian dilanjutkan dengan menggunakan spektrofotometer. Uji aktivitas antibakteri dengan menggunakan metode difusi agar. Hasil: Pada profil kromatografi diperoleh senyawa fenol, flavonoid, dan triterpenoid; indeks saponin diperoleh indeks busa sebesar 333; indeks ikan sebesar 200; dan indeks hemolitik sebesar 1.111. Pengujian fenol total sebesar 16,05±3,12% Asam Galat Ekuivalen (AGE)dan Flavonoid total sebesar 2,42±0,44% Kuarsetin Ekuivalen (KE). Uji aktivitas antibakteri diperoleh nilai MIC sebesar 60 mg/ml untuk bakteri E. coli ; 100 mg/ml untuk bakteri P. aeruginosa ; dan 30 mg/ml P. mirabilis.Kesimpulan: Kandungan metabolit sekunder yang terdapat pada ekstrak etanol daun bambu adalah flavonoid, fenol, saponin, dan triterpenoid. Ekstrak etanol daun bambu memiliki potensi menghasilkan aktivitas antibakteri terhadap bakteri patogen gram negatif isolat pasien luka diabetesKata kunci : Bambusa vulgaris Schrad ex.J.C, fenol total, flavonoid total, KHM</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/14843</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art10</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 96-106</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/14843/11444</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/14946</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The design of bioactive marine peptides as a HIV-1 protease inhibitor</dc:title>
	<dc:creator>Fakih, Taufik Muhammad</dc:creator>
	<dc:creator>Dewi, Mentari Luthfika</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV or AIDS) is a disease related to the human immune system. Given its important role in viral replication, HIV1 protease (HIV1 PR) becomes the major therapeutic target in the treatment of AIDS. In this case, we need a dynamic aspect of molecular interactions that can demonstrate the important role of conformational variability in the design of HIV1 PR inhibitors. There are several inhibitor candidates from marine organisms, such as the LLEYSL and LLEYSI bioactive peptides produced by oysters (Crassostrea gigas).Objective: Proteinpeptide docking method was used in silico to identify, evaluate, and explore the molecular interactions between bioactive peptide molecules and HIV-1 protease macromolecules.Methods: The sequencing of bioactive peptide molecules was modeled into 3D conformation using the PEPFOLD software. The best conformation was chosen for the study of molecular interactions against HIV1 protease macromolecules using the PatchDock software. The molecular interactions formed were further observed using the BIOVIA Discovery Studio 2020 software.Results: The results of this study indicated that the LLEYSL bioactive peptide had the best affinity with an ACE score of minus 1284.70 kJ per mol.Conclusion: Bioactive peptide molecule is predicted to be a candidate for HIV1 protease inhibitor.Keywords: AIDS, HIV1 protease, bioactive peptides, protein-peptide docking, in silico Intisari Latar belakang: Infeksi human immunodeficiencyvirus/acquired immunodeficiency syndrome (HIVor AIDS) adalah penyakit yang berkaitan dengan sistem kekebalan tubuh pada manusia. Mengingat perannya yang penting dalam replikasi virus, HIV1 protease (HIV1 PR) merupakan target terapi utama dalam pengobatan AIDS. Dalam hal ini, maka diperlukan aspek dinamis dari interaksi molekuler yang dapat menunjukkan peran penting dari variabilitas konformasi dalam desain inhibitor HIV-1 PR. Terdapat beberapa kandidat inhibitor yang berasal dari organisme laut, seperti peptida bioaktif LLEYSL dan LLEYSI yang dihasilkan oleh tiram (Crassostrea gigas). Tujuan: Metode penambatan molekuler berbasis protein-peptida dilakukan untuk mengdentifikasi, mengevaluasi, dan mengeksplorasi interaksi molekuler antara molekul peptida bioaktif dengan makromolekul HIV1 protease secara in silico.Metode: Sekuensing molekul peptida bioaktif terlebih dahulu dimodelkan menjadi konformasi 3D dengan menggunakan software PEPFOLD. Konformasi terbaik dipilih untuk kemudian dilakukan studi interaksi molekuler terhadap makromolekul HIV1 protease dengan menggunakan software PatchDock. Interaksi molekuler yang terbentuk diamati lebih lanjut dengan menggunakan software BIOVIA Discovery Studio 2020.Hasil: Hasil dari penelitian ini menunjukkan bahwa peptida bioaktif LLEYSL memiliki afinitaspaling baik dengan ACE score sebesar minus 1284,70 kJ per mol.Kesimpulan:Dengan demikian, molekul peptida bioaktif tersebut diprediksi dapat dijadikan sebagai kandidat inhibitor HIV1 protease.Kata kunci : AIDS, HIV1 protease, peptida bioaktif, penambatan molekuler berbasis protein-peptida, in silico.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/14946</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art6</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 160-172</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/14946/11888</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/14968</identifier>
				<datestamp>2021-07-31T16:44:00Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Isolation of alkaloids compound of ethanol extract of mangrove perepat  (S. alba) root and its antibacterial activity</dc:title>
	<dc:creator>Latief, Madyawati</dc:creator>
	<dc:creator>Muhaimin, Muhaimin</dc:creator>
	<dc:creator>Amanda, Hilda</dc:creator>
	<dc:creator>Tarigan, Indra Lasmana</dc:creator>
	<dc:creator>Aisyah, Siti</dc:creator>
	<dc:description xml:lang="en-US"> Abstract  Background: Exploration of the chemical contents and bioactivities of mangrove plants is important to discover new therapeutic agents for society and to develop its medicinal values.Objective: This study aims to isolate alkaloid compounds from the ethanol extract of Sonneratia alba root which is likely to have an antibacterial activity.Methods: Isolation was carried out using fractionation and chromatography, while antibacterial activity test was performed using the disc diffusion methods.Results: Our phytochemical screening shows that the ethanol extract has a high concentration of alkaloid compounds. The alkaloid which contain in isolate (F4) is further confirmed through UV-Vis Spectra and FT-IR spectra. The ethanol extract exhibits the antibacterial activity against S.  aureus and E.  coli with the inhibition zone of 1.5 mm and 2.5 mm, respectively.Conclusion: Alkaloid compound has been isolated from Sonneratia alba and has potential as antibacterial agent.Keywords: mangrove perepat (Sonneratia alba), alkaloid, antibacterial agent Intisari Latar Belakang: Eksplorasi kandungan kimiawi dan bioaktivitas tanaman mangrove penting dilakukan untuk menemukan agen terapeutik baru bagi masyarakat serta mengembangkan nilai medisnya.Tujuan: Penelitian ini bertujuan untuk mengisolasi senyawa alkaloid dari ekstrak etanol akar Sonneratia alba yang berpotensi menghasilkan aktivitas antibakteri.Metode: Isolasi senyawa dilakukan dengan fraksinasi dan kromatografi, sedangkan antibakteri dilakukan dengan metode difusi cakram.Hasil: Hasil skrining fitokimia yang telah dilakukan menunjukkan bahwa ekstrak etanol memiliki kandungan  alkaloid yang tinggi. Kandungan alkaloid dalam Isolat (F4) telah dikonfirmasi secara spektrofotometri UV-Vis dan FT-IR. Aktivitas antibakteri ekstrak etanol terhadap S.  aureus dan E.  coli ditunjukkan dengan dihasilkannya zona hambat sebesar 1,5 mm dan 2,5 mm.Kesimpulan: Senyawa alkaloid berhasil diisolasi dari Sonneratia alba serta memiliki potensi sebagai agen antibakteri.Kata Kunci: mangrove perepat (Sonneratia alba), alkaloid, antibakteri</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-03-17</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/14968</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art2</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 9-18</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/14968/11094</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/14981</identifier>
				<datestamp>2020-12-31T11:47:54Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Solid dispersion of quercetin-PVP K-30 and its effects on the antioxidant activity</dc:title>
	<dc:creator>Gayo, Zahara</dc:creator>
	<dc:creator>Lucida, Henny</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Quercetin (3,3’,4’,5,7-pentahydroxil-flavon) is a flavone and secondary metabolite known as flavonoid. Quercetin belongs to class II BCS that has low solubility and high permeability. The poor solubility of quercetin restricts the accessibility and bioavailability.Objectives: To increase the solubility, dissolution, and antioxidant activity in a solid dispersion system.Methods: Preparation of quersetin-PVP K-30 solid dispersion was conducted using the freeze-drying method at -96 degree C for 24 hours with a ratio of 1:1, 1:0.5, and 0.5:1 and a 1:1 physical mixture of quercetin-PVP K-30. The solid dispersion of quercetin-PVP K-30 was characterized by Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD) analysis, and FT-IR spectrophotometric analysis. Solubility test was analyzed using a UV-Vis spectrophotometer, dissolution test was done using a paddle-type dissolution tester, dissolved quercetin concentrations were analyzed using a UV-Vis spectrophotometer, and antioxidant activity was determined using the DPPH method in a UV-Vis spectrophotometer.Results: SEM analysis showed the formation of quercetin-PVP K-30 solid dispersion using the freeze-drying method, and the form changed into anhydrate as seen from the XRD results with the presence of new crystalline peaks in solid dispersion, which were not seen in pure quercetin and PVP K-30. Quercetin-PVP K-30 solid dispersion could increase the solubility by 54-fold at a ratio of 0.5:1 with 94.36%±0.85 quercetin dissolved in 120 minutes. The formation of this solid dispersion affected the antioxidant activity which was observable from the IC50 value at the best ratio of 0.5:1 reaching 0.714 microgram/mL while the IC50 value of pure quercetin is 1.102 microgram/mL.Conclusion: The formation of quercetin solid dispersion could increase the solubility and dissolution and affect the antioxidant activity.Keywords: solid dispersion, freeze-drying, quercetin, antioxidantIntisariLatar Belakang: Kuersetin (3,3’,4’,5,7-pentahydroxil flavon) adalah flavon dan merupakan metabolit sekunder yang dikenal dengan flavonoid. Kuersetin tergolong dalam BCS kelas II yaitu memiliki kelarutan rendah dan permeabilitas tinggi (low solubility and high permeability drugs), kelarutan kuersetin yang buruk membatasi aksesibilitas dan bioavailabilitasnya.Tujuan: Untuk meningkatkan kelarutan dan disolusi kuersetin serta melihat pengaruhnya terhadap aktivitas antioksidan kuersetin.Metode: Pembuatan dispersi padat menggunakan metode freeze dry pada suhu -96 derajat C selama 24 jam.Hasil: Dengan pembuatan disepersi padat kuersetin-PVP K-30 dapat meningkatkan kelarutan, disolusi dan dapat meningkatkan aktivitas antioksidan kuersetin.Kesimpulan: Uji statistik menggunakan ANOVA dua arah menunjukkan uji kelarutan dan disolusi pada pembentukan dispersi padat kuersetin-PVP K-30 terdapat perbedaan yang signifikan (p= 0,000 (Sig&amp;lt;0,05)).Kata Kunci: Dispersi padat, Freeze Dry, Kuersetin, Antioksidan</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-12-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/14981</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art6</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 144-154</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/14981/10678</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15015</identifier>
				<datestamp>2020-12-31T11:46:04Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Acute toxicity test ethanol extract of kerehau leaf (Callicarpa longifolia Lamk) using OECD 420 method</dc:title>
	<dc:creator>Istiqomah, Aulia Nurfazri</dc:creator>
	<dc:creator>Safitri, Shintya</dc:creator>
	<dc:creator>Susilawati, Elis</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Kerehau is empirically used as cooling powder to treat acne. Based on previous research, kerehau leaves have a number of activities, including wound healing, antidiabetic, and anti-inflammatory.Objectives: This study aimed to determine the safety level of a single dose of ethanol extract of kerehau leaves within a 24-hour administration period.Methods: Acute toxicity testing of ethanol extract of kerehau leaves was carried out on female Webster mice. Test animals were divided into 4 treatment groups, consisting of 1 control group and 3 test groups. The testing method referred to OECD (Organization of Economic Cooperation and Development) 420 with modified doses of 2000mg/kgBW, 5000 mg/kgBW, and 8000 mg/kgBW. The observations were made on the behaviour of animals towards toxicity symptoms for 4 hours after administration of the test substance as well as death. The death and weight gain were observed for 14 days. On the 15th day, animals were sacrificed, blood was taken, and biochemical parameters were measured. The heart, kidneys, liver, spleen, and lungs were harvested and weighed. Data was analysed using Oneway ANOVA continued with LSD and Post Hoc.Results: The results showed that ethanol extract of kerehau leaves did not cause death in all of the groups. There were significant differences in liver weight, SGPT, and SGOT levels (p&amp;lt; 0.05) at the dose of 5000 mg/kgBW. No toxicity symptoms and death were found until the end of the experiment.Conclusion: LD50 value of ethanol extract of kerehau leaves was above 8000 mg/kgBW with heart as the most affected organ.Keywords: Ethanol extract of kerehau leaves, acute toxicity test, OECD 420.Latar Belakang : Beragam  khasiat yang dimiliki daun kerehau menjadi dasar dilakukannya uji toksisitas akut untuk mengetahui adanya potensi toksik dan organ sasaran yang dipengaruhi.Metode : Metode pengujian toksisitas akut diadaptasi dari OECD 420 dengan dosis 2000 mg/kgbb, 5000 mg/kgbb dan 8000mg/kgbb. Pengamatan dilakukan  terhadap gejala toksik yang muncul, kematian dan berat badan. Pada hari ke-15 dilakukan pengukuran SGPT, SGOT , kreatinin dalam darah, indeks organ jantung, ginjal, hati, limpa dan paru-paru serta histopatologi organ hati dan ginjal.Hasil : Hasil penelitian menunjukkan ekstrak etanol daun kerehau mempengaruhi organ hati secara bermakna namun tidak menyebabkan kematian hingga dosis 8000mg/kgbb.Kata kunci : Ekstrak etanol, daun kerehau, toksisitas akut, OECD 420.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-10-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15015</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art2</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 105-111</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15015/10589</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15042</identifier>
				<datestamp>2020-12-31T11:44:09Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Treatment pattern and direct medical costs of pediatric outpatients  with actuate respiratory infection at X hospital in Jambi</dc:title>
	<dc:creator>Pranata, Hendri</dc:creator>
	<dc:creator>Rasmaladewi, Rasmaladewi</dc:creator>
	<dc:creator>Sanuddin, Mukhlis</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Introduction: Acute respiratory infection is common among the general public. Such disease and its associated symptoms encourage higher consumption of medicine. Varied medications for ARI patients incur different costs of each patient, which eventually lead to higher healthcare costs.Objectives: To identify the treatment patterns and direct medical costs among ARI pediatric patients at X Hospital in Jambi. Methods: This research was an observational study with retrospective data collection. The samples were collected in 2018.Results: The results showed that the most-frequently administered antibiotic for ARI pediatric patients was cefixime (29.17%), while the most-commonly used supportive therapy for ARI pediatric patients was the combination of antihistamines, antipyretics-analgesics, decongestant, and corticosteroid (16.67%). The total direct medical cost to ARI pediatric patients was IDR 191,097.Conclusion: The mean direct medical cost for ARI therapy was IDR 191,097. More administered therapy resulted in higher medical costs.Keywords: ARI, child, antibiotics, direct medical costs IntisariLatar belakang: Infeksi saluran pernafasan akut merupakan penyakit yang umum terjadi pada setiap kalangan masyarakat. Infeksi saluran pernafasan akut dan juga gejala yang di timbulkannya mengakibatkan tinggi nya penggunaan obat-obatan. Bervariasinya obat yang di konsumsi oleh pasien ISPA menyebabkan pembebanan biaya yang beragam dari setiap pasien yang pada akhirnya akan mempengaruhi beban biaya kesehatan yang akan ditanggung.Tujuan: Untuk mengetahui pola pengobatan dan biaya medis langsung pasien ISPA anak rawat jalan di Rumah Sakit X Jambi.Metode: Penelitian ini merupakan penelitian observasional dengan pengumpulan data dilakukan secara retrospektif. Sampel diambil pada tahun 2018.   Hasil: Hasil penelitian didapatkan bahwa antibiotik yang paling banyak digunakan pada pasien anak penderita ISPA adalah sefiksim sebesar 29,17%. Sedangkan terapi suportif yang paling banyak digunakan untuk pasien anak ISPA adalah kombinasi golongan antihistamin, antipiretik analgetik, dekongestan, kortikosteroid sebanyak 16,67%. Biaya total rata-rata medis langsung pada pasien ISPA anak rawat jalan yaitu sebesar Rp. 191.097.Kesimpulan: Biaya medis langsung yang harus dikeluarkan untuk terapi pada penyakit ISPA yaitu rata-rata sebesar Rp. 191.097. Semakin banyak terapi yang di berikan maka semakin tinggi pula biaya yang akan dikeluarkan.Kata kunci: ISPA, anak, antibiotik, biaya medis langsung</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15042</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art10</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 196-203</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15042/10818</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15042/12823</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15210</identifier>
				<datestamp>2021-07-31T16:47:42Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparison between monotherapy and combination therapy among inpatients  with community-acquired pneumonia</dc:title>
	<dc:creator>Syahniar, Rike</dc:creator>
	<dc:creator>Nabila, Audia Nizhma</dc:creator>
	<dc:creator>Kharisma, Dayu Swasti</dc:creator>
	<dc:creator>Akbar, Muhammad Afif</dc:creator>
	<dc:description xml:lang="en-US">Background: Pneumonia causes high mortality, hospitalization costs and health services. There is some growing debate regarding the efficacy of different treatment management approaches. The use of certain antibiotic regimens combination and monotherapy have been associated with improved outcomes.Objective: This study aims to determine the effectiveness of monotherapy and combination therapy on length of stay.Method: This retrospective study included patients with Community Acquired Pneumonia (CAP) who received empirical therapy between January - December 2017 at Jakarta Islamic Hospital of Cempaka Putih. Two hundred and ninety four subjects were included in this study.Results: Subjects who received monotherapy and combination therapy were 73.8% and 26.2%. Mean length of stay was 5 days. The most widely used antibiotic in this study was ceftriaxone with levofloxacin (35%) for combination therapy and levofloxacin (38,2%) for monotherapy. There is a relationship between comorbidities and long-term hospitalization (p=0.008).Conclusion: There was no significant difference between combination therapy and monotherapy with length of stay (p=0.277).Keywords: Pneumonia, monotherapy, combination therapy, Jakarta Islamic Hospital of Cempaka PutihIntisariLatar belakang: Pneumonia menyebabkan tingginya angka kematian, biaya rawat inap dan pelayanan kesehatan. Terdapat beberapa perdebatan yang berkembang mengenai efikasi pendekatan manajemen pengobatan yang berbeda. Penggunaan kombinasi rejimen antibiotik tertentu dan monoterapi telah dikaitkan dengan hasil yang lebih baik.Tujuan: untuk menentukan efektivitas monoterapi dan terapi kombinasi terhadap lama rawatinap.Metode: Penelitian retrospektif ini melibatkan pasien dengan community acquired pneumonia yang menerima terapi empiris antara Januari - Desember 2017 di Rumah Sakit Islam Jakarta (RSIJ) Cempaka Putih.Hasil: Dua ratus sembilan puluh empat subjek dilibatkan dalam penelitian ini. Subyek yang menerima monoterapi dan terapi kombinasi sebesar 73,8% dan 26,2%. Rerata lama rawat inap pada kelompok monoterapi dan dualterapi yaitu 5 hari. Antibiotik yang paling banyak digunakan dalam penelitian ini yaitu seftriakson dengan levofloksasin (35%) untuk terapi kombinasi dan levofloksasin (38,2%) untuk monoterapi. Terdapat hubungan antara komorbid dengan lama rawat inap (p=0,008).Kesimpulan: Tidak terdapat perbedaan bermakna antara terapi kombinasi dan monoterapi dengan lama rawat inap (p=0,277)Kata kunci : Pneumonia, monoterapi, terapi kombinasi, RSIJ Cempaka Putih</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15210</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art6</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 56-63</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15210/11415</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15210/12841</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15492</identifier>
				<datestamp>2020-12-31T11:44:48Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Standardization parameters for cocoa pods (Theobroma cacao L.)</dc:title>
	<dc:creator>Azah, Nida Isti</dc:creator>
	<dc:creator>Muchtarichie, Resmi</dc:creator>
	<dc:creator>Iskandar, Yoppi</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Background: Cocoa (Theobroma cacao L.) pods are a waste from chocolate production which has medicinal benefits. Cocoa pods have scientifically proved to have pharmacological activities.Objective: Standardization of plants to be used as medicine is required to control the quality and ensure the safety, efficacy, and quality.Methods: Data on the standardization parameters of cocoa pods were collected from journals published during the period 2010-2020 by searching in Google, Google Scholar, and Research Gate.Results: Standardization parameters of cocoa pods consisted of macroscopic and microscopic examinations, ash content, solute concentration in solvents, phytochemical screening, and thin layer chromatography.Conclusion: Macroscopic examination showed that the skin of cacao fruit has a brownish-yellow color and purplish red, a specific odor, and a bitter taste with four forms, namely amelonado, angoleta, cundeamor, and calabacil. Microscopic examination showed a collection of stone cells and hair covering. The moisture content of cocoa pods fulfills the requirement which is below 10%. The total ash content is 5.80 - 7.41, and the acid-insoluble ash content is 0.45 - 0.64. The concentration of solute in water is higher than in ethanol with 22.69 and 5.21, respectively. The phytochemical screening showed that cocoa pods have flavonoids, saponins, quinones, tannins, steroids, triterpenoids, monoterpenes, and sesquiterpenes. The thin-layer chromatography indicated the presence of phenolic compounds, catechol tannins, flavonoids, and terpenoids.Keywords: Cocoa pods, standardization, Theobroma cacao IntisariLatar belakang: Kulit buah kakao (Theobroma cacao L.) merupakan limbah dari produksi cokelat yang bermanfaat sebagai obat dan terbukti secara ilmiah memiliki berbagai aktivitas farmakologi.Tujuan: Standardisasi tanaman yang akan digunakan sebagai obat berguna untuk mengontrol kualitas serta memastikan keamanan, khasiat, dan mutunya.Metode: Data parameter standar kulit buah kakao dikumpulkan dari jurnal yang diterbitkan selama kurun waktu 2010-2020 dengan pencarian menggunakan situs pencarian seperti google, google scholar, dan researchgate.Hasil: Parameter standardisasi kulit buah kakao meliputi pemeriksaan makroskopik, mikroskopik, nilai kadar abu, kadar zat terlarut dalam pelarut, penapisan fitokimia, dan kromatografi lapis tipis.Kesimpulan: Pemeriksaan makroskopik, kulit buah kakao memilki warna kuning kecokelatan dan merah keunguan, bau khas, rasa pahit, dengan empat bentuk yaitu amelonado, angoleta, cundeamor, dan calabacil. Pemeriksaan mikroskopik menunjukkan adanya kumpulan sel batu dan rambut penutup. Kadar air kulit buah kakao sesuai dengan syarat yaitu berada dibawah 10%. Nilai kadar abu total 5,80 - 7,41 dan kadar abu tak larut asam 0,45 - 0,64. Kadar zat terlarut dalam air lebih tinggi dari etanol dengan nilai masing-masing 22,69 dan 5,21. Dari hasil penapisan fitokimia kulit buah kakao menunjukkan adanya senyawa flavonoid, saponin, kuinon, tannin, steroid, triterpenoid, monoterpen dan seskuiterpen. Pada kromatografi lapis tipis menunjukkan adanya senyawa fenolik, tannin katekol, flavonoid, dan terpenoid.Kata kunci : Kulit buah kakao, standardisasi, Theobroma cacao</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15492</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art9</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 182-195</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15492/10812</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15492/12877</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15492/12878</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15715</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Cost consequences analysis of hypertensive outpatients: a study in a private hospital in Yogyakarta special province</dc:title>
	<dc:creator>Pratidina, Dinasari Bekti</dc:creator>
	<dc:creator>Suryanegara, Fithria Dyah Ayu</dc:creator>
	<dc:creator>Nugraheni, Diesty Anita</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Background: Hypertension is a chronic disease that requires long-term treatment and has an impact on the cost of treatment. The costs will be greater given the loss of productivity, family burden, and social life impacted by hypertension based on patient’s perspective.Objective: The purpose of the study was to determine the costs and clinical outcome of antihypertensive therapy from the patient's perspective and to identify the discrepancies between the costs and the INA-CBGs (Indonesia Case Based Groups) tariff.Methods: The research was an observational study with a cross-sectional design. The targeted population was outpatients who had received antihypertensive therapy for at least 1 month at a private hospital in Yogyakarta. The costs included direct medical costs, direct non-medical costs, and indirect costs, while the clinical outcomes were patient’s blood pressure. The descriptive analysis was carried out to describe the characteristics of the research subjects, the clinical outcome, and the cost. Analysis of the discrepancies between the costs and the INA-CBGs tariff used the Mann-Whitney test and One-Sample t-test.Results: The results showed that the average direct medical costs, direct non-medical costs, and indirect costs from the patient’s perspective were IDR359,408.00, IDR24,617.00, and IDR 40,583.00, respectively. There was a significant difference between the real costs and the rate of INA-CBGs based on the results of statistical tests, while the cost discrepancy was IDR5,287,045.00.Conclusion: The direct non-medical costs and indirect costs of hypertensive outpatients were less than the direct medical costs.  A significant difference occurred between the real costs and INA CBG’s tariff.Keywords: hypertension, cost consequences, pharmacoeconomics, patient’s perspectiveIntisari  Latar belakang: Hipertensi termasuk penyakit kronis yang membutuhkan waktu pengobatan panjang dan biaya besar. Biaya akan lebih besar karena pasien kehilangan produktivitas, beban pada kehidupan keluarga dan masyarakat akibat penyakit hipertensi berdasarkan perspektif pasien.Tujuan: Penelitian bertujuan untuk mengetahui gambaran biaya dan outcome terapi antihipertensi berdasarkan perspektif pasien serta kesesuaian biaya riil dengan tarif INA-CBGs.Metode: Desain penelitian adalah observasional dengan rancangan cross-sectional. Populasi penelitian adalah pasien hipertensi rawat jalan di satu rumah sakit swasta Yogyakarta yang menerima terapi antihipertensi selama minimal 1 bulan. Analisis deskriptif digunakan untuk menggambarkan karakteristik subjek penelitian, outcome terapi, dan biaya terapi. Analisis kesesuaian biaya riil  dengan tarif INA-CBGs dengan uji statistik Mann Whitney dan One Sample t-test.Hasil: Hasil penelitian menunjukkan rata-rata biaya langsung medis, biaya non medis langsung, dan biaya tidak langsung berdasarkan perspektif pasien berturut-turut adalah Rp.359.408,00; Rp.24.617,00; dan Rp.40.583,00. Outcome terapi tertinggi ditunjukkan antihipertensi tunggal Calcium Channel Blocker (CCB) (60%). Terdapat perbedaan secara statistik antara biaya riil dengan tarif INA-CBGs (p=0,009 dan p=0,004) dan selisih biaya sebesar (Rp.5.287.045,00).Kesimpulan:Biaya nonmedis langsung dan biaya tidak langsung pasien hipertensi rawat jalan tidak sebesar biaya medis langsung. Perbedaan signifikan antara biaya riil dan tarif INACBG’s menjadi bahan evaluasi perbaikan tarif INACBG’s bagi BPJS Kesehatan. Hasil tersebut juga memicu pihak rumah sakit untuk melakukan evaluasi terhadap clinical pathway agar dapat memberikan terapi yang lebih efektif dan efisien.Kata kunci: hipertensi, cost consequences, farmakoekonomi, perspektif pasien</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15715</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art2</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 116-126</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15715/11887</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15720</identifier>
				<datestamp>2020-12-31T11:48:57Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">JPH203 as a potential L-Type Amino Acid Transporter 1 (LAT 1) inhibitor in the development of cancer theragnostic compounds</dc:title>
	<dc:creator>Pertiwi, Yolanda</dc:creator>
	<dc:creator>Rahayu, Driyanti</dc:creator>
	<dc:creator>Sriyani, Maula Eka</dc:creator>
	<dc:creator>Indradi, Raden Bayu</dc:creator>
	<dc:creator>Holik, Holis Abdul</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Cancer has become a major cause of global health problems. Latest research currently focuses on an approach to cancer therapy that involves specific target molecules and theragnostic (therapy and diagnostic) agents. Among the specific target molecules in cancer therapy is LAT1, which is over expressed in cancer cells but under expressed in normal cells. Therefore, LAT1 inhibition can become an alternative to cancer therapy. A number of studies have shown that JPH203 specifically inhibits LAT1, thus reducing amino acid absorption into cancer cells and inhibiting cancer cell growth.Objective: The main objective of this literature study was to determine the potential of JPH203 as a LAT1 inhibitor to be developed into a novel theragnostic agent for cancer.Methods: Various studies were summarized to outline the development of JPH203 as a therapy targeting LAT1 and potential candidate of theragnostic compounds.Results: The results of the literature study showed that JPH203 as a selective LAT1 inhibitor was able to efficiently suppress the growth of cancer cells with a low IC50 value.Conclusion: The activity of LAT1 as an amino acid transporter of cancer cells could be selectively inhibited by JPH203, thereby allowing JPH203 to be reconsidered as a potential therapy in the development of theragnostic compounds against cancer.Keywords: JPH203, theragnostic, LAT1 inhibitorIntisariLatar belakang: Kanker telah menjadi penyebab masalah kesehatan utama di dunia. Saat ini penelitian terbaru berfokus pada pendekatan terapi kanker yang melibatkan molekul target yang spesifik dan menggunakan senyawa teranostik (terapi dan diagnostik). Salah satu molekul target spesifik dalam terapi kanker adalah LAT1 yang terekspresi berlebih pada sel kanker, namun sedikit pada sel normal. Oleh karena itu, inhibisi LAT1 dapat menjadi alternatif terapi kanker. Beberapa penelitian menunjukkan inhibitor yang secara spesifik menghambat LAT1 adalah JPH203, sehingga penyerapan asam amino ke dalam sel kanker dapat berkurang dan menghambat pertumbuhan sel kanker.Tujuan: Tujuan utama dari studi literatur ini adalah untuk mengetahui potensi JPH203 yang merupakan inhibitor LAT1 dalam perannya sebagai senyawa teranostik baru terhadap penyakit kanker.Metode: Berbagai penelitian dirangkum mengenai pengembangan JPH203 sebagai terapi pentarget-LAT1 dan potensinya sebagai kandidat senyawa teranostik.Hasil: Hasil studi literatur yang dilakukan menunjukkan bahwa JPH203 sebagai inhibitor selektif LAT1 mampu menekan pertumbuhan sel kanker secara efisien dengan didapatkan hasil IC50 yang rendah.Kesimpulan: Aktivitas LAT1 sebagai transporter asam amino sel kanker dapat dihambat secara selektif oleh JPH203, sehingga dapat dipertimbangkan kembali sebagai target terapi potensial yang dapat digunakan dalam pengembangan senyawa teranostik kanker.Kata kunci : JPH203, teranostik, inhibitor LAT1</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-12-09</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15720</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art8</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 167-181</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15720/10729</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15720/12917</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15720/12918</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/15894</identifier>
				<datestamp>2020-12-31T11:46:58Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Assessment of physicochemical properties and comparison of the dissolution profile of amoxicillin caplets</dc:title>
	<dc:creator>Widiyasari, Een</dc:creator>
	<dc:creator>Sulaiman, Teuku Nanda Saifullah</dc:creator>
	<dc:description xml:lang="id-ID">Background: Marketed drugs must meet the required standards to guarantee product quality. Amoxicillin is a generic compound marketed under various trademarks as copy drugs. Amoxicillin caplets are an immediate release dosage form of BCS class I. An essential aspect of evaluating copy drugs is to assess the equivalence for their treatment to the innovator drugs to ensure the safety and effectiveness of the circulating copy drugs.Objective: The study aims to evaluate the physicochemical properties and compare the dissolution profile of amoxicillin caplets available in the market.Methods: Five amoxicillin caplet products, four test products, and one reference product were tested for their physicochemical properties and dissolution. The dissolution test was carried out with a type II device at a speed of 75 rpm in 900 mL of media buffered at pH 1.2, 4.5, and 6.8 and at a temperature of 37 +/- 0.5degrees celcius. The dissolution profile was analyzed by comparing it with the similarity factor (f2) parameters.Results: Two of the four amoxicillin caplet products had a similar dissolution profile to the reference products, namely products A and B. Products C and D were dissimilar because f2 was lower than 50 at pH 4.5. The caplets tested had almost the same dimensions, and all caplets met the requirements for uniformity of content, hardness, disintegration time, and dissolution.Conclusion: Not all of the amoxicillin caplets in the market have a similar dissolution profile to the reference products. Keywords: caplets, amoxicillin, dissolution, similarity factor Intisari Latar belakang: Sediaaan obat yang dipasarkan harus memenuhi standar yang ditetapkan untuk menjamin kualitas produk. Amoksisilin merupakan senyawa generik, dipasarkan dengan berbagai merek dagang yang merupakan obat copy. Kaplet amoksisilin merupakan sediaan dengan pelepasan segera yang termasuk dalam BCS kelas I. Komponen penting dalam mengevaluasi obat copy yaitu menilai kesetaraan terapinya terhadap obat inovator sehingga dapat menjamin bahwa obat copy yang beredar aman dan efektif. Tujuan: Penelitian ini bertujuan untuk mengevaluasi sifat fisika kimia dan uji disolusi terbandingkan sediaan kaplet amoksisilin yang beredar dipasaran.Metode: Sebanyak 5 produk kaplet amoksisilin, 4 produk uji dan 1 produk pembanding diuji sifat fisika kimia dan disolusinya. Uji disolusi dilakukan dengan alat tipe II dengan kecepatan 75 rpm dalam 900 mL media yang dibuffer pada pH 1,2; 4,5; dan 6,8 dan suhu 37 +/- 0,5derajat celcius. Profil disolusi dianalisis dengan membandingkan profil disolusi dengan parameter similiarity factor (f2).Hasil: Hasil penelitian menunjukkan 2 produk dari 4 produk kaplet amoksisilin  memiliki kemiripan profil disolusi terhadap produk pembanding yaitu produk A dan B, sementara 2 produk yang lain tidak memiliki kemiripan karena nilai f2 kurang dari sama dengan 50 pada pH 4,5 (produk C dan D). Kaplet yang diuji memiliki dimensi yang hampir sama, semua kaplet memenuhi persyaratan keseragaman sediaan, kekerasan, waktu hancur dan disolusi.Kesimpulan: Kaplet amoksisilin yang beredar tidak semuanya memiliki kemiripan profil disolusi dibandingkan produk pembanding. Kata kunci : kaplet, amoksisilin, disolusi, similiarity factor</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-10-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/15894</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art4</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 118-129</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/15894/10590</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/16015</identifier>
				<datestamp>2020-12-31T11:48:24Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Selenium species in vegetables: benefits and toxicity for the body</dc:title>
	<dc:creator>Heryadi, Alya Luthfiyani</dc:creator>
	<dc:creator>Shalihat, Ayu</dc:creator>
	<dc:creator>Pratiwi, Rimadani</dc:creator>
	<dc:creator>Mutakin, Mutakin</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Background: Selenium is one of the essential trace elements in various biological body functions. The main source of Selenium in the body is food, one of which is vegetables. Vegetables collect Selenium from the soil which is then converted into various chemical species of Selenium. Such species should be recognized since each has different biological activities.Objective: The aim of this review was to identify chemical species of Selenium in vegetables as well as the benefits and toxicity for the body.Methods: Reference searches were done in Pubmed and Google Scholar databases with the keywords Selenium speciation in plants, selenite, selenate, selenomethionine, selenocystine, and se-methylselenocysteineResults: The results of speciation in several types of vegetables showed that the chemical species of Selenium abundantly found in vegetables were selenomethionine (SeMet), selenocystine (SeCys2) and se-methylselenocysteine (Se-MeSeCys), gamma-glutamyl-Se-methyl-selenocysteine, and inorganic species. Both Selenium-enriched vegetables and the species contained therein have a variety of benefits for the body. However, excessive consumption can also cause toxic effects.Conclusion: The chemical species of Selenium in vegetables can be either organic or inorganic. Both types of species have different benefits and toxic effects. Keywords: benefits, chemical species, Selenium, toxicity, vegetable Intisari  Latar belakang: Selenium merupakan salah satu trace element esensial yang penting pada berbagai fungsi biologi tubuh. Sumber utama Selenium dalam tubuh adalah makanan, salah satunya yaitu sayuran. Sayuran mendapatkan Selenium dari tanah yang kemudian diubah menjadi berbagai spesies kimia Selenium. Spesies kimia Selenium penting untuk diketahui karena setiap spesies memiliki aktivitas biologi yang berbeda Tujuan: Review ini ditujukan untuk mengetahui spesies kimia Selenium yang terdapat pada sayuran serta manfaat dan toksisitasnya bagi tubuh Metode: Penelusuran referensi dilakukan melalui database Pubmed dan Google Scholar, dengan kata kunci Selenium speciation in plant, selenite, selenate, selenomethionine, selenocystine, dan se-methylselenocysteineHasil: Hasil spesiasi pada beberapa sayuran menunjukkan spesies kimia Selenium yang banyak terdapat dalam sayuran adalah selenomethionine (SeMet), selenocystine (SeCys2), dan Se-methylselenocysteine (Se-MeSeCys), gamma-glutamyl-Se-methyl-selenocysteine, dan spesies anorganik. Baik sayuran yang diperkaya Selenium maupun spesies yang terkandung di dalamnya memiliki berbagai manfaat bagi tubuh. Namun konsumsi yang berlebih juga dapat menyebabkan efek toksik Kesimpulan: Spesies kimia Selenium yang terdapat pada sayuran dapat berupa spesies organik maupun spesies anorganik. Kedua jenis spesies ini memiliki manfaat serta efek toksik yang berbedaKata kunci : manfaat, sayuran, Selenium, spesies kimia, toksisitas</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2020-12-09</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/16015</dc:identifier>
	<dc:identifier>10.20885/jif.vol16.iss2.art7</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 16 No. 2 (2020): Jurnal Ilmiah Farmasi; 155-166</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16015/10724</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16015/12944</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/16552</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antibacterial activity of gempol (Nauclea orientalis L.) leaf ethanolic extract and its fractions against Escherichia coli and Staphylococcus aureus</dc:title>
	<dc:title xml:lang="id-ID">Uji aktivitas antibakteri ekstrak etanol dan fraksi daun gempol (Nauclea orientalis L.) terhadap bakteri Escherichia coli dan Staphylococcus aureus</dc:title>
	<dc:creator>Kristiningrum, Nia</dc:creator>
	<dc:creator>Noviriana, Reny Diastri</dc:creator>
	<dc:creator>Wulandari, Lestyo</dc:creator>
	<dc:subject xml:lang="en-US">Gempol</dc:subject>
	<dc:subject xml:lang="en-US">Nauclea orientalis</dc:subject>
	<dc:subject xml:lang="en-US">antibacterial</dc:subject>
	<dc:subject xml:lang="en-US">diffusion</dc:subject>
	<dc:subject xml:lang="id-ID">Gempol</dc:subject>
	<dc:subject xml:lang="id-ID">Nauclea orientalis</dc:subject>
	<dc:subject xml:lang="id-ID">antibakteri</dc:subject>
	<dc:subject xml:lang="id-ID">difusi</dc:subject>
	<dc:description xml:lang="en-US">Background: The leaves of gempol (N. orientalis L.), a family of Rubiaceae, have antibacterial activity. Objective: The aim of this research was to determine the antibacterial activity of gempol leaf ethanolic extract and its fractions. Methods: The antibacterial activity test was carried out using the disk diffusion method. The positive and negative controls used were a disk of 10 μg gentamicin and 10% DMSO solution, respectively. The test solution concentrations for each sample, including for the ethanolic extract, hexane fraction, ethyl acetate, and residue of gempol leaves, were 0.25%, 0.5%, 1%, 2%, and 5%. Results: The antibacterial activity of the ethanolic extract, hexane fraction, ethyl acetate fraction, and residue of gempol leaves against E. coli and S. aureus was significantly different from each other. The residue had the highest antibacterial activity followed by that of the ethyl acetate fraction, hexane fraction, and ethanolic extract. Conclusion: The antibacterial activity of gempol leaves against S. aureus was greater than against E. coli.Keywords: Gempol, Nauclea orientalis, extract, fractions, antibacterial, diffusion
IntisariLatar Belakang: Daun gempol (N. orientalis L.) merupakan salah satu famili Rubiaceae yang telah diketahui memiliki aktivitas anthelmintik dan antibakteri.Tujuan: penelitian ini adalah untuk mengetahui aktivitas antibakteri berdasarkan zona hambat ekstrak etanol dan fraksi daun gempol.Metode: yang digunakan ialah metode difusi cakram yang menghasilkan diameter zona hambat sebagai hasil dari uji aktivitas antibakteri. Kontrol positif yang digunakan yaitu cakram gentamisin 10 μg sedangkan kontrol negatif yang digunakan yaitu DMSO 10%. Larutan uji meliputi ekstrak etanol, fraksi heksana, etil asetat, dan residu daun gempol dengan masing-masing konsentrasi yaitu 0,25%; 0,5%; 1%; 2%; dan 5%.Hasil: Aktivitas antibakteri dari ekstrak etanol, fraksi heksan, etil asetat dan residu daun gempol terhadap E. coli dan S. aureus menunjukkan perbedaan yang signifikan. Residu memiliki aktivitas antibakteri tertinggi diikuti oleh fraksi etil asetat, fraksi heksana dan ekstrak etanol.Kesimpulan: Aktivitas antibakteri pada S. aureus lebih besar dari pada E. coli.Kata kunci: Gempol, Nauclea orientalis, ekstrak, fraksi, antibakteri, difusi</dc:description>
	<dc:description xml:lang="id-ID">


Latar Belakang: Daun gempol (N. orientalis L.) merupakan salah satu famili Rubiaceae yang telah diketahui memiliki aktivitas anthelmintik dan antibakteri.
Tujuan: penelitian ini adalah untuk mengetahui aktivitas antibakteri berdasarkan zona hambat ekstrak etanol dan fraksi daun gempol.




Metode: yang digunakan ialah metode difusi cakram yang menghasilkan diameter zona hambat sebagai hasil dari uji aktivitas antibakteri. Kontrol positif yang digunakan yaitu cakram gentamisin 10 μg sedangkan kontrol negatif yang digunakan yaitu DMSO 10%. Larutan uji meliputi ekstrak etanol, fraksi heksana, etil asetat, dan residu daun gempol dengan masing-masing konsentrasi yaitu 0,25%; 0,5%; 1%; 2%; dan 5%.
Hasil: Aktivitas antibakteri dari ekstrak etanol, fraksi heksan, etil asetat dan residu daun gempol terhadap E. coli dan S. aureus menunjukkan perbedaan yang signifikan. Residu memiliki aktivitas antibakteri tertinggi diikuti oleh fraksi etil asetat, fraksi heksana dan ekstrak etanol.
Kesimpulan: Aktivitas antibakteri pada S. aureus lebih besar dari pada E. coli.



Kata kunci : Gempol, Nauclea orientalis, ekstrak, fraksi, antibakteri, difusi





</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/16552</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art1</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 1-12</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16552/13775</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/16732</identifier>
				<datestamp>2023-01-01T15:26:46Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US"> Review: Randomized Clinical Trial (RCT) study of influenza vaccine in children 6 to 35 months of age</dc:title>
	<dc:title xml:lang="id-ID">REVIEW: RANDOMIZED CLINICAL TRIAL STUDY OF INFLUENZA VACCINE IN CHILDREN AGE 6-35 MONTHS</dc:title>
	<dc:creator>Suhandi, Cecep</dc:creator>
	<dc:creator>Alodya, Cheryl</dc:creator>
	<dc:creator>Kristande, Abednego</dc:creator>
	<dc:creator>Sinuraya, Rano Kurnia</dc:creator>
	<dc:subject xml:lang="en-US">Influenza</dc:subject>
	<dc:subject xml:lang="en-US">vaccine</dc:subject>
	<dc:subject xml:lang="en-US">children</dc:subject>
	<dc:subject xml:lang="en-US">trivalent</dc:subject>
	<dc:subject xml:lang="en-US">quadrivalent</dc:subject>
	<dc:description xml:lang="en-US">Background: Influenza is a contagious viral infection disease that causes acute disorders of the respiratory tract. The prevalence of infection due to influenza virus is higher in children than adults. Thus, it is very important to vaccinate children using the most effective type of vaccine.Objectives: The purpose of this review was to investigate type of influenza vaccine with the highest effectiveness in children 6 to 35 months of age based on RCT study.Methods: The review is carried out by collecting articles from Elsevier and Medline database using “.Influenza Vaccine”, “Randomized Control Trial”, and “Children” as the keywords.Results: Based on the initial searching, it was found 6.261 articles and 9 articles that fulfill the review criteria. The results showed that the best vaccine efficacy has gotten by trivalent vaccines against the strains of viruses A (H1N1), A (H3N2), and B (Yamagata) with vaccine efficacy values of 94.1%; 100%; and 97.1%, respectively. While the use of quadrivalent vaccines against strain B (Victoria) virus with a vaccine efficacy value of 87.2%.Conclusions: Trivalent vaccine more effective for strain A and B (Yamagata) virus, moreover quadrivalent vaccine more effective for strain B (Victoria)Keywords: Influenza, vaccine, children, trivalent, quadrivalent
Intisari
Latar Belakang: Influenza merupakan suatu penyakit infeksi virus menular yang mengakibatkan gangguan akut pada saluran pernapasan. Insidensi infeksi akibat virus influenza lebih tinggi terjadi pada anak-anak dibanding dewasa. Dengan demikian, sangat penting untuk memberikan vaksinasi pada anak-anak menggunakan jenis vaksin yang paling efektif. Tujuan: Tujuan dari review ini adalah untuk menentukan jenis vaksin influenza dengan efektivitas tertinggi terhadap anak usia 6-35 bulan berdasarkan hasil studi (RCT).Metode: Review dilakukan dengan penelusuran pustaka pada database ELSEVIER dan MEDLINE dengan kata kunci “Influenza Vaccine”, “Randomized Control Trial”, dan “Children”.Hasil: Berdasarkan hasil penelusuran, diperoleh 6.261 artikel dan 9 artikel yang memenuhi kriteria review. Hasil telaah dapat menunjukkan bahwa efektivitas vaksin terbaik pada vaksin trivalent terhadap virus strain A (H1N1), A (H3N2), dan B (Yamagata) dengan nilai efikasi vaksin secara berurutan sebesar 94,1%; 100%; dan 97,1% untuk usia anak 12-35 bulan. Sedangkan penggunaan vaksin quadrivalent terhadap virus strain B (Victoria) dapat mencapai nilai efikasi vaksin 87,2% pada anak usia 6-35 bulan. Kesimpulan: Vaksin trivalent lebih efektif pada virus strain A dan B (Yamagata), sedangkan vaksin quadrivalent lebih efektif pada strain B (Victoria)Kata kunci: Influenza, vaksin, anak-anak, trivalent, quadrivalent</dc:description>
	<dc:description xml:lang="id-ID">AbstractBackground: Influenza is a contagious viral infection disease that causes acute disorders of the respiratory tract. The prevalence of infection due to influenza virus is higher in children than adults. Thus, it is very important to vaccinate children using the most effective type of vaccine.Tujuan: The purpose of this review was to investigate type of influenza vaccine with the highest effectiveness in children aged 6-35 months based on Randomized Control Trial study.Method: The review is carried out by collecting articles from Elsevier and Medline database using “Influenza Vaccine”, “Randomized Control Trial”, and “Children” as the keywords.Results: Based on the initial searching, it was found 6.261 articles and 9 articles that fulfill the review criteria. The results showed that the best vaccine efficacy has gotten by trivalent vaccines against the strains of viruses A (H1N1), A (H3N2), and B (Yamagata) with vaccine efficacy values of 94.1%; 100%; and 97.1%, respectively. While the use of quadrivalent vaccines against strain B (Victoria) virus with a vaccine efficacy value of 87.2%.Conclusion: Trivalent vaccine more effective for strain A and B (Yamagata) virus, moreover quadrivalent vaccine more effective for strain B (Victoria)Keyword: Influenza, Vaccine, Children, Trivalent, Quadrivalent AbstrakLatar Belakang: Influenza merupakan suatu penyakit infeksi virus menular yang mengakibatkan gangguan akut pada saluran pernapasan. Insidensi infeksi akibat virus influenza lebih tinggi terjadi pada anak-anak dibanding dewasa. Dengan demikian, sangat penting untuk memberikan vaksinasi pada anak-anak menggunakan jenis vaksin yang paling efektif.Tujuan: Tujuan dari review ini adalah untuk menentukan jenis vaksin influenza dengan efektivitas tertinggi terhadap anak usia 6-35 bulan berdasarkan hasil studi Randomized Control Trial.Metode: Review dilakukan dengan penelusuran pustaka pada database ELSEVIER dan MEDLINE dengan kata kunciInfluenza Vaccine Randomized Control Trial Children.Hasil: Berdasarkan hasil penelusuran, diperoleh 6.261 artikel dan 9 artikel yang memenuhi kriteria review. Hasil telaah menunjukkan efektivitas vaksin terbaik pada vaksin trivalent terhadap virus strain A (H1N1), A (H3N2), dan B (Yamagata) dengan nilai efikasi vaksin secara berurutan sebesar 94,1%; 100%; dan 97,1%. Sedangkan penggunaan vaksin quadrivalent terhadap virus strain B (Victoria) dengan nilai efikasi vaksin 87,2%.Kesimpulan: Vaksin trivalent lebih efektif pada virus strain A dan B (Yamagata), sedangkan vaksin quadrivalent lebih efektif pada strain B (Victoria)Kata kunci: Influenza, Vaksin, Anak-anak, Trivalent, Quadrivalent</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/16732</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art13</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 134-144</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16732/14531</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/16937</identifier>
				<datestamp>2021-07-31T16:44:43Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Inventarytation of medicinal plants as a self-medication by the Tolaki, Puundoho village, North Kolaka regency, Southeast Sulawesi</dc:title>
	<dc:creator>Alang, Hasria</dc:creator>
	<dc:creator>Hastuti, Hastuti</dc:creator>
	<dc:creator>Yusal, Muhammad Sri</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Traditional medicine knowledge is one of the local wisdoms and is passed down from generation to generation. Traditional medicine needs to be preserved in order to maintain the continuity of this knowledge; besides that, it requires a balance between modern medicine and herbal medicine. Herbal medicine is easy to obtain in the surrounding environment, at affordable prices and guarantees the safety of medicinal chemicals that are harmful to the body. The use of drugs for a long period of time is a habit that is harmful to the body organs because they contain certain chemical compounds that are not safe for human vital organs, so it is necessary to make an inventory effort by digging up information from traditional healers. This research is expected to make a significant contribution so that the role of herbal plants can be maintained and developed in the future.Objective: to inventory the plant species which useful as traditional medicines used by traditional healers of the Tolaki tribe in Puundoho village.Method: The method used in this research is a qualitative exploration, through an emic approach or a community and ethical perspective supported by scientific literature. The use of qualitative methods in this study is intended to describe people's knowledgeResults: The interview results with three traditional healers (mbu'wai) in Puundoho village about plants that can be used as traditional medicines. It can be found on the side of the road, garden and yard. The part of the plant used is the whole plant or part of the plant such as roots, stems, or leaves. The method to blend it is boiled or mashed. The use of traditional medicines is applied orally or topically.Conclusion: The types of traditional medicinal plants used by the Tolaki tribe in Puundoho village can be obtained from yards, gardens, and roadsides including sidaguri, ciplukan, jeringan, bangle, purslane, bandotan, boborongan, turi, meniran, ­­­­banjar berrywit, mesoyi, ketepeng, guava, ginger, kencur, blechnum nails and ketepengKeywords: Herbal medicine, inventarytation, medicinal plants, traditional medicineIntisariLatar belakang: Pengetahuan pengobatan tradisional merupakan salah satu kearifan lokal dan diperoleh secara turun-temurun dari generasi kegenerasi selanjutnya. Pergeseran zaman dan modernisasi dikhawatirkan akan menggerus kearifan lokal tersebut, sehingga perlu dilakukan inventarisasi dengan cara menggali informasi dari para penyehat tradisional. Penelitian ini diharapkan akan memberikan kontribusi yang signifikan, sehingga peran tanaman herbal dapat terus terjaga dan dikembangkan di waktu mendatang.Tujuan: untuk menginventarisasi jenis-jenis tumbuhan yang bermanfaat sebagai obat tradisional yang digunakan oleh penyehat tradisional suku Tolaki di Desa puundoho.Metode: Metode yang digunakan dalam penelitian ini adalah eksplorasi yang bersifat kualitatif, melalui pendekatan emik atau perspektif masyarakat dan etik yang didukung literatur ilmiah. Penggunaan metode kualitatif dalam penelitian ini dimaksudkan untuk mendeskripsikan pengetahuan masyarakatHasil: Hasil wawancara dengan tiga penyehat tradisional (mbu’wai) yang ada di Desa Puundoho tentang tumbuhan yang dapat digunakan sebagai obat tradisional dapat ditemukan di tepi jalan, kebun dan pekarangan. Bagian tanaman yang digunakan adalah keseluruhan bagian tanaman atau sebagian tanaman seperti akar, batang atau daun. Cara meramunya yaitu direbus atau dihaluskan. penggunaan obat tradisional tersebut dilakukan secara cara oral atau topical.Kesimpulan: jenis tanaman obat tradisional yang digunakan oleh suku Tolaki di desa Puundoho dapat diperoleh dari pekarangan, kebun, dan pinggir jalan diantaranya sidaguri, ciplukan, jeringan, bangle, krokot, bandotan, boborongan, turi, meniran, rumput beriwit banjar, mesoyi, ketepeng, jambu air, jahe, kencur, paku blechnum dan ketepeng</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-16</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/16937</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 19-33</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16937/11399</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16937/13020</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/16955</identifier>
				<datestamp>2021-07-31T16:43:17Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Comparison of antioxidant activities of tespong herbal (Oenanthe javanica DC.) extract and nanoextract using DPPH method</dc:title>
	<dc:creator>Fajar, In Rahmi Fatria</dc:creator>
	<dc:creator>Fitri, Dewi Rahma</dc:creator>
	<dc:creator>Fitriyani, Nisa</dc:creator>
	<dc:creator>Chuanvin, Michael</dc:creator>
	<dc:description xml:lang="id-ID">Background: Tespong herbs (O. javanica DC.) contain numerous chemical compounds considered beneficial for medications, including flavonoids, phenols, and tannins, which can function as antioxidants. Nanoparticles are materials with a size range of 1-1000 nanometers which can increase the bioavailability of drugs, thus accelerating the drug delivery system in the body.Objective: The aim of this study is to identify the characteristics of herbal extract and nanoextract of Tespong and to compare their antioxidant activity.Methods: Extraction of tespong herbs was done using maceration for three days, nanoextract was formulated using the ionic gelation method with herbal extract of tespong, chitosan, and Na-TPP. Antioxidant activity testing was carried out using the DPPH method.Results: The water content of tespong herbal extract was 1.78%, and the total ash content was 4.95%.  The tespong herbal nanoextract was 148.1nm in diameter with a polydispersity index of 0.362 and a zeta potential value of -39.16 mV. The IC50 values of tespong herbal extract and nanoextract were 65.424 ppm and 97.106 ppm, respectively, which fell into the strong category.Conclusion: Tespong herbal extract had a higher antioxidant activity compared to its nanoextract.Keywords:   Tespong herb, nanoextract, chitosan, Na-TPPIntisariLatar Belakang: Herba tespong (O. javanica DC.) memiliki banyak kandungan senyawa kimia yang bermanfaat dalam pengobatan diantaranya ialah senyawa flavonoid, fenol dan tanin yang dapat berfungsi sebagai antioksidan. Nanopartikel merupakan material dengan ukuran 1-1000 nanometer yang penggunaannya dapat ditujukan untuk meningkatkan bioavailabilitas obat sehingga mempercepat sistem penghantaran obat dalam tubuh.Tujuan: untuk mengetahui karakteristik ekstrak herba tespong, karakterisasi nanoekstrak herba tespong dan mengetahui perbandingan nilai aktivitas antioksidan ekstrak herba tespong dengan nanoekstrak herba tespong.Metode: Ekstraksi herba tespong menggunakan metode maserasi selama tiga hari, formulasi nanoekstrak menggunakan metode gelasi ionik terdiri dari ekstrak herba tespong, kitosan dan Na-TPP. Pengujian aktifitas antioksidan menggunakan metode DPPH.Hasil: Pengujian kadar air ekstrak menunjukkan angka 1,78% dan kadar abu total ekstrak sebesar 4,95%. Pada pengujian karakterisasi nanoekstrak herba tespong yang dibuat memiliki diameter rata-rata sebesar 148,1 nm dengan indeks polidispersitas sebesar 0,362 dengan nilai potensial zeta sebesar -39,16 mV. Nilai IC50 antioksidan ekstrak dan nanoekstrak herba tespong (O. javanica DC.) berturut –turut sebesar sebesar 65,424 ppm dan 97,106 ppm termasuk kategori kuat.Kesimpulan: Ekstrak herba tespong memiliki aktivitas antioksidan lebih tinggi dibandingkan nanoekstrak herba tespong.Kata Kunci: Herba tespong, nanoekstrak, kitosan, Na-TPP</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-03-17</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/16955</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art1</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 1-8</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/16955/11093</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/17225</identifier>
				<datestamp>2021-07-31T17:04:00Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">A cross sectional survey of side effects of antiretroviral (ARV) in outpatients HIV by Naranjo Algorithm</dc:title>
	<dc:creator>Putra, Oki Nugraha</dc:creator>
	<dc:description xml:lang="en-US">Background: The main modality in HIV patients is the administration of long-treatment antiretroviral therapy (ARV). One of the problems from the use of ARV therapy is the side effects that can reduce patient compliance in taking medication, which has the potential to cause treatment failure.Objective: This study aims to examine the side effects and their causality in the use of ARVs in outpatient HIV patients at the VCT Clinic, Bhayangkara H.S. Hospital. Samsoeri Mertojoso Surabaya.Methods: This research was a prospective observational study with a cross-sectional design. Side effect data were taken from HIV patients by interview using the Naranjo algorithm. HIV patients who met the inclusion criteria were included in the study sample using consecutive sampling. This research was conducted from January to March 2020.Results: There were 72 outpatient HIV patients who met the inclusion criteria. The most opportunistic infections found in HIV patients are tuberculosis and Pneumocystis pneumonia. The results showed that the most common side effects experienced by patients were dizziness (43%), nausea and vomiting (31%), and rash (11%) with the highest Naranjo score being in the probable category of 86%. The Naranjo score in HIV patients with opportunistic infections and with comorbidities was significantly smaller than those in HIV patients without opportunistic infections or without comorbidities with independent t-test (P &amp;lt;0.05).Conclusion: The side effects in HIV patients while undergoing treatment with antiretroviral therapy are classified as a minor side effect and the cause of the side effects that occur is thought to be due to the probable category of ARV therapy.Keywords: HIV Patients, Antiretroviral, Side Effects, Naranjo's Algorithm.IntisariPendahuluan: Modalitas utama pada pasien HIV ialah pemberian terapi antiretroviral (ARV) dalam jangka waktu yang panjang. Salah satu masalah yang timbul dari penggunaan terapi ARV ialah efek samping obat yang dapat menurunkan kepatuhan pasien dalam minum obat sehingga berpotensi menimbulkan gagal pengobatan.Tujuan: Penelitian ini bertujuan untuk mengkaji efek samping dan kausalitasnya pada penggunaan ARV pada pasien HIV rawat jalan di Poli VCT, Rumah Sakit Bhayangkara H.S. Samsoeri Mertojoso Surabaya.Metode: Penelitian ini merupakan penelitian observasional prospektif dengan desain penelitian cross-sectional. Data efek samping diambil dari pasien HIV dengan wawancara menggunakan algoritma naranjo. Pasien HIV yang memenuhi kriteria inklusi dimasukkan sebagai sampel penelitian menggunakan jenis consecutive sampling. Penelitian ini dilakukan pada bulan Januari hingga Maret 2020. Hasil: Didapatkan 72 pasien HIV rawat jalan yang memenuhi kriteria inklusi. Infeksi oportunistik terbanyak yang ditemukan pada pasien HIV ialah tuberkulosis dan Pneumocystis pneumonia. Hasil penelitian menunjukan kejadian efek samping yang paling banyak dialami pasien adalah pusing (43%), mual dan muntah (31%), ruam (11%) dengan skor Naranjo terbanyak berada pada kategori probable sebesar 86%. Hasil skor Naranjo pada pasien HIV dengan infeksi oportunistik maupun dengan penyakit penyerta lebih kecil secara signifikan dibandingkan dengan pasien HIV tanpa infeksi oportunistik maupun tanpa penyakit komorbid dengan independent t-test (P&amp;lt;0,05).Kesimpulan: Efek samping yang ditemukan pada pasien HIV selama menjalani pengobatan dengan obat antiretroviral merupakan jenis efek samping minor dan penyebab efek samping yang terjadi diduga diakibatkan oleh obat ARV dalam kategori probable.Kata kunci:Pasien HIV, antiretroviral, efek samping, algoritma Naranjo. </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-16</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/vnd.openxmlformats-officedocument.wordprocessingml.document</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/vnd.openxmlformats-officedocument.wordprocessingml.document</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/17225</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art4</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 34-45</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/17225/11400</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/17225/13032</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/17225/13033</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/17225/13034</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/17521</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Kaolin in pharmaceutical preparations: a review</dc:title>
	<dc:creator>Kamila, Rezkia Azka</dc:creator>
	<dc:description xml:lang="id-ID">Background: Kaolin is a clay mineral with Al2Si2O5(OH)4 structure which can be found in sedimentary rocks also known as clay stones. Kaolin consists of clay materials such as quartz, illite, smectite, and hematite, with the largest constituent component being kaolinite. Kaolin is one of the most common minerals with an abundant presence in the earth's crust compared to other minerals, especially in Indonesia. In the pharmaceutical sector, this clay mineral is widely used in Indonesia. Kaolin is known to be a good adsorbent and has good physical, chemical, and surface physicochemical properties. Objective: This review article aims to provide information about the uses of kaolin in the pharmaceutical industry.Methods: This review article was written by conducting a literature search study method in the PubMed, ScienceDirect, and Google Scholar databases.Results: In the pharmaceutical field, kaolin is used as an excipient in various types of medicinal preparations, one of which is as a suspension agent because of its ability to stabilize suspensions in a deflocculated state as an emulsifying agent, crushing agent, filling agent, and drug carrier. As an active substance, kaolin is widely used because it has a therapeutic activity. In the cosmetic industry, kaolin can be administered in a variety of topical dosage forms which act as skin protective agents or sunscreens.Conclusion: Based on the results of the review, it was found that kaolin, with its abundant presence on earth and its great potential in the pharmaceutical field, is used as an active medicinal substance, excipient ingredient, and in the cosmetic field as a sunscreen.Keywords: Kaolin, excipient, active pharmaceutical ingredient, cosmeticsIntisariLatar belakang: Kaolin merupakan mineral dengan struktur Al2Si2O5(OH)4 yang dapat ditemukan pada bebatuan sedimen yang juga dikenal sebagai batu lempung. Kaolin terdiri dari berbagai macam mineral lain sebagai penyusunnya seperti kuarsa, illit, smektit, hematit, dan komponen mineral penyusun yang paling besar adalah kaolinit. Kaolin adalah salah satu mineral paling umum dengan keberadaannya yang melimpah di kerak bumi dibandingkan dengan mineral lain khususnya di Indonesia dapat dimanfaatkan dalam bidang farmasi. Kaolin dikenal sebagai bahan adsorben yang baik dan juga memiliki sifat fisika, kimia, dan sifat fisikokimia permukaan yang baik.Tujuan: Ulasan artikel ini bertujuan untuk memberikan informasi mengenai kaolin di bidang kefarmasian. Metode: Ulasan artikel ini ditulis dengan melakukan metode studi penelusuran literatur dalam database Pubmed, Science Direct, dan Google Scholar.Hasil: Dalam bidang kefarmasian, kaolin digunakan sebagai bahan eksipien berbagai macam jenis sediaan obat salah satunya adalah digunakan sebagai bahan pensuspensi karena kemampuannya untuk menstabilkan suspensi dalam keadaan deflokulasi, sebagai agen pengemulsi, penghancur, pengisi, dan pembawa obat. Sebagai zat aktif kaolin banyak digunakan karena memilki aktivitas terapeutik. Dalam industri kosmetik kaolin dapat diberikan dalam berbagai macam bentuk sediaan topikal yang berfungsi sebagai agen pelindung kulit atau tabir surya.Kesimpulan: Berdasarkan hasil ulasan, didapatkan bahwa kaolin dengan keberadaan yang melimpah di bumi dan potensinya yang besar dalam bidang farmasi, diyakini memiliki peran besar dalam pengembangan di industri farmasi dan kosmetik.Kata kunci : Kaolin, Eksipien, Zat Aktif, Kosmetik</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/17521</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art5</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 145-159</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/17521/11881</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18234</identifier>
				<datestamp>2023-07-31T16:54:14Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Anticancer activity of ethanol extract, n-hexane, and the ethyl acetate fraction of tin leaves (Ficus carica l.) on MCF-7 breast cancer cell lines</dc:title>
	<dc:title xml:lang="id-ID">Aktivitas antikanker ekstrak etanol, fraksi n-heksan, dan etil asetat daun tin   (Ficus carica l.)  pada sel kanker payudara MCF-7</dc:title>
	<dc:creator>Winanta, Aji</dc:creator>
	<dc:creator>Sari, Widhi Yana</dc:creator>
	<dc:subject xml:lang="en-US">Breast Cancer</dc:subject>
	<dc:subject xml:lang="en-US">MCF-7 cells</dc:subject>
	<dc:subject xml:lang="en-US">tin leaf </dc:subject>
	<dc:subject xml:lang="en-US">Ficus carica</dc:subject>
	<dc:subject xml:lang="en-US">cytotoxic activity </dc:subject>
	<dc:description xml:lang="en-US">Abstract Background: Breast cancer is ranked as the second-highest cause of death in Indonesia. Many of the available cancer treatments result in severe adverse effects for patients. Tin (Ficus carica L.) leaves contain ingredients that can function as anticancer agents. Objective: The study aims to identify phytochemical secondary metabolites in tin leaves and the cytotoxic activity of the extract and tin leaf fraction on MCF-7 cells.Method: Tin leaf powder was macerated with 70% ethanol for 7 days. The extracts were fractionated using n-hexane and ethyl acetate. An identification test with ethanol extract was then carried out using spray reagents. The cytotoxic activity of ethanolic extract, n-hexane and ethyl acetate fraction of tin leaf was determined using the MTT method.Result: The results of the identification with TLC found that the ethanol extract of tin leaves contains flavonoids and steroids. The ethyl acetate fraction of tin leaf was thought to have weak cytotoxic properties with an IC50 value of 274.5877 ug/mL while the ethanol extract and n-heksan fraction of tin leaf do not have cytotoxic properties because they have an IC50 value of 562.827 and 576.3552 ug/mL. Conclusion: Based on the results, tin leaves have the potency to be developed as a chemopreventive agent for MCF-7 breast cancer cells.Keywords: Breast Cancer, MCF-7 cells, tin leaf (Ficus carica), cytotoxic activity</dc:description>
	<dc:description xml:lang="id-ID">Intisari Latar belakang: Kanker payudara menduduki peringkat kedua penyebab kematian tertinggi di Indonesia. Dari beberapa pilihan pengobatan kanker yang tersedia, sering kali menimbulkan efek samping yang berat bagi pasien sehingga penemuan agen kemopreventif yang alami dan aman masih terus berlangsung hingga sekarang. Salah satu bahan alam yang memiliki potensi sebagai agen kemopreventif yaitu tanaman tin (Ficus carica L.) memiliki kandungan yang dapat berfungsi sebagai antikanker. Tujuan: Penelitian ini bertujuan untuk mengidentifikasi senyawa metabolit sekunder yang terdapat dalam ekstrak etanol dan fraksi-fraksi daun tin dan efek sitotoksiknya terhadap sel MCF-7.Metode: Serbuk daun tin dimaserasi dengan alkohol 70% selama 7 hari. Dari hasil ekstrak yang didapat kemudian dilakukan fraksinasi dengan menggunakan n-heksan dan etil asetat. Uji identifikasi senyawa flavonoid dan steroid dari ekstrak etanol dilakukan dengan menggunakan pereaksi Liebermen-Burchard dan uap amoniak serta uji sitotoksik dengan menggunakan metode MTT terhadap sel MCF-7.Hasil: Hasil identifikasi dengan KLT didapatkan bahwa ekstrak etanol daun tin mengandung senyawa metabolit sekunder berupa flavonoid dan steroid. Fraksi etil asetat daun tin memiliki efek sitotoksik yang cukup toksik dengan nilai IC50 sebesar 274,58 ug/mL sedangkan ekstrak etanol dan fraksi n-heksan daun tin tidak memiliki efek sitotoksik karena memiliki nilai IC50 sebesar 562,82 dan 576,35 ug/mL. Kesimpulan: Berdasarkan hasil penelitian fraksi etil asetat daun tin memiliki potensi untuk diteliti lebih lanjut dalam upaya pengembangan sebagai agen kemopreventif terhadap sel kanker payudara MCF-7.Kata kunci: Kanker payudara, sel MCF-7, daun tin (Ficus carica), aktivitas sitotoksik</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18234</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss1.art4</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 1 (2023): Jurnal Ilmiah Farmasi; 44-51</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol19.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18234/15445</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18348</identifier>
				<datestamp>2021-07-31T16:46:19Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The immunostimulant activity of Tibb an-Nabawi natural products: a literature review</dc:title>
	<dc:creator>Priani, Sani Ega</dc:creator>
	<dc:description xml:lang="id-ID">Abstract Background: Enhancing the immune system is very important during the Covid-19 pandemic to prevent infections and reduce the risk of disease severity. Therefore, it is necessary to use natural products with an immunostimulant effect. In Islam, there is a system of treatment or disease prevention based on Al-Quran and Hadith, which is called Tibb an-Nabawi or prophetic medicine. Objective: This research aims to conduct a literature study of Tibb an-Nabawi, which has proved to be able to increase the immune system, based on Islamic and scientific approaches.Method: The research was based on a systematic literature review using research articles from the last ten years. The inclusion criteria were articles discussing the immunostimulatory activity of Tibb an-Nabawi, while the exclusion criteria were immune system enhancing herbs that were not Tibb an-Nabawi.Results: Based on the literature studies, it is known that at least six natural products based on Tibb an-Nabawi have scientifically proved to increase the immune system, namely black cumin, honey, dates, ginger, garlic, and pumpkin. The mechanism of immune system enhancement is different in each substance, but in general, they can increase humoral or cellular immunity. The active compounds contained in each of these ingredients contribute to the resulting immunostimulant activity.Conclusion: Black cumin, honey, dates, ginger, garlic, and pumpkin are natural products based on Al-Quran and Hadith, which have scientifically proved to enhance the immune system.Keywords: Tibb an-Nabawi, Thibbun Nabawi, immune system, immunostimulant, pandemic Intisari  Latar belakang:  Peningkatan sistem imun sangat penting di masa pandemic Covid-19 untuk mencegah infeksi dan menurunkan resiko keparahan penyakit. Oleh karena itu, penggunaan bahan alam dengan efek meningkatkan aktivitas sistem imun perlu dilakukan. Dalam Islam dikenal istilah thibbun Nabawi yakni pengobatan atau pencegahan penyakit berbasis Al-Quran dan Hadist.Tujuan: Melakukan studi literatur tentang bahan thibbun Nabawi yang terbukti meningkatkan sistem imun disertai kajian dari sisi Islami dan juga ilmiahnya.Metode: Penelitian berbasis systematic literature review, dengan menggunakan artikel penelitian 10 tahun terakhir. Kriteria inklusi meliputi artikel-artikel membahas aktivitas imunostimulan dari bahan-bahan thibbun Nabawi dan kriteria eksklusi adalah bahan alami peningkat sistem imun yang bukan merupakan thibbun Nabawi. Hasil: Berdasarkan studi literatur diketahui bahwa sedikitnya ada 6 bahan thibbun Nabawi yang terbukti secara ilmiah mampu meningkatkan sistem imun yakni jintan hitam, madu, kurma, jahe, bawang putih, dan labu kuning. Mekanisme peningkatkan sistem imun berbeda beda untuk setiap bahan namun secara umum bahan bahan tersebut mampu meningkatkan imunitas humoral ataupun selular. Senyawa aktif yang terkandung dalam setiap bahan tersebut berkontribusi terhadap aktivitas immunostimulant yang dihasilkanKesimpulan: Jintan hitam, madu, kurma, jahe, bawang putih, dan labu kuning merupakan bahan alam berbasis thibbun Nabawi yang terbukti secara ilmiah mampu meningkatkan system imun.Kata kunci : Thibbun Nabawi, sistem imun, imunostimulan, pandemik</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18348</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art5</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 46-55</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18348/11416</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18408</identifier>
				<datestamp>2023-01-01T15:26:05Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Cost analysis of patients with Severe Cutaneous Adverse Reactions (SCARs)</dc:title>
	<dc:title xml:lang="id-ID">Analisis biaya pasien Severe Cutaneous Adverse Reactions (SCARs)</dc:title>
	<dc:creator>Urfiyya, Qarriy 'Aina</dc:creator>
	<dc:creator>Fatkhiya, Musa Fitri</dc:creator>
	<dc:creator>Perwitasari, Dyah Aryani</dc:creator>
	<dc:creator>Febriana, Sri Awalia</dc:creator>
	<dc:creator>Supadmi, Woro</dc:creator>
	<dc:subject xml:lang="en-US">Cost analysis</dc:subject>
	<dc:subject xml:lang="en-US">societal perspective</dc:subject>
	<dc:subject xml:lang="en-US">severe cutaneous adverse reactions</dc:subject>
	<dc:description xml:lang="en-US">Background: Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptom (DRESS), were the idiosyncratic reactions most commonly caused by drugs which have an impact on increasing the patient's financial burden.
Objectives: This study aims to determine the highest cost component and the illness cost in patients suffering from Severe Cutaneous Adverse Reactions (SCARs).
Methods: This study was an analytic observational study with a cross-sectional design. We collected direct medical costs, direct non-medical costs, and indirect costs for inpatients with SJS, TEN, and DRESS at Dr. Sardjito Yogyakarta Hospital from 2014-2018, retrospectively. Based on the societal perspective, we defined the highest cost component and the illness cost in patients with SCARs.
Results: The highest cost component for SJS, and TEN patients were obtained in the health professional services (24,1% and 25,2%, respectively). Meanwhile, the highest cost component for DRESS patients was the cost of drugs (20,2%). The total illness cost of 47 SCARs patients (22 SJS patients, 6 TEN patients, and 19 DRESS patients) was IDR 666.615.321, with the highest average cost for TEN patients, followed by SJS and DRESS (IDR 16.510.595, IDR 14.205.545, and IDR 13.445.555, respectively).
Conclusions: The highest cost component was the health professional services in SJS and TEN patients and the cost of medicine for DRESS patients. The management of SCARs requires considerable cost, and it is still being a financial burden on the patients.</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Severe Cutaneous Adverse Reactions (SCARs) termasuk Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN) dan Drug Reaction with Eosinophilia and Systemic Symptom (DRESS), merupakan reaksi idiosinkratik yang paling sering disebabkan oleh obat yang berdampak pada peningkatan beban keuangan pasien.
Tujuan: Penelitian ini bertujuan untuk mengetahui komponen biaya terbesar dan biaya perawatan pada pasien yang mengalami Severe Cutaneous Adverse Reactions (SCARs).
Metode: Penelitian ini merupakan penelitian observasional analitik dengan desain cross sectional. Pengumpulan data biaya medik langsung, biaya non medik langsung dan biaya tidak langsung pada pasien rawat inap dengan SJS, TEN dan DRESS di RSUP Dr. Sardjito Yogyakarta tahun 2014-2018, secara retrospektif. Kami menghitung komponen biaya tertinggi dan biaya perawatan pasien dengan SCARs berdasarkan perspektif masyarakat.
Hasil: Komponen biaya tertinggi pada pasien SJS dan TEN adalah biaya jasa profesional kesehatan (24,1% and 25,2%), sedangkan komponen biaya tertinggi pada pasien DRESS adalah biaya obat (20,2%). Total biaya perawatan 47 pasien SCARs (22 pasien SJS, 6 pasien TEN, dan 19 pasien DRESS) adalah Rp 666.615.321, dengan biaya rata-rata tertinggi pada pasien TEN, diikuti SJS dan DRESS (Rp 16.510.595, Rp 14.205.545, and Rp 13.445.555)
Kesimpulan: Komponen biaya terbesar adalah biaya jasa professional kesehatan pada pasien SJS dan TEN, serta biaya obat bagi pasien DRESS. Penatalaksanaan SCARs membutuhkan biaya yang cukup besar, dan masih menjadi beban keuangan bagi pasien.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18408</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art12</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 123-133</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18408/14530</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18529</identifier>
				<datestamp>2023-12-31T09:55:59Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Depiction of parenteral nutrition in intensive care unit patients in one of the hospitals in Tasikmalaya City</dc:title>
	<dc:title xml:lang="id-ID">Gambaran Nutrisi Parenteral Pada Pasien Intensive Care Unit di Salah Satu Rumah Sakit di Kota Tasikmalaya</dc:title>
	<dc:creator>Alpiana, Erma Nur </dc:creator>
	<dc:creator>Alifiar, Ilham</dc:creator>
	<dc:creator>Setiawan, Fajar </dc:creator>
	<dc:subject xml:lang="en-US">ICU</dc:subject>
	<dc:subject xml:lang="en-US">parenteral nutrition</dc:subject>
	<dc:subject xml:lang="en-US">accuracy of parenteral nutrition</dc:subject>
	<dc:description xml:lang="en-US">Background: Nutrition refers to the intake of food that is beneficial for maintaining good health. Parenteral nutrition refers to the intravenous administration of substances such as carbohydrates, proteins, lipids, and electrolytes. Attaining optimal nutrition relies on exact utilization, while imprecise utilization leads to malnutrition.Objective: This study was conducted to evaluate the administration of parenteral nutrition in patients who were hospitalized in ICU of X Hospital in Tasikmalaya City and to know the relationship between the accuracy of parenteral nutrition and the factors that affect it.Method: This study is an observational one, employing a cross-sectional research design and prospectively collecting data. Data was gathered between the months of February and April in the year 2020. The acquired data is subsequently examined with SPSS, specifically employing the Chi-square test.Results: The research included a total of 23 patients who satisfied the specified criteria. These patients varied in terms of age, duration of care, nutrient intake, clinical symptoms, drug usage, and nutritional state upon admission to the ICU. The parenteral nutrition administered to patients includes Kabiven, Aminofluid, KA-EN 3B, D5%, D10%, and Hydromal. Out of the entire number of patients, only 2 achieved the required daily amount of total parenteral nutrition during therapy, whereas 21 patients fell short of meeting the minimal criterion of total daily parenteral nutrition.Conclusion: The study data reveals that certain patients have fulfilled the criteria for minimal total nutritional therapy, while others have not met the daily minimum nutritional requirements.Keywords: ICU, parenteral nutrition, accuracy of parenteral nutrition
Intisari Latar belakang: Nutrisi adalah makanan yang berguna bagi kesehatan. Nutrisi parenteral adalah zat makro maupun mikro yang dibutuhkan tubuh namun diberikan secara intravena. Nutrisi yang tepat akan membantu proses penyembuhan pasien, dan sebaliknya nutrisi yang kurang optimal dapat menghambat proses penyembuhan pasien.Tujuan: Penelitian ini dilakukan untuk mengevaluasi pemberian nutrisi parenteral pada pasien yang di rawat di ruang ICU salah satu rumah sakit di Kota Tasikmalaya.Metode: Penelitian ini merupakan penelitian observasional dengan desain penelitian yang digunakan adalah cross-sectional dan pengambilan data dilakukan secara prospektif. Sampel dalam penelitian ini adalah semua pasien yang dirawat di ICU yang diambil menggunakan teknik consecutive sampling. Data dikumpulkan mulai Februari sampai April tahun 2020. Data yang didapatkan kemudian dianalisis menggunakan SPSS yaitu uji Chi-square. Hasil: Subjek penelitian yang memenuhi kriteria inklusi sebanyak 23 pasien dengan berbagai macam usia, lama rawat, asupan nutrisi, manifestasi klinis, pemberian obat dan status nutrisi saat masuk ICU. Nutrisi parenteral yang digunakan pada pasien yaitu Kabiven®, Aminofluid, KA-EN 3B, D5%, D10% dan Hydromal. Sebanyak 2 pasien memenuhi standar minimal nutrisi parenteral total harian selama dirawat, dan 21 pasien belum memenuhi standar minimal jumlah nutrisi parenteral total hariannya.Kesimpulan: Pemberian nutrisi parenteral pada pasien ICU RS X kota Tasikmalaya belum tepat dalam memenuhi kebutuhan nutrisi pasien, karena hanya 2 pasien yang sudah memenuhi syarat minimal terapi nutrisi total, namun terdapat 21 pasien yang masih belum memenuhi standar minimal nutrisi yang harus dipenuhi setiap hari sedangkan hasil uji statistik dengan menggunakan Chi-Square diperoleh hasil yang menunjukkan tidak terdapat hubungan yang signifikan antara data demografi pasien dengan ketepatan pemberian nutrisi parenteral. Kata kunci: ICU, nutrisi parenteral, ketepatan pemberian nutrisi parenteral</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Nutrisi adalah makanan yang berguna bagi kesehatan. Nutrisi parenteral adalah zat makro maupun mikro yang dibutuhkan tubuh namun diberikan secara yang diberikan melalui intravena. Nutrisi  yang tepat akan membantu proses penyembuhan pasien, dan sebaliknya nutiri yang kurang optimal dapat menghambat proses penyembuhan pasien.Tujuan: Penelitian ini dilakukan untuk mengevaluasi pemberian nutrisi parenteral pada pasien yang di rawat di ruang ICU salah satu rumah sakit di Kota Tasikmalaya.Metode: Penelitian ini merupakan penelitian obsevasional dengan desain penelitian yang digunakan adalah cross sectional dan pengambilan data dilakukan secara prospektif. Data dikumpulkan mulai februari sampai April tahun 2020. Data yang didapatkan kemudian dianalisis.Hasil: subjek penelitian yang memenuhi kriteria sebanyak 23 pasien dengan berbagai macam usia, lama rawat, asupan nutrisi, manifestasi klinis, pemberian obat dan status nutrisi saat masuk ICU. Nutrisi parenteral yang digunakan pada pasien yaitu Kabiven, Aminofluid, KA-EN 3B, D5%, D10% dan Hydromal. Sebanyak 2 pasien memnuhi standar minimal nutrisi parenteral total harian selama dirawat, dan 21 pasien belum memenuhi standara minimal jumlah nutrisi parenteral total hariannya.Kesimpulan: dari data penelitian ini dapat terlihat bahwa Sebagian pasien sudah memenuhi syarat inimal terapi nutrisi total, namun masih terdapat pasien yang belum memenuhi standar minimal nutrisi yang harus dipenuhi setiap hari.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18529</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art12</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 143-151</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18529/16065</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18552</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Correlation between potassium administration and resolution in patients with diabetic ketoacidosis</dc:title>
	<dc:creator>Oktaviani, Rina</dc:creator>
	<dc:creator>Ikawati, Zullies</dc:creator>
	<dc:creator>Yasin, Nanang Munif</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of acute diabetes mellitus (DM). Insulin is one of the therapies for DKA, which can reduce potassium levels by shifting potassium from extracellular to intracellular. Consequently, early administration of potassium is important in the resolution of DKA.Objective: To determine the correlation between potassium administration and resolution in patients with DKA and the factors affecting such resolution.Methods: An observational study was employed with a retrospective cohort design for inpatients with a diagnosis of DKA during the period of January 2015-August 2020 at Dr. Sardjito Hospital Yogyakarta. Appraisal of the resolution of DKA variable was based on the achievement of blood glucose targets, followed by 2 criteria of serum bicarbonate, pH, and anion gap during 24 hours of therapy. This study involved 55 patients divided into groups with potassium administration and without potassium administration. Data were analyzed using the chi-square test and multivariate logistic regression.Results: The resolution of DKA achieved in less than equal to 24 hours in the group with potassium was 48.5% (16 patients) while it was 18.2% (4 patients) without potassium. Based on the chi-square analysis, there was a relationship between potassium administration and the resolution of DKA (p=0.045; RR=2.667; 95%CI=1.028-6.920). The multivariate analysis showed that the severity and history of DM were positively related to the resolution of DKA (p=0.025; OR: 8.901; 95%CI=1.318-60.123 and p=0.017; OR: 0.090; 95%CI=0.012-0.652).Conclusion: Potassium administration resulted in 48.5% of the DKA patients achieving a resolution in less than equal to 24 hours from the commencement of DKA therapy. The severity and history of DM became the factors that affected the resolution of DKA.Keywords: diabetic ketoacidosis, potassium, resolution Intisari  Latar belakang: Ketoasidosis diabetik (KAD) adalah komplikasi akut diabetes melitus (DM) yang mengancam jiwa. Insulin merupakan salah satu terapi KAD, yang dapat menurunkan kadar kalium dengan cara memindahkan kalium dari ekstraseluler ke intraseluler, sehingga pemberian awal terapi kalium berperan penting dalam resolusi KAD.Tujuan: Mengetahui hubungan pemberian kalium dengan resolusi pada pasien KAD dan faktor yang mempengaruhi resolusi.Metode: Penelitian observasional dengan rancangan kohort retrospektif pada pasien rawat inap dengan diagnosis KAD periode Januari 2015–Agustus 2020 di RSUP Dr. Sardjito Yogyakarta. Penilaian variabel resolusi KAD adalah ketercapaian target glukosa darah, diikuti 2 kriteria dari serum bikarbonat, pH, dan anion gap selama 24 jam terapi. Penelitian melibatkan 55 pasien yang terbagi ke dalam kelompok pemberian kalium dan tanpa pemberian kalium. Data dianalisis menggunakan uji chi-square dan multivariate logistic regression.Hasil: Resolusi KAD yang dicapai selama kurang dari sama dengan 24 jam pada kelompok dengan pemberian kalium sebesar 48,5% (16 pasien) dan 18,2% (4 pasien) tanpa pemberian kalium. Berdasarkan analisis chi-square, terdapat hubungan antara pemberian kalium dengan resolusi KAD (p=0,045; RR=2,667; 95%CI=1,028-6,920). Hasil analisis multivariat menunjukkan derajat keparahan dan riwayat DM berhubungan positif terhadap resolusi KAD (p=0,025; OR=8,901; 95%CI=1,318-60,123 dan p=0,017; OR=0,090; 95%CI=0,012-0,652).Kesimpulan: Pemberian kalium menghasilkan 48,5% pasien KAD yang mencapai resolusi kurang dari sama dengan 24 jam dari awal terapi KAD dimulai. Derajat keparahan dan riwayat DM merupakan faktor yang mempengaruhi resolusi KAD.Kata kunci: ketoasidosis diabetik, kalium, resolusi </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18552</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 127-136</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18552/11890</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18751</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Identification of waste: DOWNTIME in the outpatient prescription services at the pharmacy installation of Rumah Sakit Islam Siti Hajar Mataram</dc:title>
	<dc:creator>Atikah, Nur</dc:creator>
	<dc:creator>Parhatiwi, Sari Nanchi</dc:creator>
	<dc:creator>Pertiwi, Ajeng Dian</dc:creator>
	<dc:creator>Utami, Evi Fatmi</dc:creator>
	<dc:creator>Firman, Firman</dc:creator>
	<dc:description xml:lang="id-ID">Background: The hospital pharmacy installation is a health service unit that is required to provide professional services and improve quality which is oriented towards achieving patient satisfaction. Waste identification in pharmaceutical services is important because it has an impact on stakeholder satisfaction. Objective: Identifying waste using the DOWNTIME method for the outpatient prescription services at the pharmacy installation of Rumah Sakit Islam Siti Hajar Mataram. Methods: The study used the cross-sectional design, with the population being all outpatients who were provided with pharmaceutical services during February – April 2019 as well as all staff. Data were tabulated and analyzed descriptively. Critical waste was obtained through questionnaires and the root causes of critical waste were obtained through in-depth interviews with 5-why methods.Results: Waste waiting had the highest rate compared to other wastes, reaching 44% or 53 out of 121 respondents, followed by inventory (26%), extra processing (19%), transportation (14%), defects (14%), motion (13%), over production (8%), and non-utilized skills (7%). Meanwhile, from the staff respondents, waiting was also the highest waste (18%), followed by inventory (16%), motion (13%), over production (12%), transportation (12%), non-utilized skills (10%), extra processing (10%), and defects (9%). The root cause of waste waiting was the frequent drug unavailability due to delays in payment of services from the cooperating party to the hospital as well as the narrow service areas.Conclusion:Waste waiting became the critical waste with the highest percentage of dissatisfaction in the patient respondents (44%) and staff respondents (18%).Keywords: Waste, DOWNTIME, outpatient prescription services, pharmacy installation of RSI Siti Hajar MataramIntisari Latar belakang: Instalasi farmasi rumah sakit (IFRS) merupakan unit pelayanan kesehatan yang diharuskan untuk melayani secara profesional dan meningkatkan mutu yang berorientasi pada tercapainya kepuasan pasien. Identifikasi waste dalam pelayanan kefarmasian penting, karena berdampak kepada kepuasan stakeholder. Tujuan: Melakukan identifikasi waste dengan metode DOWNTIME di IFRS Rawat Jalan RSI Siti Hajar Mataram. Metode: Desain penelitian adalah cross sectional, dengan populasi seluruh pasien rawat jalan yang diberikan pelayanan kefarmasian pada bulan Februari–April tahun 2019, dan seluruh staf IFRS. Data ditabulasi dan dianalisis secara deskriptif. Waste kritis diperoleh melalui penyebaran kuisioner dan akar penyebab waste kritis diperoleh melalui wawancara mendalam dengan metode 5 why. Hasil: Waste waiting mendapat angka paling tinggi dibandingkan waste yang lainnya, dimana 44% atau 53 responden dari 121 responden. Kemudian disusul oleh inventory (26%), extra preccesing (19%), transportation (14%), defect (14%), motion (13%), over production (8%) dan non-utilized skill (7%). Bagi responden staf IFRS, waiting juga menjadi waste tertinggi (18%), diikuti oleh inventory (16%), motion (13%), over production (12%), transportation (12%), non-utilized skill (10%), extra processing (10%), dan defect (9%). Akar penyebab waste waiting adalah sering terjadi kekosongan obat akibat keterlambatan pembayaran jasa pelayanan dari pihak kerjasama kepada rumah sakit serta area pelayanan yang sempit. Kesimpulan:Waste waiting menjadi waste kritis dengan persentase ketidakpuasan tertinggi pada responden pasien (44%) dan pada responden staf (18%).Kata kunci :Waste, DOWNTIME, pelayanan resep, pasien rawat jalan, IFRS RSI Siti Hajar Mataram</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18751</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art1</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 107-115</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18751/11876</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18751/13172</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18784</identifier>
				<datestamp>2023-12-31T09:55:59Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Indonesian marine active compound as main protease inhibitor of SARS-CoV-2: molecular docking study</dc:title>
	<dc:title xml:lang="id-ID">SENYAWA AKTIF KELAUTAN INDONESIA SEBAGAI INHIBITOR PROTEASE UTAMA SARS-CoV-2: STUDI DOCKING MOLEKULER</dc:title>
	<dc:creator>Manno, Mohamad Reski</dc:creator>
	<dc:creator>Utami, Dwi</dc:creator>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">chondroitin sulfate</dc:subject>
	<dc:subject xml:lang="en-US">6LU7 and 2GTB receptors</dc:subject>
	<dc:subject xml:lang="en-US">molecular docking</dc:subject>
	<dc:description xml:lang="en-US">Background: Many natural and synthetic treatments are used to help the COVID-19 (Coronavirus Disease 2019) patient's recovery, but the effectiveness of inhibiting this virus still needs to be studied further.Objective: To predict whether chondroitin sulfate compounds in sea cucumbers have antiviral activity in COVID-19.Methods: The antiviral activity of chondroitin sulfate was tested on COVID-19 based on its interaction with the 6LU7 and 2GTB proteins, which are the main proteases (M pro) found in COVID-19, using the molecular docking method in silico. The research stages were the preparation of the 6LU7 and 2GTB protein structure databases, the preparation and optimization of the 3D chondroitin sulfate structure using the Biovia Discovery Studio application, and the validation of the molecular docking and chondroitin sulfate docking methods on the 6LU7 and 2GTB proteins using the Autodock 4.2 application.Results: Chondroitin sulfate has a higher affinity and forms hydrogen bonds with 6LU7 protein with an affinity value for the 6LU7 receptor (-9.5 kcal/mol) with RMSD I.b. (0.000) and RMSD u.b. (0.000) compared to 2GTB protein, which has a lower affinity, namely the affinity value of the 2GTB receptor (-7.7 kcal/mol) with RMSD I.b. (0.000) and RMSD u.b. (0.000).Conclusion: Based on the results of molecular docking studies, chondroitin sulfate has potential as an antiviral activity because it has affinity with 6LU7 and 2GTB proteins, which can inhibit the infection pathway of the COVID-19 virus.Keywords: COVID-19, chondroitin sulfate, 6LU7 and 2GTB receptors, molecular docking
IntisariLatar belakang: Banyak pengobatan secara alami atau pun sintetik yang digunakan untuk membantu kesembuhan pasien COVID-19 (Coronavirus Disease 2019) tetapi efektifitas dalam menghambat virus ini masih perlu untuk dikaji lebih dalam lagi.Tujuan: Untuk memprediksi suatu hubungan aktivitas senyawa kondroitin sulfat pada teripang pasir sebagai antivirus pada COVID-19.Metode: Dilakukan uji aktivitas kondroitin sulfat sebagai antivirus pada COVID-19 berdasarkan interaksinya pada protein 6LU7 dan 2GTB yang merupakan protease utama (M pro) yang ditemukan pada COVID-19, menggunakan metode molecular docking secara in silico. Tahapan penelitian yang dilakukan adalah penyiapan database struktur protein 6LU7 dan 2GTB, preparasi dan optimasi struktur 3D kondroitin sulfat menggunakan aplikasi Biovia Discovery Studio, serta validasi metode molecular docking dan docking kondroitin sulfat pada protein 6LU7 dan 2GTB menggunakan aplikasi Autodock 4.2.Hasil: Kondroitin sulfat memiliki afinitas yang lebih tinggi dan membentuk ikatan hidrogen dengan protein 6LU7 dengan nilai afinitas untuk reseptor 6LU7 (-9.5 kcal/mol) dengan RMSD I.b. (0.000) dan RMSD u.b. (0.000) dibandingkan dengan protein 2GTB yang memiliki afinitas yang lebih rendah yaitu dengan nilai afinitas reseptor 2GTB (-7.7 kcal/mol) dengan RMSD I.b. (0.000) dan RMSD u.b. (0.000).Kesimpulan: Berdasarkan hasil penelitian molecular docking, kondroitin sulfat memiliki potensi aktivitas sebagai antivirus karena memiliki afinitas dengan protein 6LU7 dan 2GTB yang mampu menghambat jalur infeksi virus COVID-19.Kata kunci: COVID-19, kondroitin sulfat, reseptor 6LU7 dan 2GTB , molecular docking</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang : Covid-19 (Corona Virus Disease 2019) merupakan wabah penyakit yang menginfeksi saluran pernafasan pada manusia. Banyak pengobatan secara alami atau pun sintetik yang digunakan untuk membantu kesembuhan pasien tetapi efektifitas dalam menghambat virus ini masih perlu untuk dikaji lebih dalam lagi. Saat ini tidak ada pengobatan yang efektif untuk melawan COVID-19.Tujuan : Untuk memprediksi suatu hubungan apakah senyawa kondroitin sulfat pada teripang pasir mempunyai aktifitas anti virus pada Covid-19.Metode : Dilakukan uji aktivitas kondroitin sulfat sebagai anti virus pada Covid-19 berdasarkan interaksinya pada protein 6LU7 DAN 2GTB yang merupakan protease utama (M pro) yang ditemukan pada COVID-19, menggunakan metode molecular docking secara in silico. Tahapan penelitian yang dilakukan adalah penyiapan database struktur protein 6LU7 DAN 2GTB, preparasi dan optimasi struktur 3D kondroitin sulfat menggunakan aplikasi Biovia Discovery Studio, serta validasi metode molecular docking dan docking kondroitin sulfat pada protein 6LU7 DAN 2GTB menggunakan aplikasi Autodock 4.2.Hasil : Kondroitin sulfat memiliki afinitas yang lebih tinggi  dan membentuk ikatan hidrogen dengan protein 6LU7 dengan nilai afinitas untuk reseptor 6LU7 (-9.5 kcal/mol) dengan rmsd I.b. (0.000) dan rmsd u.b (0.000) dibandingkan dengan protein 2GTB yang memiliki afinitas yang lebih rendah yaitu dengan nilai afinitas reseptor 2GTB (-7.7 kcal/mol) dengan rmsd I.b. (0.000) dan rmsd u.b (0.000). Kondroitin sulfat memiliki potensi aktivitas sebagai anti virus karena memiliki afinitas dengan protein 6LU7 DAN 2GTB yang mampu menghambat jalur infeksi virus Covid-19.Kesimpulan : Berdasarkan hasil penelitian molekular docking, ligan kondroitin sulfat yang bekerja pada reseptor 6LU7 mempunyai nilai binding affinity lebih baik dibanding dengan ligan kondroitin sulfat yang bekerja pada  reseptor 2GTB. Dengan nilai affinity untuk reseptor 6LU7 (-9.5 kcal/mol) dengan rmsd I.b. (0.000) dan rmsd u.b (0.000) dan untuk reseptor 2GTB (-7.7 kcal/mol) dengan rmsd I.b. (0.000) dan rmsd u.b (0.000). Kondroitin sulfat memiliki potensi aktivitas sebagai anti virus karena memiliki afinitas dengan protein 6LU7 DAN 2GTB yang mampu menghambat jalur infeksi virus Covid-19.Kata kunci : Covid-19, Kondroitin sulfat,  Reseptor 6LU7 DAN 2GTB , Docking molecular.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18784</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art16</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 182-194</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18784/16083</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18814</identifier>
				<datestamp>2024-01-02T02:51:10Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The differences in the efficacy of nifedipine and methyldopa as antihypertensive therapy in patients with preeclampsia at Dr. H. Moch Ansari Saleh hospital</dc:title>
	<dc:title xml:lang="id-ID">Perbedaan Efektivitas Terapi Antihipertensi Nifedipin dan Metildopa Pada pasien preeklamsia di  RSUD Dr. H. Moch. Ansari Saleh</dc:title>
	<dc:creator>Kurniawan, Guntur</dc:creator>
	<dc:creator>Wati, Helmina</dc:creator>
	<dc:creator>Annisa, Rezka</dc:creator>
	<dc:subject xml:lang="en-US">nifedipine</dc:subject>
	<dc:subject xml:lang="en-US">methyldopa</dc:subject>
	<dc:subject xml:lang="en-US">hypertension</dc:subject>
	<dc:subject xml:lang="en-US">blood pressure</dc:subject>
	<dc:description xml:lang="en-US">Background: Preeclampsia in pregnant women can occur with elevated blood pressure &amp;gt;140/90 mmHg. Nifedipine and methyldopa can be used as antihypertensive therapy in pre-eclampsia patients. These two drugs have differences in their mechanisms of action to decrease blood pressure. Objective: To evaluate the effects of nifedipine and methyldopa in hospitalized pregnant female patients at RSUD Dr. H. Moch. Ansari Saleh from January to December 2018.Method: This research method was descriptive-observational, obtaining data retrospectively. This research included 30 hypertensive pregnant women who were divided into the nifedipine group or the methyldopa group. The blood pressure measurements of the patients were documented before and after therapy. The data was evaluated with an independent sample t-test.Result: The outcomes of this research indicated that nifedipine reduced the systolic blood pressure from the average of 159.33 to 127.66 mmHg and in the methyldopa group from the average of 162.67 to 137.33 mmHg (p &amp;lt; 0.05). The mean arterial pressure (MAP) after using nifedipine was 99.44 ± 10.15 mmHg, and after using methyldopa, it was 106.22 ± 7.65 mmHg (p &amp;lt;0.05).Conclusion: Nifedipine was more effective than methyldopa in lowering blood pressure in pre-eclampsia subjects.Keywords: Nifedipine, methyldopa, hypertension, blood pressure
Intisari Latar belakang: Ciri-ciri hipertensi pada ibu hamil ditandai dengan peningkatan tensi darah diatas 140/90 mmHg yang dapat menyebabkan terjadinya preeklampsia. Nifedipin dan metildopa digunakan sebagai terapi antihipertensi khususnya pada pasien preeklampsia. Kedua obat tersebut memiliki perbedaan pada mekanisme kerja untuk mengurangi tekanan pada pembuluh arteri.Tujuan: Menganalisa efek pemakaian obat nifedipin dan metildopa pada subyek wanita hamil dan dirawat inap di RSUD Dr. H. Moch. Ansari Saleh di tahun 2018.Metode: Jenis penelitian ini adalah observasional deskriptif dengan memperoleh data secara retrospektif. Jumlah subyek sebanyak 30 pasien ibu hamil dengan kondisi hipertensi dibagi menjadi kelompok nifedipin atau kelompok metildopa. Data tekanan darah diambil sebelum dan sesudah pengobatan yang diperoleh dari rekam medis pasien yang kemudian diuji dengan independent sample t-test.Hasil: Nifedipin dapat mengurangi tekanan darah sistolik dari rerata 159,33 mmHg ke 127,66 mmHg dan pada grup metildopa dari rerata 162,67 mmHg ke 137,33 mmHg (p &amp;lt;0,05). Hasil rerata tekanan arteri (MAP) subyek setelah menggunakan nifedipin yaitu 99,44 ± 10,15 mmHg dan pada metildopa yaitu 106,22 ± 7,65 mmHg (p &amp;lt;0,05). Kesimpulan: Nifedipin lebih efektif dibandingkan dengan metildopa dalam menurunkan tensi darah pada wanita hamil dengan preeklampsia. Kata kunci: Nifedipin, metildopa, hipertensi, tekanan darah</dc:description>
	<dc:description xml:lang="id-ID">Latar Belakang: Hipertensi pada kehamilan ditandai dengan meningkatnya tekanan darah di atas 140/90 mmHg. Dua jenis terapi antihipertensi yang digunakan pada ibu hamil yaitu nifedipin dan metildopa yang memiliki perbedaan di mekanisme kerja dalam menurunkan tekanan darah.Tujuan : Mengetahui perbedaan efektivitas terapi antihipertensi nifedipin dan metildopa pada pasien ibu hamil di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin periode Januari-Desember 2018.Metode : Penelitian ini merupakan penelitian observasional deskriptif dengan pengambilan data secara retrospektif. Sampel dalam penelitian ini berjumlah 30 pasien hamil dengan kondisi hipertensi, yang dibagi menjadi dua kelompok pengobatan yaitu kelompok nifedipin dan kelompok metildopa. Data tekanan darah diambil sebelum dan sesudah pengobatan yang diperoleh dari rekam medis pasien yang kemudian dianalisis dengan uji independent sample T-test dan Mann-Whitney U test.Hasil penelitian: Nifedipin dapat menurunkan tekanan darah systole dari 159,33±13,34 menjadi 127,66±12,93 mmHg dan pada kelompok metildopa dari 162,67±12,23 menjadi 137,33±10,99 mmHg (p &amp;lt;0,05). Hasil MAP pasien sesudah mendapatkan terapi nifedipin yaitu 99,44 ± 10,15 mmHg dan pada terapi metildopa yaitu106,22 ± 7,65 mmHg (p &amp;lt;0,05).Kesimpulan : terdapat perbedaan  efektivitas penurunan tekanan darah pada kelompok nifedipin dan kelompok  metildopa.Kata Kunci : Nifedipin, Metildopa, Hipertensi</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18814</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art14</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 161-168</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18814/16079</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18830</identifier>
				<datestamp>2021-08-02T09:23:09Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">A study of antioxidant potential from herbal plants and the effects on Parkinson’s disease</dc:title>
	<dc:creator>Pratiwi, Indri Nuraeni</dc:creator>
	<dc:creator>Aligita, Widhya</dc:creator>
	<dc:creator>Kaniawati, Marita</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Parkinson's disease is the most common neurodegenerative disorder affecting more than 10 million people worldwide. This disease is characterized by progressive dopaminergic neuron damage in the substantia nigra. This damage can be triggered by aging and the presence of oxidative stress because of free radicals. Antioxidants can inhibit the formation of free radicals and reduce oxidative stress, so they can be used as an alternative treatment for Parkinson's disease.Objective: This review article aimed to provide information about the antioxidant effects of selected herbal plants on Parkinson's disease.Method: This study used literature study methods sourced from national and international scientific journals published in the last 5 years (2016-2020). Literature search were carried out using databases such as Google Scholar, PubMed®, ScienceDirect, and Garuda Portal.Results: The high content of antioxidants in plants could protect nerve cells from oxidative damage and reduce symptoms such as tremors, muscle stiffness, impaired coordination and motor balance in test animals.Conclusion: Natural antioxidants from herbal plants proved to be able to prevent oxidative stress caused by free radicals and reduce symptoms of Parkinson's disease.Keywords: Parkinson's disease, antioxidants, oxidative stress, herbal plantsIntisariLatar belakang: Penyakit Parkinson merupakan gangguan neurodegeneratif paling umum yang mempengaruhi lebih dari 10 juta orang di seluruh dunia. Penyakit ini ditandai dengan kerusakan neuron dopaminergik secara progresif di substansia nigra. Kerusakan tersebut dapat dipicu oleh penuaan dan adanya stres oksidatif akibat adanya radikal bebas. Antioksidan mampu menghambat pembentukan radikal bebas dan mengurangi stres oksidatif, sehingga dapat digunakan sebagai salah satu alternatif pengobatan penyakit Parkinson.Tujuan: Review artikel ini bertujuan untuk memberikan informasi mengenai pengaruh antioksidan dari beberapa tanaman herbal terpilih terhadap penyakit Parkinson.Metode: Penelitian ini menggunakan metode studi literatur yang bersumber dari jurnal ilmiah nasional maupun internasional yang diterbitkan 5 tahun terakhir (2016-2020). Pencarian literatur dilakukan dengan menggunakan database seperti Google Scholar, PubMed®, ScienceDirect, dan Portal Garuda.Hasil: Kandungan antioksidan yang tinggi dapat melindungi sel saraf dari kerusakan oksidatif dan mampu mengurangi gejala seperti tremor, kekakuan otot, gangguan koordinasi, dan keseimbangan motorik pada hewan uji.Kesimpulan: Antioksidan alami dari tanaman herbal terbukti mampu mencegah terjadinya stres oksidatif yang diakibatkan oleh radikal bebas dan mengurangi gejala dari penyakit Parkinson.Kata kunci : Penyakit Parkinson, antioksidan, stres oksidatif, tanaman herbal</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18830</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art9</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 80-95</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18830/11442</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/18855</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Review: Neuroprotective effect of herbal plant extracts against Parkinson's disease</dc:title>
	<dc:creator>Salsabila, Syifa Fitriyanda</dc:creator>
	<dc:creator>Aligita, Widhya</dc:creator>
	<dc:creator>Mulyani, Yani</dc:creator>
	<dc:description xml:lang="id-ID">Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons and the exist of alpha-synuclein aggregates in the substantia nigra pars compacta (SNpc). Among the various types of neuroprotective therapy, natural products are potential therapeutic agents for PD.Objective: The aim of this study is to describe the neuroprotective effect of herbal plant extracts against Parkinson's Disease (PD).Method: The search strategy was carried out on electronic databases, namely Google Scholar, ScienceDirect, and PubMed. There are 111 scientific journals that have been filtered into 20 scientific journals which are international journals published in the last 5 years (2015-2020). The keywords used include Parkinson's Disease, Neuroprotective Effects, Neuroprotection, Plant Extracts, Natural Products and Parkinson's Disease Model.Results: Several experimental studies have shown the neuroprotective ability of various plant extracts to protect against neurotoxicity, through several neuroprotective pathways including antioxidant activity, anti-inflammatory activity, and antiapoptotic activity.Conclusion: Herbal plant extracts have been shown to have strong neuroprotective effects, making them as potential drug candidates for prevention or treatment of Parkinson's Disease (PD). There are Mucuna pruriens, Centella asiatica, Camellia sinensis, Ginkgo biloba, and Uncaria rhynchophylla.Keywords: Parkinson's Disease (PD), neuroprotective, extract.Intisari Latar belakang: Penyakit Parkinson adalah gangguan neurodegeneratif progresif yang disebabkan oleh hilangnya neuron dopaminergik dan adanya agregat yang mengandung alfa-synuclein di substansia nigra pars compacta. Diantara berbagai jenis terapi pelindung saraf, produk alami merupakan agen terapi yang potensial untuk PD.Tujuan: Untuk menggambarkan efek pelindung saraf ekstrak tanaman herbal terhadap penyakit Parkinson.Metode: Strategi pencarian dilakukan pada database elektronik yaitu Google Scholar, ScienceDirect, dan PubMed. Terdapat 111 Jurnal ilmiah yang telah di saring menjadi 20 jurnal ilmiah dan merupakan jurnal internasional yang diterbitkan 5 tahun terakhir (2015-2020). Kata kunci yang digunakan diantaranya Parkinson’s Disease, Neuroprotective Effects, Neuroprotection, Plant Extracts, Natural Products dan Parkinson’s Disease Model.Hasil: Beberapa studi eksperimen menunjukkan kemampuan pelindung saraf dari berbagai ekstrak tanaman untukmelindungineurotoksisitas, melalui beberapa jalur pelindung saraf diantaranya aktivitas antioksidan, aktivitas antiinflamasi, dan aktivitas antiapoptosis.Kesimpulan: Ekstrak tanaman herbal terbukti memiliki efek pelindung saraf yang kuat sehingga menjadikannya sebagai calon obat potensial untuk terapi pencegahan atau pengobatan penyakit Parkinson, diantaranya ekstrak tanaman Mucuna pruriens, Centella asiatica, Camellia sinensis, Ginkgo biloba, dan  Uncaria rhynchophylla.Kata kunci: Penyakit Parkinson. pelindung saraf, ekstrak</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/18855</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art9</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 198-209</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18855/11882</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/18855/13182</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19043</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Cytotoxic test of extract and fractions from Blumea balsamifera leaves using  Brine Shrimp Lethality Test (BSLT)</dc:title>
	<dc:title xml:lang="id-ID">Uji sitotoksik ekstrak dan fraksi daun sembung (Blumea balsamifera) dengan metode Brine Shrimp Lethality Test (BSLT)</dc:title>
	<dc:creator>Rahmi, Azimatur</dc:creator>
	<dc:creator>Afriani, Tika</dc:creator>
	<dc:creator>Aini</dc:creator>
	<dc:subject xml:lang="en-US">Brine shrimp lethality test</dc:subject>
	<dc:subject xml:lang="en-US">cytotoxic</dc:subject>
	<dc:subject xml:lang="en-US">Blumea balsamifera leaf</dc:subject>
	<dc:subject xml:lang="id-ID">Brine shrimp lethality test</dc:subject>
	<dc:subject xml:lang="id-ID">daun sembung (Blumea balsamifera)</dc:subject>
	<dc:subject xml:lang="id-ID">sitotoksik</dc:subject>
	<dc:description xml:lang="en-US">Background: Cancer is one of the main causes of death in the world for which no medicine has been found to date. One of the potential plants is Blumea balsamiferia.Objective: This study aimed to determine the cytotoxic effect of B. balsamifera leaf extract and fractions.Methods: The test was carried out using the Brine Shrimp Lethality Test (BSLT) on 48-hour-old shrimp (Artemia salina Leach) larvae. The concentrations of the test sample used were 10, 100, and 1000 ppm. Meanwhile, the negative control group was DMSO. Observations were made for 24 hours on larva deaths. The LC50 value was obtained using the probit analysis.Results: The ethyl acetate fraction and ethanol extract were in the highly toxic category with LC50 values of 11.03 ppm and 20.28 ppm, while the n-hexane fraction and water fraction were in the toxic range with LC50 values of 67.82 ppm and 448.56 ppm, respectively.Conclusion: The extract and fractions of B. balsamifera leaves have a cytotoxic effect.Keywords: Brine shrimp lethality test, cytotoxic, Blumea balsamifera leaf
Intisari
Latar belakang: Kanker merupakan salah satu penyebab utama kematian di dunia yang belum ditemukan obatnya hingga sekarang. Salah satu tanaman yang berpotensi yaitu tumbuhan sembung (Blumea balsamiferia).Tujuan: Penelitian ini untuk mengetahui efek sitotoksik ekstrak dan fraksi daun sembung.Metode: Pengujian dilakukan dengan metode Brine Shrimp Lethality Test (BSLT) menggunakan larva udang (Artemia salina Leach) yang berumur 48 jam. Konsentrasi sampel uji yang yang digunakan 10, 100, dan 1000 ppm. Kontrol negatif menggunakan DMSO. Pengamatan dilakukan selama 24 jam pada kematian larva. Nilai LC50 diperoleh menggunakan analisis probit.Hasil: Fraksi etil asetat dan ekstrak etanol berada dalam kategori sangat toksik dengan nilai LC50 11,03 ppm dan 20,28 ppm sedangkan fraksi n-heksan dan fraksi sisa air berada pada rentang toksik dengan nilai LC50 67,82 ppm dan 448, 56 ppm.Kesimpulan: Ekstrak daun sembung memiliki efek sitotoksik.Kata kunci: Brine shrimp lethality test, daun sembung (Blumea balsamifera), sitotoksik</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Kanker merupakan salah satu penyebab utama kematian di dunia yang belum ditemukan obatnya hingga sekarang. Salah satu tanaman yang berpotensi yaitu tumbuhan sembung (Blumea balsamifera).
Tujuan: Penelitian ini untuk mengetahui efek sitotoksik ekstrak dan fraksi daun sembung.
Metode: Pengujian dilakukan dengan metode Brine Shrimp Lethality Test (BSLT) menggunakan larva udang (Artemia salina Leach) yang berumur 48 jam. Konsentrasi sampel uji yang yang digunakan 10, 100, dan 1000 ppm. Kontrol negatif menggunakan DMSO. Pengamatan dilakukan selama 24 jam pada kematian larva. Nilai LC50 diperoleh menggunakan analisis probit.
Hasil: Fraksi etil asetat dan ekstrak etanol berada dalam kategori sangat toksik dengan nilai LC50 11,03 ppm dan 20,28 ppm sedangkan fraksi n-heksan dan fraksi sisa air berada pada rentang toksik dengan nilai LC50 67,82 ppm dan 448, 56 ppm.
Kesimpulan: Ekstrak daun sembung memiliki efek sitotoksik.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19043</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 26-33</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19043/13835</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19072</identifier>
				<datestamp>2023-01-01T16:07:59Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Interferons and its use in children with COVID-19: A narrative review</dc:title>
	<dc:creator>Chairunnisa, Chairunnisa</dc:creator>
	<dc:creator>Suharjono, Suharjono</dc:creator>
	<dc:subject xml:lang="en-US">Interferon</dc:subject>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">children</dc:subject>
	<dc:description xml:lang="en-US">Background: All ages, including children, are susceptible to the disease COVID-19. The severity of COVID-19 in children is mild than in adults. One of the recommended antiviral drugs for COVID-19 in children is interferon.
Objective: To describe the efficacy and safety of using interferon in children with COVID-19
Method: The article is a narrative study. The main databases in the article search process in this literature review are PubMed and Google Scholar.
Results: The articles could potentially be involved in this study were 28 articles. A total of 13 articles included the criteria, 9 articles discussed the use of interferon against respiratory syndrome, 4 articles on interferon in children, and one reference from a literature search.
Conclusion: Interferon therapy in COVID-19 in children has a high cure rate but needs to be evaluated in a larger sample of pediatric patients.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19072</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art18</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 192-204</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19072/14536</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19078</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">A Review: The pharmacokinetics and pharmacodynamics of metformin-herb interactions    </dc:title>
	<dc:title xml:lang="id-ID">Review :  Interaksi farmakokinetik dan farmakodinamik metformin-herbal</dc:title>
	<dc:creator>Cicih, Ating</dc:creator>
	<dc:creator>aligita, Widhya</dc:creator>
	<dc:creator>susilawati, Elis</dc:creator>
	<dc:subject xml:lang="en-US">pharmacokinetic</dc:subject>
	<dc:subject xml:lang="en-US">pharmacodynamic</dc:subject>
	<dc:subject xml:lang="en-US">herb-drug</dc:subject>
	<dc:subject xml:lang="en-US">metformin</dc:subject>
	<dc:subject xml:lang="id-ID">metformin</dc:subject>
	<dc:subject xml:lang="id-ID">farmakokinetik</dc:subject>
	<dc:subject xml:lang="id-ID">farmakodinamik</dc:subject>
	<dc:subject xml:lang="id-ID">herbal-obat</dc:subject>
	<dc:description xml:lang="en-US">Background: Diabetes mellitus is a metabolic disorder characterized by hyperglycemia. Metformin is the first-line therapy for type-2 diabetes mellitus. The combination of synthetic drugs with herbs was reported to be superior and popular compared to monotherapy. However, drug-herb interactions can have both beneficial and detrimental effects.Objective: This review aimed to identify the interactions that occur between the antidiabetic drug metformin and herbs.Methods: A literature search was done through ScienceDirect, ResearchGate, Pharmaceutics, and Genes by MDPI databases using the keywords metformin, antidiabetic, herb-drug, interaction, pharmacology, combination, pharmacokinetics, and pharmacodynamics.Results: The combination of metformin and such herbs as Korean ginseng (Panax ginseng), Lonicera japonica, Houttuynia cordata, mulberry (Morus alba), banana (Musa sapientum), Momordica charantia, coconut (Cocos nucifera), and Scutellaria baicalensis showed pharmacokinetic interactions in the form of increasing plasma metformin uptake mediated by MATE1 inhibition and increased OCT1, as well as hOCT2 inhibition which caused decreased metformin uptake in the kidneys. The pharmacodynamic interactions showed a direct effect, both additive and synergistic effects, in reducing blood glucose levels.Conclusion: Consuming metformin with herbs shows the potential for drug interactions in terms of both pharmacokinetics and pharmacodynamics.Keywords: pharmacokinetic, pharmacodynamic, herb-drug, metformin
IntisariLatar belakang: Diabetes melitus yaitu gangguan metabolisme yang ditandai dengan hiperglikemia. Metformin merupakan lini pertama pengobatan DM tipe 2. Kombinasi obat sintetis dengan herbal telah dilaporkan menjadi lebih unggul dan populer dibandingkan pengobatan monoterapi saja. Penggunaan obat sintetis dengan herbal dapat memicu interaksi obat yang dapat memberikan efek menguntungkan ataupun merugikan.Tujuan: Review ini bertujuan untuk mengetahui interaksi yang terjadi antara obat antidiabetes metformin dengan herbal.Metode: Penelusuran pustaka melalui database Sciencedirect, Researchgate, Pharmaceutics, dan Genes MDPI dengan penggunaan kata kunci seperti metformin, antidiabetic, herb-drug, interaction, pharmacology, combination, pharmacokinetic, dan pharmacodynamic.Hasil: Kombinasi obat metformin dengan herbal seperti ginseng Korea (Panax ginseng), kamperfuli (Lonicera japonica), amis-amisan (Houttuynia cordata), murbei (Morus alba), pisang (Musa sapientum), pare (Momordica charantia), kelapa (Cocos nucifera), dan kopiah Cina (Scutellaria baicalensis) menunjukkan interaksi farmakokinetik berupa peningkatan penyerapan metformin dalam plasma yang diduga dimediasi oleh penghambatan MATE1 dan peningkatan OCT1, serta penghambatan hOCT2 yang menyebabkan penurunan penyerapan metformin di ginjal. Adapun interaksi farmakodinamiknya menunjukkan efek yang searah baik aditif maupun sinergis dalam penurunan kadar glukosa darah.Kesimpulan: Konsumsi metformin dengan herbal menunjukkan adanya potensi interaksi obat baik secara farmakokinetik ataupun farmakodinamik.Kata kunci: farmakokinetik, farmakodinamik, herbal-obat, metformin</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Diabetes melitus yaitu gangguan metabolisme yang ditandai dengan hiperglikemia. Metformin merupakan lini pertama pengobatan DM tipe 2. Kombinasi obat sintetis dengan herbal telah dilaporkan menjadi lebih unggul dan populer dibandingkan pengobatan monoterapi saja. Penggunaan obat sintetis dengan herbal dapat memicu interaksi obat yang dapat memberikan efek menguntungkan ataupun merugikan.
Tujuan: Review ini bertujuan untuk mengetahui interaksi yang terjadi antara obat antidiabetes metformin dengan herbal.
Metode: Penelusuran pustaka melalui database Sciencedirect, Researchgate, Pharmaceutics, dan Genes MDPI dengan penggunaan kata kunci seperti metformin, antidiabetic, herb-drug, interaction, pharmacology, combination, pharmacokinetic, dan pharmacodynamic.
Hasil: Kombinasi obat metformin dengan herbal seperti ginseng Korea (Panax ginseng), kamperfuli (Lonicera japonica), amis-amisan (Houttuynia cordata), murbei (Morus alba), pisang  (Musa sapientum), pare (Momordica charantia), kelapa (Cocos nucifera), dan kopiah Cina (Scutellaria baicalensis) menunjukkan interaksi farmakokinetik berupa peningkatan penyerapan metformin dalam plasma yang diduga dimediasi oleh penghambatan MATE1 dan peningkatan OCT1, serta penghambatan hOCT2 yang menyebabkan penurunan penyerapan metformin di ginjal. Adapun interaksi farmakodinamiknya menunjukkan efek yang searah baik aditif maupun sinergis dalam penurunan kadar glukosa darah.
Kesimpulan: Konsumsi metformin dengan herbal menunjukkan adanya potensi interaksi obat baik secara farmakokinetik ataupun farmakodinamik.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19078</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art2</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 13-25</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19078/13838</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19233</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Anti-inflammatory activity of the topical formulation of Drymoglossum piloselloides (L) Presl. extract on mice</dc:title>
	<dc:creator>Yuda, Putu Era Sandhi Kusuma</dc:creator>
	<dc:creator>Suwirtawati, Ni Putu Dewanty</dc:creator>
	<dc:creator>Dewi, Ni Luh Kade Arman Anita</dc:creator>
	<dc:description xml:lang="id-ID">Background: Chronic inflammation of the joints that occur in the condition of gout or osteoarthritis and rheumatoid arthritis often causes repeated inflammation which requires patients to take a long-term pain medication, leading to serious side effects. Alternative treatment especially from herbal ingredients in a topical form is needed.Objective: This study aims to evaluate the anti-inflammatory activity of the leaves extract of Drymoglossum piloselloides (L) Presl. in mice to prove their potential as an anti-inflammatory agent.Methods: Mice were divided into four groups (n=7), namely positive control (sodium diclofenac emulgel), negative control (placebo), P1 (emulgel extract 2.5%), and P2 (emulgel extract 5%). The anti-inflammatory activity test was carried out on mice with carrageenan-induced paw edema by measuring the relative changes in the volume of inflammation at 0 and 3 hours after treatment. Data were analyzed using the Kruskal-Wallis and Mann-Whitney tests with a confidence level of 95%.Results: The emulgel contained flavonoids, triterpenoids, steroids, tannins, and quinones. The anti-inflammatory test showed a significant inhibition of inflammation (p &amp;lt;0.05) at concentrations of 2.5% and 5%. This anti-inflammatory activity could be influenced by the phytochemical compounds contained in the emulgel.Conclusion:Drymoglossum piloselloides (L) Presl. emulgel at concentrations of 2.5% and 5% had an anti-inflammatory activity on mice with carrageenan-induced paw edema.Keywords: inflammation, Drymoglossum piloselloides (L) Presl., emulgelIntisari Latar belakang: Peradangan kronis pada persendian dapat terjadi pada kondisi gout ataupun osteoartritis dan rheumatoid arthritis (RA) sering kali menimbulkan inflamasi berulang yang mengharuskan pasien mengkonsumsi obat nyeri atau anti-inflamasi nonsteroid dan kortikosteroid dalam waktu lama sehingga dapat menimbulkan efek samping yang serius, sehingga diperlukan alternatif pengobatan yang relatif lebih aman terutama dari bahan herbal dalam bentuk topikal. Tujuan: Penelitian ini bertujuan untuk menguji aktivitas antiinflamasi emulgel ekstrak daun paku sisik naga (Drymoglossum piloselloides (L) Presl.) pada mencit untuk membuktikan potensinya sebagai anti-inflamasi.Metode: Mencit dibagi empat kelompok (n=7) yaitu kontrol positif (emulgel natrium diklofenak), kontrol negatif (placebo), P1 (emulgel ekstrak konsentrasi 2,5%) dan P2 (emulgel ekstrak konsentrasi 5%). Selanjutnya dilakukan pengujian anti-inflamasi pada mencit paw edema yang diinduksi karagenan dengan mengukur perubahan volume peradangan kaki mencit pada jam ke-0 dan jam ke-3 setelah perlakuan. Data selanjutnya dianalisis menggunakan uji Kruskal-Wallis dan Mann-Whitney dengan taraf kepercayaan 95%.Hasil: Hasil uji aktivitas anti-inflamasi menunjukan adanya penghambatan peradangan yang signifikan (p&amp;lt;0,05) baik pada konsentrasi 2,5% maupun maupun 5% pada jam ke-3. Kesimpulan:Emulgel ekstrak daun paku sisik naga konsentrasi 2,5% dan 5% memiliki aktivitas anti-inflamasi pada paw edema mencit yang diinduksi karagenan.Kata kunci : inflamasi, Drymoglossum piloselloides (L) Presl., emulgel</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19233</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art4</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 137-144</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19233/11879</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19235</identifier>
				<datestamp>2023-12-31T09:55:59Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation of atorvastatin calcium tablets by liquisolid technique using propylene glycol as a solvent and some carrier materials</dc:title>
	<dc:title xml:lang="id-ID">Liquisolid tablets formulation of atorvastatin calcium using propylene glycol as solvent and some carrier materials  Formulasi tablet likuisolid kalsium atorvastatin dengan pelarut propilenglikol dan beberapa bahan pembawa</dc:title>
	<dc:creator>Windriyati, Yulias Ninik</dc:creator>
	<dc:creator>Rini, Melany Dyah Sulistyo </dc:creator>
	<dc:creator>Anggara, Dwi Aji </dc:creator>
	<dc:creator>Fitriani, Nina </dc:creator>
	<dc:description xml:lang="en-US">Background: Marketed tablets of drugs must fulfill the required standards of dissolution to guarantee the equivalent of reference. Atorvastatin calcium needs enhanced dissolution since this compound includes Biopharmaceutical Classification System (BCS) Class II drugs with low solubility and high permeability. This means that dissolution affects the bioavailability of drugs. Objective: This research aimed to develop a formulation of atorvastatin calcium tablets by liquisolid system using propylene glycol as a solvent and some carrier materials that are equivalent to the reference product.Method: Different formulations of liquisolid tablets were conducted using different quantities of carrier materials like Avicel PH 101, Avicel PH 102, and Neusilin US2, with Aerosil 200 as the coating material. The liquisolid powder was compressed into tablets by the direct compressing method. X-ray diffractometry (XRD) and FTIR analysis were used to find out more about the liquisolid tablets' properties and how the drug and excipients might interact with each other. Results: The liquisolid tablets of atorvastatin calcium were within the acceptable limit criteria. The dissolution of AA4 tablets was higher compared to conventional and marketed tablets. The XRD and Fourier transform infrared (FTIR) analyses showed no chemical interactions between the drug and the excipient.Conclusion: The liquisolid formulation can then be developed as an alternative for the production of atorvastatin calcium tablets in the pharmaceutical industry.Keywords: Atorvastatin calcium, dissolution, liquisolid, propylene glycol
Intisari Latar belakang: Sediaan tablet yang dipasarkan harus memenuhi standar disolusi yang ditetapkan untuk menjamin ekivalensinya dengan produk standar. Kalsium atorvastatin perlu ditingkatkan disolusinya, karena termasuk dalam kelas II Sistem Klasifikasi Biofarmasetik (BCS) dengan sifat kelarutan yang rendah dan permeabilitas yang tinggi. Disolusi kalsium atorvastatin mempengaruhi bioavailabilitasnya.Tujuan: Penelitian ini bertujuan mengembangkan formulasi tablet likuisolid menggunakan pelarut propilen glikol dan beberapa bahan pembawa sebagai alternatif formulasi tablet kalsium atorvastatin yang bioekivalen dengan produk standar.Metode: Tablet likuisolid dibuat dengan menambahkan berbagai komposisi bahan pembawa seperti Avicel PH 101, Avicel PH 102, dan Neusilin US2, serta Aerosil 200 sebagai pelapis pada dispersi kalsium atorvastatin dalam propilen glikol hingga terbentuk serbuk likuisolid. Serbuk likuisolid dikompresi langsung menjadi tablet setelah ditambahkan penghancur dan pelincir. Tablet likuisolid kalsium atorvastatin dievaluasi karakteristiknya dan dianalisis dengan XRD dan FTIR untuk mengetahui adanya interaksi antara zat aktif dengan eksipien yang digunakan. Hasil: Tablet likuisolid kalsium atorvastatin memenuhi kriteria tablet dalam literatur dan kompendia. Tablet likuisolid AA4 memenuhi kriteria penerimaan uji disolusi dalam Farmakope Indonesia (FI). Hasil analisis XRD dan FTIR tablet likuisolid AA4 menunjukkan tidak ada interaksi kimia antara zat aktif dengan eksipien. Kesimpulan: Formulasi tablet likuisolid dapat dikembangkan sebagai alternatif untuk produksi tablet kalsium atorvastatin di industri farmasi.Kata kunci: Kalsium atorvastatin, disolusi, likuisolid, propilen glikol</dc:description>
	<dc:description xml:lang="id-ID">Abstract Background: Marketed tablets of drugs must fulfill the required standards of dissolution to guarantee the equivalent to reference. Atorvastatin calcium needs to be enhanced dissolution since this compound included BCS Class II drugs with low solubility and high permeability. This meaning that the dissolution affects the bioavailability of drugs.Objective: This research aimed to develop a formulation of a liquisolid tablet using propylene glycol as a solvent and some carrier materials in various compositions to increase the dissolution of atorvastatin calcium.Method: Different formulations of liquisolid tablets were conducted using different quantities of carrier material like Avicel PH 101, Avicel PH 102, and Neusilin US2, while Aerosil 200 as the coating material. The liquisolid powder was compressed into tablets by the direct compressing method. The liquisolid tablets were characterized for their properties and possible drug-excipient interaction by XRD and FTIR analysis.Results: The liquisolid tablets of atorvastatin calcium were within the acceptable limits criteria. The dissolution of AA4 tablets was higher compared to marketed tablets. Based on the XRD and FTIR analysis, no chemical interactions between drug and excipient.Conclusion: The liquisolid formulation can then be developed as an alternative for the production of atorvastatin calcium tablets in the pharmaceutical industry.Keywords: Atorvastatin calcium, Dissolution, Liquisolid, propylene glycol Intisari Latar belakang: Sediaan tablet yang dipasarkan harus memenuhi standar disolusi yang ditetapkan untuk menjamin ekivalensinya dengan produk standar. Kalsium atorvastatin perlu ditingkatkan disolusinya karena termasuk dalam kelas II Sistem Klasifikasi Biofarmasetik dengan sifat kelarutan yang rendah dan permeabilitas yang tinggi. Disolusi kalsium atorvastatin mempengaruhi bioavailabilitasnya.Tujuan: Penelitian ini bertujuan mengembangkan formulasi tablet likuisolid menggunakan pelarut propilenglikol dan beberapa bahan pembawa dengan variasi komposisi untuk meningkatkan disolusi kalsium atorvastatin.Metode: Tablet likuisolid dibuat dengan menambahkan berbagai komposisi bahan pembawa seperti Avicel PH 101, Avicel PH 102, dan Neusilin US2, serta  Aerosil 200 sebagai pelapis pada suspensi kalsium atorvastatin dalam propilenglikol. Serbuk likuisolid yang terbentuk lalu dikempa menjadi tablet dengan cetak langsung. Tablet likuisolid kalsium atorvastatin dievaluasi karakteristiknya dan dianalisis dengan XRD dan FTIR untuk mengetahui adanya interaksi antara zat aktif dengan eksipien yang digunakan.  Hasil: Tablet likuisolid kalsium atorvastatin memenuhi kriteria tablet dalam literatur dan kompendia. Disolusi tablet likuisolid AA4 lebih tinggi dibandingkan dengan tablet yang beredar di pasaran. Hasil analisis XRD dan FTIR menunjukkan tidak ada interaksi kimia antara zat aktif dengan eksipien.Kesimpulan: Formulasi tablet likuisolid dapat dikembangkan sebagai alternatif untuk produksi tablet kalsium atorvastatin di industri farmasi.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19235</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art15</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 169-181</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19235/16082</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19287</identifier>
				<datestamp>2021-08-02T09:38:03Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Evaluation of medicines storage at “X” primary healthcare, Sleman Regency</dc:title>
	<dc:title xml:lang="id-ID">Evaluasi penyimpanan obat di Puskesmas &quot;X&quot; Kabupaten Sleman</dc:title>
	<dc:creator>Rugiarti, Novi Dwi</dc:creator>
	<dc:creator>Hidayati, Atika Nurul</dc:creator>
	<dc:creator>Medisa, Dian</dc:creator>
	<dc:creator>Nugraheni, Diesty Anita</dc:creator>
	<dc:description xml:lang="en-US">AbstractBackground: Medicines storage is one of the stages in drug management, which plays an essential role in ensuring the quality and availability of drugs. Therefore, it is necessary to evaluate medicines storage by comparing the performance with the storage efficiency indicators.Objective: This study aimed to determine the efficiency of medicines storage in “X” Primary Healthcare, Sleman Regency.Methods: This research was an observational study during April-May 2020 in “X” Primary Healthcare. Data collection was carried out retrospectively. Data were analyzed based on drug efficiency indicators, including the percentage of expired drugs, the percentage of dead stock, and turnover ratio (TOR).Results: The results showed 2.45% expired drugs, 2.45% deadstock, and 5.2 times TOR. The most expired drugs were pipemidic acid 400 mg, nifedipine 10 mg, and carbamazepine 200 mg.Conclusion: The storage of medicines in &quot;X&quot; Primary Healthcare was not yet efficient.Keywords: Drug storage, efficiency, primary healthcare</dc:description>
	<dc:description xml:lang="id-ID">Background: Evaluation of drug storage in a primary health care is an important process in drug management. Evaluation use with indicators. Some of indicators are Percentage of expired date drugs, percentage of stockout and Turn Over Ratio (TOR).  Objective: This study aimed to know the efficiency of drug storage in Mlati II primary health care Methods: This observation research use retrospective data.Results: Percentage of expired date drugs was 2.45% and percentage stockout was 2.45% and Turn Over Ratio was 5.2 timesConclusion: Drug storage has not efficient yet.Keywords: Evaluation, drug storage, primary health care IntisariLatar belakang: Penyimpanan obat merupakan salah tahap dalam pengelolaan obat yang berperan penting untuk menjamin kualitas dan ketersediaan obat. Oleh karena itu, perlu dilakukan evaluasi penyimpanan obat dengan membandingkan antara capaian dengan indikator efisiensi penyimpanan.Tujuan: Mengetahui efisiensi penyimpanan obat di Puskesmas “X” Kabupaten Sleman.Metode: Penelitian ini merupakan penelitian observasional pada bulan April-Mei 2020 di Puskesmas “X”, Kabupaten Sleman. Pengambilan data dilakukan secara retrospektif. Data dianalisis berdasarkan indikator efisiensi obat yang meliputi persentase obat kadaluarsa, persentase stok mati, dan Turn Over Ratio (TOR).Hasil: Hasil penelitian menunjukkan persentase obat kadaluarsa  sebesar 2,45%, stok mati 2,45 % dan TOR 5,2 kali. Sebagian besar obat yang kadaluarsa yaitu asam pipemidat 400 mg, nifedipine 10 mg, dan karbamazepin 200 mg.Kesimpulan: Berdasarkan hasil penelitian dapat disimpulkan bahwa penyimpanan obat di Puskesmas “X” masih belum efisien.Kata kunci : Efisiensi, penyimpanan obat, puskesmas </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19287</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art8</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 74-79</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19287/11443</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19287/11462</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19298</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The role of Short Chain Fatty Acids (SCFAs) in the incidence of hypertension</dc:title>
	<dc:title xml:lang="id-ID">Peran Short Chain Fatty Acids (SCFAs) Terhadap Kejadian Hipertensi</dc:title>
	<dc:creator>Sulaeman, Agus</dc:creator>
	<dc:creator>Novriana, Puput</dc:creator>
	<dc:creator>Kaniawati, Marita</dc:creator>
	<dc:subject xml:lang="en-US">gut microbiota</dc:subject>
	<dc:subject xml:lang="en-US">SCFA</dc:subject>
	<dc:subject xml:lang="en-US">hypertension</dc:subject>
	<dc:description xml:lang="en-US">Background: Hypertension is a persistently elevated arterial blood pressure called the silent killer because sufferers often do not show signs and symptoms. Low Short Chain Fatty Acids (SCFA) is a risk factor for hypertension. Therefore, many efforts have been made in overcoming hypertension through the role of SCFA. Objective: This review article was conducted to see the SCFA mechanism against the incidence of hypertension so that it is hoped that we can find medicinal plants that can prevent and treat hypertension.Method: This article is compiled based on a review of several works of literature related to the role of SCFA in hypertension from articles published in the electronic database.Results: The SCFA mechanism is involved in lowering blood pressure through G-protein coupled receptors (GPCRs). Acetate binding to GPR43 causes hyperpolarization of the colonic epithelium, propionate activates GPR41 signals located in the vascular endothelium and butyrate binds to GPR109a and exerts anti-inflammatory effects. It was also found that giving baicalin and olive oil was shown to increase SCFA-producing bacteria.Conclusion: The role of SCFA in the development of hypertension occurs through the mechanism of diffusion and transport of solutes from SCFA which then activates GPCRs including GPR43, GPR41, and GPR109a so that they have a vasodilating effect by reducing inflammation, improving intestinal permeability, decreasing sympathetic nerve activity, and increasing Treg cells. Keywords: gut microbiota; SCFA; hypertension
Intisari Latar belakang: Hipertensi adalah tekanan darah arteri yang meningkat secara persisten disebut juga silent killer karena penderita sering tidak menampakkan tanda dan gejala. Rendahnya Short Chain Fatty Acids (SCFA) menjadi faktor risiko dari hipertensi. Oleh karena itu, telah banyak upaya yang dilakukan dalam mengatasi hipertensi melalui peran SCFA.Tujuan: Review artikel ini dilakukan untuk melihat mekanisme SCFA terhadap kejadian hipertensi sehingga diharapkan dapat mencari tanaman obat yang dapat mencegah dan mengobati hipertensi.Metode: Artikel ini disusun berdasarkan review beberapa literatur yang terkait peran SCFA dalam hipertensi dari artikel yang diterbitkan di electronic database.Hasil: Mekanisme SCFA yang terlibat dalam penurunan tekanan darah melalui G-protein coupled receptors (GPCRs). Asetat mengikat GPR43 menyebabkan hiperpolarisasi epitel kolon, propionat mengaktifkan sinyal GPR41 yang terletak di endotel vaskuler dan butirat mengikat GPR109a memberikan efek anti-inflamasi. Kesimpulan: Peran SCFA dalam perkembangan hipertensi terjadi melalui mekanisme adanya difusi dan transport zat terlarut dari SCFA yang kemudian mengaktivasi GPCR termasuk GPR43, GPR41 dan GPR109a sehingga memberikan efek vasodilatasi dengan menurunkan inflamasi, memperbaiki permeabilitas usus, menurunkan aktivitas saraf simpatis dan meningkatkan sel Treg.Kata kunci: mikrobiota usus; SCFA; hipertensi</dc:description>
	<dc:description xml:lang="id-ID">Background: Hypertension is a persistent increase in arterial blood pressure and is called the silent killer. Low SCFA is a risk factor for metabolic syndrome and hypertension. Therefore, many efforts have been made in overcoming hypertension through the role of SCFA.Objective: This review article was conducted to see the SCFA mechanism against the incidence of hypertension so that it is hoped that we can find medicinal plants that can prevent and treat hypertension.Method: This article is compiled based on a review of several literature related to the role of SCFA in hypertension from articles published in the database.Results: The SCFA mechanism is involved in lowering blood pressure through G-protein coupled receptors (GPCRs). Acetate binding to GPR43 causes hyperpolarization of the colonic epithelium, propionate activates GPR41 signals located in the vascular endothelium and butyrate binds to GPR109a exerts anti-inflammatory effects. It was also found that giving baicalin and olive oil was shown to increase SCFA-producing bacteria.Conclusion: It was also found that giving baicalin and olive oil was shown to increase SCFA-producing bacteria. Impaired gut microbiota balance is associated with increased blood pressure. Administration of baicalin and olive oil has been shown to increase SCFA-producing bacteria. SCFA mechanism in reducing blood pressure by activating  GPCR including GPR43, GPR41 and GPR109a.Keywords: gut microbiota; SCFA; hypertension</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19298</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art11</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 110-122</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19298/13889</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19575</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The identification of drug related problems (DRPs) using profilaxis antibiotics in orthopedic surgical patients at a Government Hospital in Yogyakarta</dc:title>
	<dc:creator>Murdiana, Happy Elda</dc:creator>
	<dc:description xml:lang="id-ID">Background: Antibiotic prophylaxis in orthopedic surgery cases aims to prevent surgery site infections (SSI). For antibiotic prophylaxis, it is recommended to use the first generation of cephalosporin, namely cefazolin which can kill the bacteria commonly found in orthopedic surgery infection. The prophylactic administrationof cefotaxime is not the first line but is definitive for surgical prophylaxis.Objective: The aim of this study was to determine the rationale for the use of antibiotic prophylaxis for orthopedic surgery, the drug problems (DRPs) that occurred and their potential interactions.Method: This study was conducted using a cross sectional design with a total sampling technique of medical record samples from January to February 2019 at the Government Hospital in Yogyakarta. Observational analytical descriptive data processing by ensuring the appropriate of indications, route of administration,timing of administration and an appropriate of prophylactic doses as well as how to compare DPRs to the literature and analysis of potential co drug interaction with Drug Information Handbook (DIH), AHFS Clinical Drug Information, Drug Interaction Facts, and Interactions Stockley’s Drug Interaction.Results: All patients received appropriate therapy for indication, type of drug, routes of administration for pre and postoperative. All patients received an under dose of ranitidine and 1 patient (1,69%) received an over dose of piracetam. Potential interactions that occur include ketorolac-ranitidine, NSAIDs with other NSAIDs, NSAIDs-ranitidine, NSAIDs-ACEi, NSAIDs-bisoprolol, bisoprolol-calcium, calcium-vitamin C, and paracetamol-ranitidine.Conclusion: Pre and postoperative prophylactic antibiotics are rational. The accompanying drug, ranitidine and piracetam were not properly doses. Drug interactions in this study are potential.Keywords: prophylaxis antibiotic, orthopedic surgery, cefotaxim, DRPs IntisariLatar belakang: Profilaksis antibiotic pada kasus bedah ortopedi bertujuan mencegah timbulnya Infeksi Luka Operasi (ILO). Profilaksis antibiotik untuk bedah disarankan menggunakan sefalosporin generasi pertama yaitu cefazolin yang dapat membunuh bakteri s. aureus yang biasa terdapat pada infeksi bedah ortopedi. Pemberian profilaksis cefotaxim bukan lini pertama tetapi direkomendasikan untuk profilaksis bedah.Tujuan: Penelitian ini bertujuan mengetahui kerasionalan (DRPs) penggunaan antibiotik profilaksis bedah ortopedi dan obat penyerta yang diberikan.Metode: Penelitian ini menggunakan metode rancangan cross sectional, teknik total sampel dilakukan dalam pengambilan sampel rekam medis bulan Januari–Februari 2019 di Rumah Sakit Pemerintah di Yogyakarta. Pengolahan data deskriptif analitik observasional dengan menganalisa ketepatan indikasi, jenis obat, rute pemberian, waktu pemberian dan ketepatan dosis antibiotic profilaksis serta obat penyerta dengan cara membandingkan DRPs terhadap literatur dan menganalisa potensi interaksi obat penyerta dengan buku Drug Information Handbook (DIH), AHFS Clinical Drug Informaton, Interaction Drug Fact, dan Stockley’s Drug Interaction.Hasil: Semua pasien mendapatkan terapi tepat indikasi, jenis obat, rute pemberian, dan tepat dosis pemberian obat untuk pre dan paska pembedahan. Semua pasien menerima dosis kurang untuk terapi penyerta ranitidin dan 1 pasien (1,69%) menerima piracetam dosis berlebih. Potensial interaksi yang terjadimeliputi ketorolak-ranitidin, NSAID dengan NSAID lain, NSAID-ranitidin, NSADI ACEI, NSAID-bisoprolol, bisoprolol-kalsium, kalsium-vitamin C, dan paracetamol-ranitidinKesimpulan: Pemberian antibiotik profilaksis pra dan paska pembedahan rasional. Obat penyerta berupa ranitidin dan piracetam tidak tepat dosis. Interaksi obat pada penelitian ini bersifat potensial.Kata kunci: antibiotik profilaksis, bedah ortopedi, cefotaxim, DRPs</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19575</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art10</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 210-225</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19575/11883</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19575/13282</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19604</identifier>
				<datestamp>2024-01-02T02:54:07Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Monoterpenoid and sesquiterpenoid active compounds from essential oils of the rhizomes of the Zingiberaceae family</dc:title>
	<dc:title xml:lang="id-ID">Senyawa aktif monoterpenoid dan sesquiterpenoid dari minyak atsiri rimpang suku Zingiberaceae</dc:title>
	<dc:creator>Shifa, Hasna Nur</dc:creator>
	<dc:creator>Marliani, Lia</dc:creator>
	<dc:creator>Suhardiman, Aris</dc:creator>
	<dc:subject xml:lang="en-US">essential oil</dc:subject>
	<dc:subject xml:lang="en-US">rhizome</dc:subject>
	<dc:subject xml:lang="en-US">Zingiberaceae</dc:subject>
	<dc:subject xml:lang="en-US">terpenoid</dc:subject>
	<dc:description xml:lang="en-US">Background: Plants of the Zingiberaceae family are widely grown and cultivated in Indonesia. One of the uses of these plants by the community is as traditional medicine. The part of the plant that is often used as a traditional medicine in the Zingiberaceae family is the rhizome. The potential of Zingiberaceae as a drug is closely related to its pharmacological activity and the active compounds it contains. Essential oils are materials contained in the Zingiberaceae family and have the potential to be active compounds.Objective: This review article was compiled to study the compounds contained in the essential oil of the Zingiberaceae family and the biological activities of these compounds.Method: Article reviews were conducted using an electronic literature search method through journal portals such as Google Scholar, Science Direct, and Research Gate using keywords, namely identification of the chemical content of essential oils, rhizomes, Zingiberaceae, biological activity, and pharmacological activity.Results: This study found that the main terpenoid compounds in the essential oil from the rhizome of the Zingiberaceae family are α-cineol, β-pinene, β-sesquiphellandrene, and α-Zingiberene. Each of them has a different pharmacological activity, such as antibacterial, antiviral, or cytotoxic.Conclusion: The essential oil from the rhizomes of the Zingiberaceae family has great potential to be developed as a medicinal ingredient with antibacterial, antiviral, and anticancer properties. Before being used as a drug, it is necessary to carry out further research on toxicity, biopharmaceutical, and clinical research.Keywords: Essential oil, rhizome, Zingiberaceae, terpenoid
Intisari Latar belakang: Tumbuhan suku Zingiberaceae banyak tumbuh dan dibudidayakan di Indonesia. Salah satu pemanfaatan tumbuhan tersebut oleh masyarakat adalah sebagai obat tradisional. Bagian tumbuhan yang sering dimanfaatkan sebagai obat tradisioal dari suku Zingiberaceae adalah rimpang. Potensi suku Zingiberaceae sebagai obat berhubungan erat dengan aktivitas farmakologi dan senyawa aktif yang dikandungnya. Minyak atsiri merupakan zat yang terkandung dalam suku Zingiberaceae dan berpotensi sebagai senyawa aktif. Tujuan: Review artikel ini disusun untuk mengkaji senyawa yang terkandung pada minyak atsiri rimpang tanaman suku Zingiberaceae dan aktivitas biologi dari senyawa tersebut. Metode: Review artikel dilakukan menggunakan metode pencarian literatur secara elektronik melalui portal jurnal seperti Google Scholar, Science Direct, dan Research Gate dengan menggunakan kata kunci yaitu identifikasi kandungan kimia minyak atsiri, rimpang, Zingiberaceae, aktivitas biologi, aktivitas farmakologi.Hasil: Senyawa terpenoid yang banyak terkandung dalam minyak atsiri rimpang suku Zingiberaceae, yaitu 1,8-cineol, α-pinene, β–pinene, β-sesquiphellandrene dan α-Zingiberene. Masing-masing memiliki aktivitas farmakologi berbeda seperti antibakteri, antivirus, dan sitotoksik.Kesimpulan: Minyak atsiri dari rimpang suku Zingiberaceae berpotensi besar untuk dikembangkan sebagai bahan obat seperti antibakteri, antivirus dan antikanker. Sebelum digunakan sebagai obat ,perlu dilakukan penelitian lebih lanjut mengenai toksisitas, biofarmasetika, dan penelitian secara klinis.Kata kunci: Minyak atsiri; rimpang; Zingiberaceae, terpenoid</dc:description>
	<dc:description xml:lang="id-ID">Intisari Latar belakang: Tumbuhan suku Zingiberaceae banyak tumbuh dan dibudidayakan di Indonesia. Salah satu pemanfaatan tumbuhan tersebut oleh masyarakat adalah sebagai obat tradisional. Bagian tumbuhan yang sering dimanfaatkan sebagai obat tradisioal dari suku Zingiberaceae adalah rimpang. Potensi suku Zingiberaceae sebagai obat berhubungan erat dengan aktivitas farmakologi dan senyawa aktif yang dikandungnya. Minyak atsiri merupakan zat yang terkandung dalam suku Zingiberaceae dan berpotensi sebagai senyawa aktif. Tujuan: Review artikel ini disusun untuk mengkaji senyawa yang terkandung pada minyak atsiri rimpang tanaman suku Zingiberaceae dan aktivitas biologi dari senyawa tersebut. Metode: Review artikel dilakukan menggunakan metode pencarian literatur secara elektronik melalui portal jurnal seperti Google Scholar, Science Direct, dan Research Gate dengan menggunakan kata kunci yaitu identifikasi kandungan kimia minyak atsiri, rimpang, Zingiberaceae, aktivitas biologi, aktivitas farmakologi.Hasil: Senyawa terpenoid yang banyak terkandung dalam minyak atsiri rimpang suku Zingiberaceae, yaitu 1,8-cineol, α-pinene, β–pinene, β-sesquiphellandrene dan α-Zingiberene. Masing-masing memiliki aktivitas farmakologi berbeda seperti antibakteri, antivirus, dan sitotoksik.Kesimpulan: Minyak atsiri dari rimpang suku Zingiberaceae berpotensi besar untuk dikembangkan sebagai bahan obat seperti antibakteri, antivirus dan antikanker. Sebelum digunakan sebagai obat ,perlu dilakukan penelitian lebih lanjut mengenai toksisitas, biofarmasetika, dan penelitian secara klinis.Kata kunci: Minyak atsiri; rimpang; Zingiberaceae, terpenoid</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19604</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art17</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 195-208</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19604/16085</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19673</identifier>
				<datestamp>2023-12-31T09:55:59Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Transdermal patch formulation from kombucha green tea as an antibacterial Staphylococcus aureus </dc:title>
	<dc:title xml:lang="id-ID">Formulasi Patch Transdermal Dari Kombucha Teh Hijau Sebagai Antibakteri Staphylococcus aureus</dc:title>
	<dc:creator>Muhsinin, Soni</dc:creator>
	<dc:creator>Pertiwi, Tria Wulandari</dc:creator>
	<dc:creator>Zaelani, Diki</dc:creator>
	<dc:subject xml:lang="en-US">Green tea</dc:subject>
	<dc:subject xml:lang="en-US">kombucha</dc:subject>
	<dc:subject xml:lang="en-US">paper disc diffusion</dc:subject>
	<dc:subject xml:lang="en-US">patch</dc:subject>
	<dc:subject xml:lang="en-US">S. aureus</dc:subject>
	<dc:description xml:lang="en-US">Background: Fermentation of green tea with kombucha starter can increase the content of polyphenols and catechins. Both of these secondary metabolites have antibacterial and antioxidant activity. The transdermal patch can be applied to the skin as an antibacterial.Objective: The purpose of this study was to formulate a patch of kombucha green tea that has antibacterial activity against S. aureus.Method: The research started with the fermentation of kombucha green tea; patch formulations with kombucha variations of 10% (F1), 15% (F2), and 20% (F3); patch evaluation; and activity testing using the paper disc diffusion method.Results: The results showed an increase in antibacterial activity in kombucha green tea (fermented) by 40.58%. The evaluation results of the kombucha patch show that all formulas (F1, F2, and F3) have a weight and thickness that are not significantly different from the comparison (market patches), while the pH stability shows that all formulas show a stable pH for 28 days of storage.Conclusion: Kombucha green tea can be formulated in the form of a patch and has potential as an antibacterial against S. aureus.Keywords: Green tea, kombucha, paper disc diffusion, patch, S. aureus
Intisari Latar belakang: Fermentasi teh hijau dengan stater kombucha dapat meningkatkan kandungan polifenol dan katekin. Kedua metabolit sekunder tersebut mempunyai aktivitas sebagai antibakteri dan aktioksidan. Patch merupakan sediaan transdermal yang dapat diaplikasikan di kulit sebagai antibakteri.Tujuan: Penelitian yang telah dilakukan bertujuan untuk melakukan formulasi sediaan patch dari kombucha teh hijau yang mempunyai aktivitas sebagai antibakteri terhadap S. aureus.Metode: Tahapan penelitian dimulai dari fermentasi kombucha teh hijau; formulasi patch dengan variasi kombucha 10% (F1), 15% (F2), dan 20% (F3); evaluasi sediaan patch; dan uji aktivitas menggunakan metode difusi cakram kertas.Hasil: Hasil penelitian menunjukan peningkatan aktivitas antibakteri pada kombucha teh hijau (hasil fermentasi) sebesar 40,58%. Hasil evaluasi patch kombucha, semua formula (F1, F2, dan F3) mempunyai bobot dan ketebalan yang tidak berbeda signifikan dengan pembanding (patch yang ada di pasaran), sedangkan stabilitas pH, semua formula menunjukan pH yang stabil selama penyimpanan 28 hari.Kesimpulan: Kombucha teh hijau dapat diformulasikan dalam bentuk sediaan patch dan mempunyai potensi sebagai antibakteri terhadap S. aureus.Kata kunci: Difusi cakram kertas, kombucha, patch, S. aureus, teh hijau</dc:description>
	<dc:description xml:lang="id-ID">Background: Fermentation of green tea with kombucha starter can increase the content of polyphenols and catechins. Both of these secondary metabolites have activity as antibacterial and antioxidant. The transdermal patch can be applied to the skin as an antibacterial.Objective: The purpose of this study was to formulate a patch of kombucha green tea which has antibacterial activity against S. aureus.Method: The research started with the fermentation of kombucha green tea; patch formulations with kombucha variations of 10% (F1), 15% (F2), and 20% (F3); patch evaluation; and activity test using the paper disc diffusion method.Results: The results showed an increase in antibacterial activity in kombucha green tea (fermented) by 40.58%. The evaluation results of the kombucha patch, all formulas (F1, F2, and F3) have a weight and thickness that are not significantly different from the comparison (market patches), while the pH stability, all formulas show a stable pH for 28 days of storage.Conclusion: The conclusion of this study is that kombucha green tea can be formulated in the form of a patch and has potential as an antibacterial against S.aureus.Keywords: Green Tea; Kombucha; Paper Disc Diffusion; Patch; S.aureus</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19673</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art19</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 220-231</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19673/16092</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19696</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The use of anti-hyperlipidemia in a private hospital in Yogyakarta during 2013-2019</dc:title>
	<dc:creator>Febrianti, Yosi</dc:creator>
	<dc:creator>Saepudin, Saepudin</dc:creator>
	<dc:creator>Medisa, Dian</dc:creator>
	<dc:creator>Tetuko, Haryo</dc:creator>
	<dc:creator>Hasanah, Siti Nurul Fadhillah</dc:creator>
	<dc:description xml:lang="id-ID">Background: Lipid modifying agents have an important role in the primary and secondary prevention of cardiovascular diseases such as coronary heart disease and stroke. The use of lipid-modifying agents tends to increase along with the increasing prevalence of these diseases.Objectives: To determine the utilization of lipid modifying agents for hospitalized patients in a private hospital in Yogyakarta during the period of 2013 - 2019 in regard to the agents used and their quantity.Methods: The main data for this study were aggregate data on the use of lipid modifying agents for hospitalized patients during 2013-2019 obtained from the hospital pharmacy department. After identification of the names of lipid modifying agents, the quantities of these drugs were then calculated in units of defined daily dose (DDD) and the final quantity was expressed in DDD/100 bed days (BD). The R2 value from linear regression was used to determine the trend of use of individual agents over the period.Results: There were two pharmacological subgroups of lipid modifying agents used during the period of 2013 – 2019 with an average of total quantity of 14.81 DDD/100 BD. Utilization of statins was approximately 90% of the total use, and utilization of fibrates tended to decrease over the period. Individually, simvastatin use decreased significantly over the period (R2 = 0.885), but atorvastatin use continued to increase (R2 = 0.908) with 10-fold increase from 2013 to 2019.Conclusion: The lipid modifying agents used during the period 2013 - 2019 were predominantly statins, and the utilization of atorvastatin increased significantly during this period.Keywords: lipid modifying agents, ATC/DDD, fibrates, statinsIntisariLatar Belakang: Antihiperlipidemia memiliki peran penting dalam pencegahan primer maupun sekunder penyakit kardiovaskular terutama penyakit jantung koroner dan stroke. Penggunaan golongan obat tersebut di berbagai fasilitas kesehatan cukup tinggi seiring dengan masih tingginya prevalensi penyakit kardiovaskular.Tujuan: Untuk mengetahui profil penggunaan antihiperlipidemia untuk pasien rawat inap di salah satu rumah sakit swasta di Yogyakarta selama periode tahun 2013 – 2019 berdasarkan jenis obat dan kuantitas penggunaannya.Metode: Data utama yang digunakan dalam penelitian ini adalah data agregat penggunaan antihiperlipidemia untuk pasien rawat inap selama tahun 2013 - 2019 yang diperoleh dari instalasi farmasi rumah sakit. Setelah mengetahui jenis obat antihiperlipidemia yang digunakan, kuantitas penggunaan obat-obat tersebut dihitung dalam satuan defined daily dose (DDD) dan kuantitas akhir dinyatakan dalam DDD/100 bed days (BD). Nilai R2 dari persamaan garis lurus digunakan untuk mengetahui kecenderungan peningkatan atau penurunan penggunaan obat antihiperlipidemia secara individual selama periode tahun 2013 – 2019.Hasil: Terdapat dua golongan antihiperlipidemia yang digunakan selama periode tahun 2013 – 2019, yaitu golongan statin dan fibrat, dengan rata-rata kuantitas penggunaan secara total sebesar 14,81 DDD/100 BD. Penggunaan antihiperlipidemia golongan statin secara rata-rata sekitar 90% dari keseluruhan antihiperlipidemia yang digunakan dan penggunaan obat golongan fibrat cenderung menurun dari tahun ke tahun. Secara individual, simvastatin menunjukkan penggunaan yang menurun secara signifikan dari tahun ke tahun (R2=0,885) namun sebaliknya penggunaan atorvastatin terus meningkat (R2=0,908) dengan peningkatan hampir 10 kali lipat dari tahun 2013 ke tahun 2019.Kesimpulan: Antihiperlipidemia yang digunakan selama periode tahun 2013 – 2019 sebagian besar merupakan golongan statin dan atorvastatin yang penggunaannya yang meningkat secara signifikan.Kata kunci: antihiperlipidemia, ATC/DDD, fibrat, statin</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19696</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art7</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 173-181</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19696/11880</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/19962</identifier>
				<datestamp>2021-07-31T16:49:14Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Development innovation of silver nanoparticles used leaves of banana  (Musa sapientum) as eco-friendly bioreductor</dc:title>
	<dc:creator>Nugroho, Bambang Hernawan</dc:creator>
	<dc:creator>Artikawati, Rika</dc:creator>
	<dc:creator>Suparmi, Suparmi</dc:creator>
	<dc:description xml:lang="en-US"> Abstract Background: Silver nanoparticle could be developed by natural reducing agent like Epigallocatechin Gallate (EGCG) of banana leaves (Musa sapientum) as bioreductor in biosynthesis.Objective: This study aimed to examine the formulation and characterization of silver nanoparticles using the combination of banana leaf (M. sapientum) extract containing epigallocatechin gallate (EGCG) for biosynthesis. The biosynthesis of silver nanoparticles is eco-friendly and low energy process.Method: Each formula was added with 500microlitre AgNO3. Identification of nanoparticles was characterized by duration of its discoloration, its absorbance using UV/Vis spectrophotometer and FTIR, its particle size using PSA, and its morphology under TEM.Result: The silver nanoparticle formation need less than 15 minutes. The measurement of its absorbance showed the wavelength of this silver nanoparticles are in the range of 410-480nm. Characterization using FTIR showed a decrease in absorption of the functional -OH group spectrum. This particle has the smallest particle size in value of 57.16 ± 0.40 nm in spherical shape.Conclusion: Nanosilver could be prepared using banana leaf extract using low energy biosynthesis process.Keywords: characterization, nanosilver, banana leaf (M. sapientum) Intisari Latar belakang: Nanopartikel perak dapat dihasilkan melalui bahan pereduksi dari alam yang mengandung  epigallocatechin gallate (EGCG) yang terdapat pada daun pisang (Musa sapientum) sebagai bioreduktor.Tujuan: Penelitian ini bertujuan untuk membuat formulasi dan karakterisasi nanopartikel perak menggunakan kombinasi ekstrak daun pisang (M. sapientum) yang mengandung EGCG.Metode: Masing-masing formula ditambahkan dengan 500mikrolitre AgNO3. Kemudian dilakukan Identifikasi dan karakterisasi nanopartikel dengan melihat parameter perubahan warna, spektrofotometri UV-Vis dan FTIR, pengamatan partikel dengan PSA dan pengamatan morfologi partikel dengan TEM.Hasil: Hasil pengamatan menunjukkan bahwa terjadi perubahan warna kurang dari 15 menit setelah pencampuran. Hasil pengukuran pada UV-Vis spektrofotometer memiliki resonasi permukaan plasmon pada daerah 410-480 nm. Karakterisasi menggunakan FTIR menunjukkan penurunan penyerapan spektrum gugus -OH fungsional. Ukuran partikel terkecil yang diperoleh yaitu pada 57,16±0,40 nm dan berbentuk sferis. Kesimpulan: Nanopartikel perak dapat dibuat dengan menggunakan ekstrak daun pisang melalui proses biosintesis rendah energi.Kata kunci: karakterisasi, nanopartikel perak, daun pisang (M. sapientum)</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/19962</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss1.art7</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 1 (2021): Jurnal Ilmiah Farmasi; 64-73</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/19962/11440</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20001</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effects of n-acetylcysteine administration as a preventive therapy for contrast-induced nephropathy after percutaneous coronary intervention in the elderly</dc:title>
	<dc:title xml:lang="id-ID">Efek Pemberian N-Asetilsistein sebagai Terapi Pencegahan Contrast Induced Nephropathy Pasca Intervensi Koroner Perkutan pada Lansia</dc:title>
	<dc:creator>Veryanti, Putu Rika</dc:creator>
	<dc:creator>Agripa, Gamaliel</dc:creator>
	<dc:subject xml:lang="en-US">N-acetylcysteine</dc:subject>
	<dc:subject xml:lang="en-US">preventive therapy</dc:subject>
	<dc:subject xml:lang="en-US">contrast-induced nephropathy (CIN)</dc:subject>
	<dc:subject xml:lang="en-US">percutaneous coronary intervention (PCI) </dc:subject>
	<dc:subject xml:lang="en-US">elderly</dc:subject>
	<dc:description xml:lang="en-US">Background: Contrast-induced nephropathy (CIN) is a common complication in patients undergoing percutaneous coronary intervention (PCI). The Elderly is one of the risk factors for CIN and increase mortality. N-acetylcysteine is recommended as preventive therapy for CIN post PCI due to its antioxidant activity. However, previous studies have shown that the effectiveness of n-acetylcysteine as preventive therapy for CIN is still inconsistent. Objective: The aim of this study was to determine the effect of N-acetylcysteine as preventive therapy for CIN post PCI in the elderly. Method: This study used a retrospective study design. Data collection was carried out at one General Hospital in Jakarta from January until March 2020. The medical records in the 2019 period were used for the population. We included an elderly patient who underwent PCI by purposive sampling technique and obtained 78 samples. Data were analyzed by paired t-test to determine the effect of N-acetylcysteine as preventive therapy for CIN post PCI in the elderly. Results: The characteristic of elderly patients who underwent PCI were dominated by males (66.67%) with a GFR &amp;lt;60 mL/min/1.73m2 (74.36%). About 92.31% of patients did not have CIN and only 7.69% of patients showed a significant acute renal impairment (LFG decreased &amp;gt; 20%). Overall, there was an increase in average GFR value (2.33±7.90) in elderly who underwent PCI after n-acetylcysteine administration (p=0.011).Conclusion: N-acetylcysteine was effective in preventing the incidence of CIN post PCI in the elderly.Keywords: N-acetylcysteine, preventive therapy, contrast-induced nephropathy (CIN), percutaneous coronary intervention (PCI), elderly
IntisariLatar belakang: Contrast Induced Nephropathy (CIN) diketahui sebagai komplikasi yang banyak terjadi pada pasien yang menjalani intervensi koroner perkutan (IKP). Usia lanjut merupakan salah satu faktor resiko terjadinya CIN dan dapat meningkatkan mortalitas. N-asetilsistein direkomendasikan sebagai terapi pencegahan CIN pasca IKP karena dihubungkan dengan aktivitas antioksidannya. Namun dari berbagai penelitian terkait efektivitas N-asetilsistein untuk mencegah CIN masih beragam dan tidak konsisten.Tujuan: Tujuan penelitian ini untuk mengetahui efek N-asetilsistein sebagai terapi pencegahan CIN paska IKP pada lansia.Metode: Penelitian menggunakan rancangan studi retrospektif. Pengambilan data dilakukan di salah satu rumah sakit umum di Jakarta pada bulan Januari – Maret 2020. Sampel yang digunakan adalah data rekam medik pasien periode tahun 2019 yang menjalani IKP dan berusia lanjut. Pengambilan sampel menggunakan teknik purposive sampling, diperoleh 78 sampel yang memenuhi kriteria inklusi dan eksklusi. Data diolah dan dianalisis dengan uji-t berpasangan untuk mengetahui efek N-asestilsistein sebagai terapi pencegahan CIN paska IKP pada lansia.Hasil: Karakteristik pasien lansia yang menjalani IKP didominasi oleh laki-laki (66,67%) dengan nilai LFG &amp;lt;60 mL/min/1,73m2 sebanyak 74,36%. Dari 78 pasien yang diberi terapi N-Asetilsistein, 92,31% diantaranya tidak mengalami CIN dan hanya 7,69% yang mengalami penurunan nilai LFG &amp;gt;20%. Secara keseluruhan, terjadi peningkatan rata-rata nilai LFG pada lansia yang menjalani IKP setelah pemberian N-asetilsistein sebesar 2,33±7,90 (p=0,011).Kesimpulan: N-asetilsistein efektif dalam mencegah kejadian CIN paska IKP pada lansia.Kata kunci: N-asetilsistein, contrast induced nephropathy (CIN), intervensi koroner perkutan (IKP), lansia</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Contrast Induced Nephropathy (CIN) diketahui sebagai komplikasi yang banyak terjadi pada pasien yang menjalani intervensi koroner perkutan (IKP). Usia lanjut merupakan salah satu faktor resiko terjadinya CIN dan dapat meningkatkan mortalitas. N-Asetilsistein direkomendasikan sebagai terapi pencegahan CIN pasca IKP karena dihubungkan dengan aktivitas antioksidannya. Namun dari berbagai penelitian terkait efektivitas N-Asetilsistein untuk mencegah CIN masih beragam dan tidak konsisten.Tujuan: Tujuan dari penelitian ini adalah untuk mengetahui efek N-Asetilsistein sebagai terapi pencegahan CIN pasca IKP pada lansia.Metode: Penelitian ini menggunakan rancangan studi retrospektif. Pengambilan data dilakukan di RSUPN Dr. Cipto Mangunkusumo pada Bulan Januari – Maret 2020. Sampel yang digunakan adalah data rekam medik pasien periode tahun 2019 yang menjalani IKP dan berusia lanjut. Melalui teknik purposive sampling, diperoleh 78 sampel yang memenuhi kriteria inklusi dan eksklusi. Data diolah dan dianalisis dengan uji-t berpasangan untuk mengetahui efek N-Asestilsistein sebagai terapi pencegahan CIN pasca IKP pada lansia.Hasil: Karkteristik pasien lansia yang menjalani IKP didominasi oleh laki-laki (66,67%) dengan nilai LFG &amp;lt;60 ml/min/1,73m2 sebanyak 74,36%. Dari 78 pasien yang diberi terapi N-Asetilsistein, 92,31% diantaranya tidak mengalami CIN dan hanya 7,69% yang mengalami penurunan nilai LFG &amp;gt;20%. Secara keseluruhan, terjadi peningkatan rata-rata nilai LFG pada lansia yang menjalani IKP setelah pemberian N-Asetilsistein sebesar 2,33±7,90 (p=0,011).Kesimpulan: N-Asetilsistein efektif dalam mencegah kejadian CIN pasca IKP pada lansia.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20001</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art7</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 64-72</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20001/13879</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20078</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antioxidant potential of telang flowers (Clitoria ternatea L.) as an inhibitor of hyperpigmentation due to ultraviolet exposure</dc:title>
	<dc:title xml:lang="id-ID">Antioxidant Potential of Telang Flower (Clitoria ternatea L.) As an Inhibitor of Hyperpigmentation Ultraviolet Exposure. Potensi Antioksidan Bunga Telang (Clitoria ternatea L.) Sebagai Penghambat Hiperpigmentasi Akibat Paparan Sinar Ultraviolet</dc:title>
	<dc:creator>Rosalita Jelantik, Ni Putu Anggun Cipta</dc:creator>
	<dc:creator>Cahyaningsih, Erna</dc:creator>
	<dc:description xml:lang="en-US">Background: Hyperpigmentation is a condition in which increased melanin production causes the formation of dark spots and lesions on the face. Antioxidants are used to reduce melanin production. Telang flowers have an antioxidant potential because it contains anthocyanins and other flavonoids. The potential of telang flowers is important to be recognized as a source of natural antioxidants that inhibit hyper-pigmentation on the skin due to UV exposure. Objective: To learn about the potential of telang flowers (Clitoria ternatea L.) as an inhibitor of skin hyperpigmentation due to UV exposureMethods: Data was collected using a systematic review method. The data was obtained from Google Scholar, ScienceDirect, and PubMed databases with the keywords “Clitoria ternatea L. antioxidant activity”; “phytochemical analysis of Clitoria ternatea”; “traditional use of Clitoria ternatea L”; “protective UV effect of Clitoria ternatea L.Results: Flavonol glycosides are the most common flavonoids found in telang flowers. Flavonoids exhibit antioxidant properties by counteracting the formation of free radicals caused by UV radiation in the melanin biosynthetic pathway. In addition, flavonoids act as metal chelators on tyrosinase, thereby inactivating tyrosinase during melanogenesis. Telang flowers also have the ability to absorb UV-B and UV-C, playing a role in modulating the protective effect against UVR exposure on the skin.Conclusion: Telang flowers have the potential as an inhibitor of skin hyper-pigmentation due to UV exposure.Keywords: Antioxidant, telang flower, hyper-pigmentation, ultraviolet
IntisariLatar belakang: Hiperpigmentasi merupakan keadaan bertambahnya produksi melanin yang menyebabkan terbentuknya lesi dan noda hitam pada wajah. Antioksidan diketahui dapat digunakan untuk mengurangi produksi melanin. Bunga telang memiliki potensi antioksidan, karena terdapat antosianin dan flavonoid lainnya. Potensi bunga telang penting diketahui sebagai sumber antioksidan alami penghambat hiperpigmentasi pada kulit akibat paparan sinar UV.Tujuan: Untuk mempelajari mengenai potensi bunga telang (Clitoria ternatea L.) sebagai penghambat hiperpigmentasi kulit akibat paparan sinar UVMetode: Pengumpulan data dilakukan menggunakan basis data Google Scholar, Science Direct dan PubMed dengan kata kunci “Clitoria ternatea L. antioxidant activity”; “phytochemical analysis of Clitoria ternatea”; “traditional use of Clitoria ternatea L”; “protective UV effect of Clitoria ternatea L.Hasil: Flavonol glikosida merupakan flavonoid yang paling banyak dijumpai pada bunga telang. Flavonoid menunjukkan sifat antioksidan dengan menangkal pembentukan radikal bebas yang disebabkan oleh radiasi UV pada jalur biosintesis melanin. Selain itu, flavonoid bertindak sebagai pengkelat logam pada tirosinase, sehingga menonaktifkan aktivitas tirosinase selama melanogenesis. Bunga telang juga memiliki kemampuan dalam menyerap UV-B dan UV-C yang berperan dalam memodulasi efek perlindungan terhadap paparan UVR pada kulit.Kesimpulan: Bunga telang memiliki potensi sebagai penghambat hiperpigmentasi kulit akibat paparan sinar UV.Kata kunci: Antioksidan, bunga telang, hiperpigmentasi, sinar ultraviolet</dc:description>
	<dc:description xml:lang="id-ID">Abstract Background: Hyperpigmentation is a condition of increased melanin production which causes the formation of dark spots and lesions on the face. Antioxidants are known to be used to reduce melanin production. Telang flower has antioxidant potential, because it contains anthocyanins and other flavonoids. The potential of Telang flower is important to know as a source of natural antioxidants that inhibit hyperpigmentation on the skin due to UV exposure. Objective: To learn about the potential of Telang flower (Clitoria ternatea L.) as an inhibitor of skin hyperpigmentation due to UV exposureMethod: Data was collection using Google Scholar, Science Direct and PubMed databases with the keywords “Clitoria ternatea L. antioxidant activity”; “phytochemical analysis of Clitoria ternatea”; “traditional use of Clitoria ternatea L”; “protective UV effect of Clitoria ternatea L.Results: Flavonol glycosides are the most common flavonoids found in the Telang flower. Flavonoids exhibit antioxidant properties by counteracting the formation of free radicals caused by UV radiation in the melanin biosynthetic pathway. In addition, flavonoids act as metal chelators on tyrosinase, thereby inactivating tyrosinase activity during melanogenesis. Telang flower also has the ability to absorb UV-B and UV-C which plays a role in modulating the protective effect against UVR exposure on the skin.Conclusion: Telang flower has potential as an inhibitor of skin hyperpigmentation due to UV exposure.Keywords: Antioxidant, Telang Flower, Hyperpigmentation, Ultraviolet Intisari Latar belakang: Hiperpigmentasi merupakan keadaan bertambahnya produksi melanin yang menyebabkan terbentuknya lesi dan noda hitam pada wajah. Antioksidan diketahui dapat digunakan untuk menurangi produksi melanin. Bunga Telang memiliki potensi antioksidan, karena terdapat antosianin dan flavonoid lainnya. Potensi bunga Telang penting diketahui sebagai sumber antioksidan alami penghambat hiperpigmentasi pada kulit akibat paparan sinar UV.Tujuan: Untuk mempelajari mengenai potensi bunga Telang (Clitoria ternatea L.) sebagai penghambat hiperpegmentasi kulit akibat paparan sinar UVMetode: Pengumpulan data dilakukan menggunakan basis data Google Scholar, Science Direct dan PubMed dengan kata kunci “Clitoria ternatea L. antioxidant activity”; “phytochemical analysis of Clitoria ternatea”; “traditional use of Clitoria ternatea L”; “protective UV effect of Clitoria ternatea L.Hasil: Flavonol glikosida merupakan flavonoid yang paling banyak dijumpai pada bunga Telang. Flavonoid menunjukkan sifat antioksidan dengan menangkal pembentukan radikal bebas yang disebabkan oleh radiasi UV pada jalur biosintesis melanin. Selain itu, flavonoid bertindak sebagai pengkelat logam pada tirosinase, sehingga menonaktifkan aktivitas tirosinase selama melanogenesis. Bunga Telang juga memiliki kemampuan dalam menyerap UV-B dan UV-C yang berperan dalam memodulasi efek perlindungan terhadap paparan UVR pada kulit.Kesimpulan: Bunga Telang memiliki potensi sebagai penghambat hiperpigmentasi kulit akibat paparan sinar UV.Kata kunci : Antioksidan, Bunga Telang, Hiperpigmentasi, Sinar ultraviolet.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20078</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art5</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 45-54</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20078/13836</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20200</identifier>
				<datestamp>2022-03-19T07:53:34Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Potential drug interactions analysis of COVID-19 patients at a hospital in West Java</dc:title>
	<dc:creator>Kusumawardani, Larasati Arrum</dc:creator>
	<dc:creator>Maria, Nisa</dc:creator>
	<dc:creator>Fanani, Yumna Nabila</dc:creator>
	<dc:description xml:lang="en-US">Background: Treatment guidelines of COVID-19 are changing continuously by involving many off-label and various symptomatic or supportive drugs. The use of these various drugs might increase the patient’s risk of developing drug interactions.Objective: The study aimed to analyze potential drug-drug interactions in COVID-19 inpatients and the correlated factors.Method: A cross-sectional study was conducted in a hospital by using inpatients admitted from August-December 2020. Potential drug-drug interaction was analyzed by using Lex-Interact® software.Results: From 107 patients, the majority of them are in moderate severity-degree (98.1%), having comorbidities (93.5%), and polypharmacy (98.1%). The average of potential drug interactions was 8.47±8,04, with most of the interaction in risk rating C-monitor therapy. Major potential drug interactions found were prolongation of QT interval and disturbance of drug absorption in the gastrointestinal tract. A positive correlation occurred between drug interactions found and comorbidity (r=0.436), number of drugs per prescription (r=0.674), and length of stay (r=0.222)Conclusions: COVID-19 patient is at risk for developing potential drug interactions that can affect the patient's physiological condition and reduce drug effect. It is necessary to manage the medication schedule, therapy modification, administration route changing, dosage adjustment, and monitoring of effects that might occur because of the drug interactions.Keywords: drug interaction, COVID-19, inpatient, correlated factor IntisariLatar belakang: Tatalaksana pengobatan COVID-19 terus berkembang dengan melibatkan berbagai jenis obat off-label dan berbagai obat terapi simptomatik ataupun suportif. Penggunaan berbagai jenis obat ini membuat pasien berisiko mengalami interaksi obat.Tujuan: Penelitian ini bertujuan untuk menganalisis potensi interaksi antar obat yang dapat terjadi pada pasien COVID-19 rawat inap serta faktor yang mempengaruhinya.Metode: Penelitian dilakukan dengan desain cross-sectional menggunakan sampel pasien rawat inap di rumah sakit pada periode Agustus-Desember 2020. Analisis potensi interaksi antar obat dilakukan dengan menggunakan Lexi-Interact®Hasil: Sebanyak 107 sampel pasien didapatkan mayoritas dalam tingkat keparahan sedang (98,1%), memiliki komorbid (93,5%), dan polifarmasi (98,1%). Rata-rata jumlah potensi interaksi obat yang dialami adalah 8,47± 8,04 dengan tingkat interaksi paling banyak pada kategori C (pantau terapi) (54,61%). Potensiinteraksi obat mayor yang banyak ditemukan adalah adanya perpanjangan pada interval QT serta gangguan absorpsi obat di saluran cerna. Terdapat korelasi positif antara potensi interaksi obat dengan faktor komorbid (r=0,436), jumlah obat per resep (r=0,674), serta lama rawat inap (r= 0,222).Kesimpulan: Pasien COVID-19 memiliki risiko tinggi untuk mengalami potensi interaksi obat yang dapat mempengaruhi kondisi fisiologis pasien dan mengurangi efek terapi obat. Maka dari itu, perlu dilakukan pengaturan waktu minum, modifikasi terapi, perubahan rute pemberian, penyesuaian dosis, serta pemantauan efek obat yang mungkin muncul akibat interaksinya.Kata kunci : interaksi obat, COVID-19, rawat inap, faktor yang mempengaruhi</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20200</dc:identifier>
	<dc:identifier>10.20885/jif.vol17.iss2.art8</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 17 No. 2 (2021): Jurnal Ilmiah Farmasi; 182-197</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20200/11889</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20200/13395</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20222</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Combination of ethanolic extract on total flavonoid Centella asiatica L. leaves  and Imperata cylindrica L. roots with UV-VIS spectrophotometric method</dc:title>
	<dc:creator>Widiyana, Anita Puspa</dc:creator>
	<dc:creator>Herlina, Sri</dc:creator>
	<dc:creator>Illian, Didi Nurhadi</dc:creator>
	<dc:description xml:lang="en-US">Background: Flavonoids are widely employed as phytomedicines and as secondary metabolites generated by plants, where they serve key roles in plant physiology. Antioxidant, anti-inflammatory, anticancer, antibacterial, antifungal, and antiviral activities are only a few of the potential biological effects of flavonoids. The discovery of medicinal plants containing flavonoid chemicals is potential as a supportive and preventative treatment, notably for COVID-19 which has caused a pandemic in several countries, including Indonesia.Objective: This study aimed to determine the total flavonoid content in the ethanolic extracts of C. asiatica leaves and Imperata cylindrica roots to find the potential of flavonoid-rich plants as an alternative source of COVID-19 treatment.Methods: The ethanolic extracts from the combination of C. asiatica leaves and I. cylindrica roots (with five combination ratios) were tested for total flavonoid content using the UV-Vis Spectrophotometry method. The total flavonoid content of the extract combination was analyzed using a one-way ANOVA test.Results: The total flavonoid contents of the combination of C. asiatica leaf and I. cylindrica root extracts at a ratio of 1:1, 2:3, 3:2, 4:1, and 1:4 were 45.88 ± 0.08, 42.14 ± 0.08, 40.52 ± 0.08, 66.28 ± 0.08, and 40.88 ± 0.13 mg/g EQ, respectively. The homogeneity with Levene's test obtained a p-value of 0.303. The one-way ANOVA exhibited the p-value of F-test statistics &amp;lt; 0.001. Conclusion: The total flavonoid contents of ethanolic extracts from C. asiatica leaves and I. cylindrica roots are at a ratio of 4:1 &amp;gt; 1:1 &amp;gt; 2:3 &amp;gt; 1:4 &amp;gt; 3:2. The high total flavonoid content plays a role in increasing anti-inflammatory and immunomodulatory activities in COVID-19 patients.Keywords: Total flavonoid content, C. asiatica, I. cylindrica, UV-Vis Spectrophotometry, COVID-19</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-21</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20222</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art6</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 55-63</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20222/13854</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20714</identifier>
				<datestamp>2023-07-31T16:54:14Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Drug utilization pattern and cost estimates of antihypertensive drugs in pharmacies BPJS Kesehatan back-referral program in Kudus Regency</dc:title>
	<dc:creator>Wildayanti</dc:creator>
	<dc:creator>Wijayanti, Tri </dc:creator>
	<dc:creator>Andayani , Tri Murti </dc:creator>
	<dc:subject xml:lang="en-US">ATC/DDD</dc:subject>
	<dc:subject xml:lang="en-US">DU 90%</dc:subject>
	<dc:subject xml:lang="en-US">hypertension</dc:subject>
	<dc:subject xml:lang="en-US">national formulary</dc:subject>
	<dc:subject xml:lang="en-US">PRB</dc:subject>
	<dc:description xml:lang="en-US">AbstractBackground: Hypertension is one of the main causes of mortality and morbidity in Indonesia. Drug usage, utilization patterns, and cost estimates are important elements in calculating drug needs in the forecasting of drug needs plans for pharmacies.Objective: to determine the pattern of drug use with the Anatomical Therapeuetik Chemical (ATC)/Defined Daily Dose (DDD) and Drug Use 90% (DU90%) methods and the estimated cost of antihypertensives with the use of antihypertensive drugs based on the national formulary.Methods: This research uses observational methods using a cross-sectional design. Retrospective data collection includes prescription from BPJS Kesehatan back-referral program (PRB) which goes into pharmacy A, B, and C for the period 2020.Results: The most widely used drugs at pharmacy A, B and C based on ATC/DDD classification were amlodipine, candesartan, ramipril, hydrochlorothiazide, and lisinopril. Amlodipine was the most frequent drug in the DU segment 90%. The highest cost of using the drug was candesartan 16 mg (Rp 4,381,531). The percentages of adherence to the use of antihypertensive drugs with the national formulary in pharmacy A, B, and C were 73.91%, 80%, and 68.42%, respectively.Conclusion: In general, the highest consumption of antihypertensive drugs in Back-Referral Program (PRB) pharmacies in the area of Kudus Regency, which is included in the DU segment 90%, was amlodipine, and the suitability of drugs with the National Formulary has not reached 100%. Referring to the results of the pattern of use of PRB drugs in this study, it is hoped that there will be better coordination between BPJS Kesehatan and pharmacies regarding the distribution and availability of PRB drugs.Keywords: ATC/DDD, DU 90%, hypertension, national formulary, PRB
IntisariLatar belakang: Hipertensi merupakan salah satu penyebab utama mortalitas dan morbiditas di Indonesia. Pola pemakaian obat dan perkiraan biaya merupakan elemen penting dalam menghitung rencana kebutuhan obat di apotek. Tujuan: Penelitian ini bertujuan untuk mengetahui pola penggunaan obat dengan metode Anatomical Therapeuetik Chemical (ATC)/ Defined Daily Dose (DDD), DU 90%, perkiraan biaya antihipertensi dan kesesuaian penggunaan obat antihipertensi dengan Formularium Nasional (Fornas).Metode: Penelitian menggunakan metode observasional dengan desain cross sectional. Pengumpulan data dilakukan secara retrospektif meliputi resep Program Rujuk Balik (PRB) yang masuk ke apotek A, B dan C pada periode 2020.Hasil: Penggunaan obat di apotek A, B dan C berdasarkan ATC/DDD yang banyak digunakan yaitu amlodipin, candesartan, ramipril, hidroklorotiazid dan lisinopril. Segmen DU 90% penggunaan obat tertinggi adalah amlodipin dan biaya penggunaan obat tertinggi yaitu candesartan 16mg sebesar Rp4.381.531,00. Persentase kesesuaian penggunaan obat antihipertensi dengan Fornas pada apotek A, B, dan C yaitu 73,91%, 80%, dan 68,42%. Kesimpulan: Secara umum konsumsi obat antihipertensi terbanyak di apotek PRB Kabupaten Kudus yang masuk dalam segmen DU 90% adalah amlodipin serta kesesuaian obat dengan Fornas belum mencapai 100%. Merujuk pada hasil pola penggunaan obat PRB pada penelitian ini, diharapkan adanya koordinasi yang lebih baik antara BPJS Kesehatan dengan pihak apotek mengenai distribusi dan ketersediaan obat PRB.Kata kunci: ATC/DDD, DU 90%, hipertensi, formularium nasional, PRB</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20714</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss1.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 1 (2023): Jurnal Ilmiah Farmasi; 31-43</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol19.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20714/15444</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20801</identifier>
				<datestamp>2023-01-01T15:40:41Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Screening of Eurycoma longifolia compounds on the cell cycle with docking through cyclin interaction</dc:title>
	<dc:title xml:lang="id-ID">Skrining senyawa Eurycoma longifolia terhadap siklus sel dengan metode docking melalui interaksi cylcin</dc:title>
	<dc:creator>Hadi, Samsul</dc:creator>
	<dc:creator>Anwar, Khoerul </dc:creator>
	<dc:creator>Komari, Noer </dc:creator>
	<dc:creator>Azhara, Desiya Ramayanti </dc:creator>
	<dc:creator>Rosanti, Diah Aulia </dc:creator>
	<dc:subject xml:lang="en-US">Docking</dc:subject>
	<dc:subject xml:lang="en-US">Eurycoma longifolia</dc:subject>
	<dc:subject xml:lang="en-US">cyclin</dc:subject>
	<dc:description xml:lang="en-US">Background: The community has known pasak bumi for generations to increase sexual desire in men (aphrodisiac). Besides, it can improve the performance of sports athletes and as an antistress, reduce tension, anger, and confusion. Objective: This relatively large number of uses encourages researchers to want to do in silico screening of active compounds against antitumors by going through 2 stages, namely through online PASS and docking. Method: Docking method to see the stability interaction of compounds with cyclin. In this test, Pyrx was used as a docking tool with various cell cycle-related targets, namely cyclin D3 (PDB ID: 3G33), cyclin A (PDB ID: IJSU), cyclin A (PDB ID, cyclin C (1ZP2), cyclin D (ID PDB: 2W9F), cyclin H (PDB ID: 1KXU), and cyclin T (PDB ID: 3BLR). Results: The docking result showed that each cyclin showed the best interaction with these compounds: Cyclin A and 9-Methoxycanthin-6-one 3-N-oxide (-8.6 Kcal/mol), cyclin H and Niloticin (-8.0 Kcal/mol), cyclin D3 is 9-Methoxycanthin-6-one 3-N-oxide (-7.2 Kcal/mol), cyclin D is Eurycolactone F (-8.4 Kcal/mol), cyclin C is and Niloticin (-7.5 Kcal/mol), and cyclin T and Niloticin (-8.2 Kcal/mol). Conclusion: Based on the docking score obtained, the stability of the interaction is predicted to occur in cyclin A and 9-Methoxycanthin-6-one 3-N-oxide (ΔG: -8.6 Kcal/mol).
Intisari
Latar belakang: Pasak bumi telah dikenal oleh masyarakat secara turun-temurun untuk meningkatkan gairah seksual pada pria (afrodisiaka). Disamping itu dapat meningkatkan performa atlet olahraga dan sebagai antistress, menurunkan tegangan, kemarahan, dan kebingungan. Tujuan: Penggunaan yang relatif banyak ini mendorong peneliti berkeinginan melakukan skrining senyawa aktif terhadap antitumor secara in silico dengan melalui 2 tahap yaitu melalaui PASS online dan docking. Metode: Metode docking dipakai untuk melihat interaksi stabilitas senyawa dengan cylin. Dalam pengujian ini, Pyrx digunakan sebagai alat docking dengan berbagai target yang berhubungan dengan siklus sel, yaitu cyclin D3 (PDB ID: 3G33), cyclin A (PDB ID: IJSU), cyclin C (PDB ID: 1ZP2), cyclin D (ID PDB: 2W9F), cyclin H (ID PDB: 1KXU), dan cyclin T (ID PDB: 3BLR). Hasil: Hasil docking pada masing-masing cyclin menunjukkan interaksi terbaik dengan senyawa berikut ini: cyclin A dan 9-Methoxycanthin-6-one 3-N-oxide (-8,6 Kkal/mol), cyclin H dan Niloticin (-8,0 Kkal/mol), cyclin D3 dan 9-Methoxycanthin-6-one 3-N-oxide (-7,2 Kkal/mol), cyclin D dan Eurycolactone F (-8,4 Kkal/mol), cyclin C dan Niloticin (-7,5 Kkal/mol), serta cyclin T dan Niloticin (-8,2 Kkal/mol). Kesimpulan: Berdasarkan skor docking yang diperoleh, kestabilan interaksi diprediksi akan terjadi pada cyclin A dengan 9-Methoxycanthin-6-one 3-N-oxide (ΔG: -8.6 Kkal/mol).</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Pasak bumi telah dikenal oleh masyarakat secara turun-temurun untuk meningkatkan gairah seksual pada pria (afrodisiaka). Disamping itu dapat meningkatkan performa atlet olahraga dan sebagai antistress, menurunkan tegangan, kemarahan, dan kebingungan. 
Tujuan: Penggunaan yang relatif banyak ini mendorong peneliti berkeinginan melakukan skrining senyawa aktif terhadap antitumor secara in silico dengan melalui 2 tahap yaitu melalaui PASS online dan docking.  
Metode: Metode docking dipakai untuk melihat interaksi stabilitas senyawa dengan cylin. Dalam pengujian ini, Pyrx digunakan sebagai alat docking dengan berbagai target yang berhubungan dengan siklus sel, yaitu cyclin D3 (PDB ID: 3G33), cyclin A (PDB ID: IJSU), cyclin C (PDB ID: 1ZP2), cyclin D (ID PDB: 2W9F), cyclin H (ID PDB: 1KXU), dan cyclin T (ID PDB: 3BLR). 
Hasil: Hasil docking pada masing-masing cyclin menunjukkan interaksi terbaik dengan senyawa berikut ini: cyclin A dan 9-Methoxycanthin-6-one 3-N-oxide (-8,6 Kkal/mol), cyclin H dan Niloticin (-8,0 Kkal/mol), cyclin D3 dan 9-Methoxycanthin-6-one 3-N-oxide (-7,2 Kkal/mol), cyclin D dan Eurycolactone F (-8,4 Kkal/mol), cyclin C dan Niloticin (-7,5 Kkal/mol), serta cyclin T dan Niloticin (-8,2 Kkal/mol). 
Kesimpulan: Berdasarkan skor docking yang diperoleh, kestabilan interaksi diprediksi akan terjadi pada cyclin A dengan 9-Methoxycanthin-6-one 3-N-oxide (delta G: -8.6 Kkal/mol).</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20801</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art15</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 153-163</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20801/14533</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/20872</identifier>
				<datestamp>2023-01-01T16:18:10Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Characterization and determination of total flavonoid content of extract and fraction of papaya jantan flower (Carica papaya L.) using UV-Vis spectrophotometry</dc:title>
	<dc:title xml:lang="id-ID">Karakterisasi dan Penetapan Kadar Flavonoid Total Ekstrak dan Fraksi Bunga Pepaya Jantan (Carica papaya L.) dengan Spektrofotometri UV-Vis</dc:title>
	<dc:creator>Pratiwi, Dilla Nur</dc:creator>
	<dc:creator>Utami, Nastiti</dc:creator>
	<dc:creator>Pratimasari, Diah</dc:creator>
	<dc:subject xml:lang="en-US">Carica</dc:subject>
	<dc:subject xml:lang="en-US">flavonoid</dc:subject>
	<dc:subject xml:lang="en-US">cinnamoyl</dc:subject>
	<dc:subject xml:lang="en-US">benzoyl</dc:subject>
	<dc:subject xml:lang="en-US">spectrophotometry UV-Vis</dc:subject>
	<dc:description xml:lang="en-US">Background: The potential of pepaya jantan flowers (Carica papaya L.) as functional herbal ingredients, such as antioxidants, is influenced by the activity of secondary metabolites, one of which is flavonoids.
Objective: This study aims to determine the total flavonoid content and characterization of flavonoids in the ethanol extract and flower fraction of papaya jantan (Carica papaya L.).
Method: Pepaya jantan flower was extracted by maceration using ethanol 70% then fractionated using multilevel fractionation. The identification of flavonoids was tested using Taubeck, Wilstater, and TLC. Extract and fractions were determined of flavonoid content using the colorimetric method and identification of flavonoids based on the wavelength of cinnamoyl and benzoyl in the spectrum UV-Vis.
Results: The results of the determination of flavonoid content showed that ethanol extract was the highest at 0.6805 ± 0.0045 %QE and n-hexane fractions were the lowest at 0.4178 ± 0.0058 %QE. Identification of flavonoids using the UV-Vis spectroscopy method showed the absorption of substituted 3-OH flavonol and free 3-OH flavonol. 
Conclusion: The highest flavonoid content was found in the ethanol extract of papaya jantan flower. The types of flavonoids in the extract and fractions of male papaya flower indicated the type of flavonol based on the wavelength of cinnamoyl and benzoyl.</dc:description>
	<dc:description xml:lang="id-ID">AbstractBackground: The potential of male papaya flowers (Carica papaya L.) as functional herbal ingredients, such as antioxidants, is influenced by the activity of secondary metabolites, one of them is flavonoid.Objective: This study to determine the content of flavonoid and characterization flavonoids in ethanol extract and fractions of male papaya flower (Carica papaya L.).Method: Male papaya flower was maceration using ethanol 70% then fractionated using multilevel fractionation. Identification flavonoid was tested by using the Taubeck, Wilstater, and TLC. Extract and fractions were determined the content of flavonoid using colorimetric method and identification of flavonoids based on the wavelength of cinnamoyl and benzoyl in the spectrum UV-Vis.Results: The results of the determination of flavonoid content showed that ethanol extract was the highest 0.6805 ± 0.0045 %QE and n-hexane fractions was the lowest 0.4178 ± 0.0058 %QE. Identification of flavonoids using UV-Vis spectroscopy method showed the absorption of substituted 3-OH flavonol and free 3-OH flavonol.Conclusion: The highest flavonoid content was found in the ethanol extract of male papaya flower. The types of flavonoids in the extract and fractions of male papaya flower indicated the type of flavonol based on the wavelength of cinnamoyl and benzoyl.Keywords: carica, flavonoid, cinnamoyl, benzoyl, UV-Vis Intisari Latar belakang: Potensi bunga pepaya jantan (Carica papaya L.) sebagai bahan fungsional herbal, seperti antioksidan dipengaruhi oleh aktivitas dari metabolit sekunder, salah satunya flavonoid.Tujuan: Penelitian ini bertujuan untuk mengetahui kadar flavonoid total serta karakterisasi flavonoid dalam ekstrak etanol dan fraksi bunga pepaya jantan (Carica papaya L.).Metode: Bunga pepaya jantan dilakukan maserasi dengan etanol 70%, dilanjutkan fraksinasi bertingkat. Identifikasi flavonoid dilakukan menggunakan metode Taubeck, Wilstater dan KLT. Kadar flavonoid ekstrak dan fraksi ditetapkan menggunakan metode kolorimetri serta identifikasi flavonoid berdasarkan pita cinnamoyl dan benzoyl pada spektrum UV-Vis.Hasil: Hasil penetapan kadar flavonoid menunjukkan bahwa ekstrak etanol memiliki kadar tertinggi sebesar 0,6805 ± 0,0045 %QE, serta kadar terendah dalam fraksi n-heksan sebesar 0,4178 ± 0,0058 %QE. Identifikasi flavonoid metode spektrofotometri UV-Vis menunjukkan penyerapan flavonol 3-OH substitusi dan flavonol 3-OH bebas.Kesimpulan: Kadar flavonoid tertinggi ditemukan dalam ekstrak etanol bunga pepaya. Jenis flavonoid dalam ekstrak dan fraksi bunga pepaya jantan mengindikasikan jenis flavonol berdasarkan panjang gelombang dari cinnamoyl dan benzoyl.Kata kunci : carica, flavonoid, cinnamoyl, benzoyl, UV-Vis</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/20872</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art20</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 219-233</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/20872/14538</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21181</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Pigment screening, phytochemical test, and cytotoxicity testing of the ethanol extract of Holothuria atra sea cucumber from Lemukutan island waters </dc:title>
	<dc:title xml:lang="id-ID">Skrining Pigmen, Uji Fitokimia, dan Sitotoksik Ekstrak Etanol Teripang Holothuria atra dari Perairan Pulau Lemukutan</dc:title>
	<dc:creator>Yuliana, Wenti </dc:creator>
	<dc:creator>Idiawati, Nora </dc:creator>
	<dc:creator>Prayitno, Dwi Imam</dc:creator>
	<dc:description xml:lang="en-US">Background: Holothuria atra is a type of sea cucumber found in the waters of Lemukutan Island, West Kalimantan, which has economic and ecological benefits. Personal experience found the presence of a water-soluble pigment when isolating sea cucumbers, which was bright red, thus drawing attention. Research on the water-soluble pigment of the ethanol extract of H. atra from Lemukutan Island waters has not been carried out yet. Natural pigments in sea cucumbers have a specific role as part of secondary metabolite compounds with the potential of having antimicrobial, antifungal, anticancer, antitumor, antiviral, anticoagulant, and antioxidant activities.Objective: This study aimed to determine the natural pigments, secondary metabolites, and cytotoxic compounds in the ethanolic extract of H. atra.Methods: Samples of H. atra were extracted with 96% ethanol. The pigment analysis used UV-Vis spectrophotometry while the secondary metabolites were tested by the phytochemical screening method, and the cytotoxicity testing involved the Brine Shrimp Lethal Toxicity (BSLT) method.Results: The obtained optimum absorption was 230 nm, which indicated a melanin pigment. The phytochemical test on the ethanolic extract of H. atra found flavonoid, phenolic, alkaloid, saponin, and triterpenoid compounds. The cytotoxicity test based on LC50 was 6.985 ppm, indicating the extract was categorized as extremely toxic because it was &amp;lt;30 ppm.Conclusion: The pigment in H. atra is melanin, the secondary metabolites consist of flavonoids, phenolics, alkaloids, saponins, and triterpenoids, and it has a highly toxic activity.Keywords: Holothuria atra, melanin, phytochemical test, BSLT, cytotoxic
IntisariLatar belakang: Holothuria atra adalah salah satu jenis teripang yang ditemukan di Perairan Pulau Lemukutan Kalimantan Barat, memiliki manfaat ekonomi maupun ekologi. Pengalaman saat pengambilan sampel dijumpai adanya pigmen larut air dari tempat sampel, berwarna merah cerah dan menarik perhatian. Penelitian tentang pigmen larut air pada ekstrak etanol H. atra dari perairan Pulau Lemukutan belum pernah dilakukan. Pigmen alami pada teripang memiliki peranan tertentu, sebagai bagian dari senyawa metabolit sekunder berpotensi sebagai antimikroba, antijamur, antikanker, antitumor, antivirus, antikoagulan dan antioksidan.Tujuan: Penelitian ini bertujuan mengetahui pigmen alami, senyawa metabolit sekunder dan potensi sitotoksik pada ekstrak etanol H. atra.Metode: Sampel H. atra diekstraksi dengan etanol 96%. Analisis pigmen menggunakan spektrofotometri UV-Vis, pengujian senyawa metabolit sekunder dengan metode skrining fitokimia dan uji sitotoksik menggunakan metode Brine Shrimp Lethal Toxicity (BSLT).Hasil: Serapan optimum yang dihasilkan oleh ekstrak etanol adalah 230 nm yang merupakan pigmen melanin. Hasil uji fitokimia pada ekstrak etanol H. atra ditemukan senyawa flavonoid, fenolik, alkaloid, saponin dan triterpenoid. Uji sitotoksik berdasarkan LC50 adalah 6,985 ppm menunjukkan ekstrak dengan kategori sangat toksik karena nilainya &amp;lt;30 ppm.Kesimpulan: Pigmen pada H.atra yaitu melanin. Kadungan ekstrak etanol metabolit sekunder teridiri dari flavonoid, fenolik, alkaloid, saponin dan triterpenoid serta memiliki aktivitas toksistas yang sangat toksik.Kata kunci: Holothuria atra, melanin, uji fitokmia, BSLT, sitotoksik</dc:description>
	<dc:description xml:lang="id-ID">Holothuria atra is a type of sea cucumber found in the waters of Lemukutan Island, West Kalimantan, which has economic and ecological benefits. Personal experience shown the presence of water-soluble pigments when isolating sea cucumbers, it was bright red and attracts attention. Research on water soluble pigment on ethanol extract of H. atra from the waters of Lemukutan Island has not been carried out yet. Natural pigments in sea cucumbers have a certain role, as part of secondary metabolite compounds that have potential as antimicrobial, antifungal, anticancer, antitumor, antiviral, anticoagulant and antioxidant compounds.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21181</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art4</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 34-44</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21181/13834</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21344</identifier>
				<datestamp>2023-01-01T15:51:05Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Potential of the superoxide dismutase enzyme from corn kernels (Zea mays L.) for the repair of 3T3 fibroblast cells exposed to ultraviolet A light</dc:title>
	<dc:title xml:lang="id-ID">Potensi Enzim Superoksida Dismutase dari Biji Jagung (Zea Mays L.) untuk Perbaikan Sel Fibroblas 3t3 Yang Dipaparkan Sinar Ultraviolet A</dc:title>
	<dc:creator>Pratiwi, Mustika Endah</dc:creator>
	<dc:creator>Peranginangin, Jason Merari </dc:creator>
	<dc:creator>Asiya, Isna Jati </dc:creator>
	<dc:creator>Indrayati, Ana </dc:creator>
	<dc:subject xml:lang="en-US">Corn kernel</dc:subject>
	<dc:subject xml:lang="en-US">anti-photoaging</dc:subject>
	<dc:subject xml:lang="en-US">SOD</dc:subject>
	<dc:subject xml:lang="en-US">3T3 fibroblast cell </dc:subject>
	<dc:description xml:lang="en-US">Background: UV-A radiation induct disorder to the skin called photoaging. It requires treatment with antioxidant agent. Superoxide dismutase (SOD) is the first line antioxidant in the treatment of free radicals. 
Objective: This study aimed to find out anti-photoaging activities of SOD extract of corn (Zea mays L.) kernels on radiated UV-A rays 3T3 fibroblast cells.
Method: SOD extraction of corn kernels was done by centrifugation, precipitation and dialysis method. The activity of SOD extract in corn kernels was measured by WST-1 method. Anti-photoaging activity test of SOD extract in corn kernels was done on radiated UV-A rays 3T3 fibroblast cells with parameters of cell viability. Anti-photoaging activity test using cell control, negative, sample and positive control.  
Results: SOD activity showed that the highest percent inhibition value was SOD extract of corn kernels in precipitation of ammonium sulphate concentration was 60-90% with inhibition percentage was 65.50%. The result of anti-photoaging activity SOD extract of corn kernels showed significant difference in the value of percent cell viability in fibroblast cells between the extract group and the negative control group with the highest percent cell viability in SOD extract corn kernels with the concentration was 100 mg/mL, namely 142.31%.
Conclusion: SOD extract from corn kernels has proven had antioxidant activity that could be used as anti-photoaging through fibroblast cell reparation mechanism.</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Radiasi sinar UV-A memicu gangguan pada kulit yang disebut fotoaging. Fotoaging ditangani dengan zat antioksidan. SOD merupakan antioksidan enzimatis lini pertama dalam penanganan radikal bebasTujuan: Tujuan dari penelitian ini adalah untuk mengetahui aktifitas antifotoaging ekstrak SOD biji jagung pada sel fibroblas 3T3 yang dipaparkan sinar UV-A.Metode: Ekstraksi SOD biji jagung dilakukan menggunakan metode sentrifugasi, presipitasi dan dialisis. Aktivitas SOD dari ekstrak SOD biji jagung dilakukan dengan menggunakan metode WST-1. Aktivitas antifotoaging ekstrak SOD biji jagung dilakukan pada sel fibroblas 3T3 yang dipaparkan sinar UV-A dengan parameter viabilitas sel. Pengujian aktivitas antifotoaging menggunakan kontrol sel, kontrol negatif, sampel dan kontrol positif. Hasil pengukuran aktivitas antifotoaging ekstrak SOD biji jagung dianalisis menggunakan One Way ANOVA dengan uji Tukey.Hasil: Persen inhibisi aktivitas SOD tertinggi yaitu pada ekstrak SOD biji jagung presipitasi amonium sulfat konsentrasi 60-90%. Aktivitas antifotoaging ekstrak SOD biji jagung menunjukkan perbedaan bermakna pada nilai persen viabilitas sel pada sel fibroblas antara kelompok ekstrak dengan kelompok kontrol negatif dengan hasil persen viabilitas sel tertinggi yaitu pada ekstrak SOD biji jagung konsentrasi 100 mg/ml. Nilai EC90 untuk parameter viabilitas sel yaitu sebesar 12,57 mg/ml dan 69,47 mg/ml.Kesimpulan: Ekstrak SOD dari biji jagung terbukti memiliki aktivitas sebagai antioksidan yang dapat digunakan sebagai anti fotoaging melalui mekanisme perbaikan sel fibroblast.Kata kunci : Biji jagung, antifotoaging, kolagen, SOD, sel fibroblas 3T3</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21344</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art16</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 164-177</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21344/14534</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21445</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Optimization of cardamom fruit ethanol extract gel with combination of HPMC and Sodium Alginate as the gelling agent using Simplex Lattice Design</dc:title>
	<dc:creator>Putri, Wati Eliana</dc:creator>
	<dc:creator>Anindhita, Metha Anung</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Cardamom has been studied and proven to be effective as an antibacterial. Gel preparations are preferred because they have advantages such as being easy to apply, providing a cooling effect, and being able to deliver drugs well.Objective: The purpose of this study was to make a gel formulation of ethanolic cardamom fruit extract by optimizing the combination of the gelling agent of HPMC and sodium alginate using the simplex lattice design (SLD).Methods: Cardamom fruit extract was obtained by extracting cardamom fruit simplicia using 70% ethanol. The formulation of the gel preparation from cardamom fruit extract was optimized using the SLD method on Design Expert. There were 5 gel formulas made and evaluated including organoleptic, pH, viscosity, spreadability, and adhesion. The independent variables in SLD were the amount of HMC and sodium alginate, while the responses included viscosity, spreadability, and adhesion. Optimal formula selection is done by using a numerical approach.Results: FI (HPMC 3.75% and sodium alginate 2.75%) and FII (HPMC 3.50% and sodium alginate 3.00%) met the test criteria for all the tests performed. The optimal formula suggested by SLD is a combination of 3.53% HPMC and 2.98% sodium alginate with a desirability value of 1.00. The predicted value for each response was the viscosity of 214.83 dPa.s, dispersion of 5.38 cm, and adhesion of 50.08 seconds. The optimal formula showed a dispersion value of 5.37cm. The results of the t-test indicated that the dispersion value of the observed results is not significantly different from the prediction software.Conclusion: Based on this research, it can be concluded that the use of a combination of HPMC and sodium alginate as a gelling agent can be optimized by using a simplex lattice design to obtain the optimum formula for cardamom fruit extract gel.Keywords: gel, hpmc, sodium alginate, SLD, kapulaga IntisariLatar Belakang: Kapulaga telah diteliti dan terbukti dapat dimanfaatkan sebagai antibakteri. Sediaan gel disukai karena memiliki keunggulan antara lain mudah merata bila dioleskan, memberikan efek dingin serta dapat menghantarkan obat dengan baik.Tujuan: Penelitian ini bertujuan untuk membuat formulasi sediaan gel ekstrak buah kapulaga dengan mengoptimasi penggunaan kombinasi gelling agent HPMC dan natrium alginat menggunakan metode Simplex Lattice Design (SLD). Metode: Ekstrak buah kapulaga diperoleh dengan mengekstraksi simplisia buah kapulaga menggunakan etanol 70%. Formulasi sediaan gel dari ekstrak buah kapulaga dioptimasi menggunakan metode SLD pada Design Expert. Terdapat 5 formula gel yang dibuat dan dievaluasi meliputi organoleptis, pH, viskositas, daya sebar, dan daya lekat. Variabel bebas pada SLD adalah jumlah HMC dan natrium alginat, sedangkan responnya meliputi viskositas, daya sebar, dan daya lekat. Pemilihan formula optimum dilakukan menggunakan pendekatan numerical.  Hasil: FI (HPMC 3,75% dan natrium alginat 2,75%) dan FII (HPMC 3,50% dan natrium alginat 3,00%) memenuhi kriteria uji semua pengujian yang dilakukan. Formula optimal yang disarankan SLD adalah kombinasi HPMC 3,53% dan natrium alginat 2,98% memiliki desirability 1,00 dengan prediksi viskositas bernilai 214,83 dPa.s, daya sebar bernilai 5,38 cm, dan daya lekat 50,08 detik. Pengujian terhadap formula optimal hasil optimasi SLD menunjukkan nilai daya sebar 5,37cm sesuai dengan nilai respon pada SLD. Hasil uji-t menunjukkan nilai daya sebar hasil observasi tidak berbeda signifikan dibandingkan dengan prediksi software.Kesimpulan: Berdasarkan penelitian ini dapat disimpulkan bahwa penggunaan variasi HPMC dan natrium alginat sebagai gelling agent dalam formula gel ekstrak buah kapulaga dapat dioptimasi menggunakan simplex lattice design.Kata kunci : gel, hpmc, natrium alginat, SLD, kapulaga </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21445</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art13</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 107-120</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21445/12159</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21458</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The study of drug interaction on pneumonia patients at RSUP Dr. M. Djamil Padang</dc:title>
	<dc:creator>Azyenela, Lola</dc:creator>
	<dc:creator>Aria, Mimi</dc:creator>
	<dc:creator>Aristya, Lana</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Pneumonia is one of the diseases that cause high rates of toddler deaths in the world. In Indonesia, pneumonia is the second cause of death of infants and toddlers after diarrheal diseases. Most pneumonia patients are treated with other diseases so many pneumonia patients receive more than two types of drugs in one prescription, this has the potential for drug interactions with drugs.Objective: The aim of this study was to look at potential occurrences of drug interactions in toddler patients at Dr.M. Djamil Padang Hospital hospitalized in 2019.Methods: This research was nonexperimental research design with cross-sectional descriptive methods of analysis and the data retrieved retrospectively. The patient's medical records were analyzed using the Drugs.com software and Medscape.Results: There were 62 patients who met the inclusion criteria. Among them, there were 5 pneumonia patients (8.1%) who experienced drug interactions with drugs, with the pharmacokinetic category as many as 3 cases (42.9%) affecting metabolism and drug interactions in the pharmacodynamic category by 4 cases (57.1%). Based on the severity of drug interactions, this study found 1 minor case (14.3%), 5 moderate cases (71.4%), and 1 major case (14.3%).Conclusion: From the results of the study it can be concluded that there was a potential for drug interactions in pneumonia toddler patients at Dr.M. Djamil Padang Hospital in the period 2019.Keywords: Bronchopneumonia, drug Interactions, toddlerIntisariLatar belakang: Pneumonia merupakan penyakit infeksi saluran pernapasan penyebab kematian utama pada balita di seluruh dunia. Di Indonesia, pneumonia menduduki peringkat kedua penyebab kematian bayi dan balita setelah diare. Pneumonia dapat disebabkan karena bakteri yang menyerang saluran pernapasan. Tatalaksana terapi pada pneumonia umumnya kombinasi beberapa obat. Hal ini berpotensi menimbulkan masalah pengobatan khususnya interaksi obat. Tujuan: Penelitian ini bertujuan untuk melihat kejadian interaksi obat pada pasien balita di instalasi rawat inap anak RSUP Dr. M. Djamil tahun 2019. Metode: Desain penelitian yang digunakan adalah cross-sectional deskriptif dengan pengambilan data secara retrospektif melalui rekam medis pasien. Setiap jenis obat yang tertulis rekam medis dianalisis dengan menggunakan bank data dari software Drug.com dan Medscape. Hasil: Data diambil dari 62 pasien, berdasarkan jumlah tersebut dapat diidentifikasi 5 pasien mengalami interaksi obat (8,1%), terdiri dari 71,4% moderat, 14,3% minor dan 14,3% mayor. Kesimpulan: Interaksi obat yang sering terjadi pada pasien balita dengan pneumonia adalah penggunaan kaptopril dengan furosemid. Kata kunci: Balita, interaksi obat, pneumonia</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21458</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art15</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 128-135</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21458/12163</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21461</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Anti-hypercholesterolemic activity of herbal juice with shelf life of 50 and 100 days in male rats induced by PTU and high-fat diet</dc:title>
	<dc:creator>Meisyayati, Sari</dc:creator>
	<dc:creator>Rasyad, Ade Arinia</dc:creator>
	<dc:creator>Nanda, Frelis Setya</dc:creator>
	<dc:creator>Lestari, Ayu</dc:creator>
	<dc:creator>Ferianto, Alex</dc:creator>
	<dc:creator>Wahyudi, Rizki</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Herbal juice with the composition of rosella flower, garlic, red ginger, dan lime extract, apple cider vinegar andhoney has been proven to be effective as an anti-hypercholesterolemia and has a high level of safety through acute and sub chronic toxicity tests that have been carried out. To be marketed, it is also necessary to know how long this herbal juice formula preserve its antihyperlipidemic effect during the storage process.Objective: This study was aimed to examine the effectiveness of herbal juice stored for 50 days and 100 days in PTU-induced rats and high-fat diet.Methods: This test used 6 groups of animals consists of group I (Na CMC 0.5%/negative control), group II (fresh herbal juice), group III (herbal juice stored 50 days at room temperature), group IV (herbal juice stored for 50 days at cold temperatures), group V (herbal juice stored for 100 days at room temperature), and group VI (herbal juice stored for 100 days at cold temperatures). The dosage of the test preparation was 5.4 ml/kg given once a day for 10 days. Induction was carried out using PTU ad libitum and high-fat diet twice a day for 10 days. Measurement of serum total cholesterol levels was carried out on day 0 and 11 using the CHOD-PAP method.Results: Groups II and IV could reduce cholesterol significantly compared to the negative control group (p&amp;lt;0.05), while the other groups could increase blood cholesterol level.Conclusion: Herbal juice showed effectiveness as anti-hypercholesterolemia in male white rats after being stored for 50 days and 100 days. Shelf life and temperature do not reduce its activity.Keywords:anti-hypercholesterolemia, herbal juice, shelf life, temperatureIntisariLatar belakang:Jus herbal dengan komposisi sari bunga rosella, bawang putih, jahe merah, jeruk nipis, cuka apel dan madu telah terbukti efektif sebagai antihiperkolestrolemia dan memiliki tingkat keamanan yang tinggi melalui uji toksisitas akut dan subkronik yang telah dilakukan. Untuk dapat dipasarkan, perlu pula diketahui seberapa lama formula jus herbal ini mampu mempertahankan efek antihiperlipidemianya selama proses penyimpanan.Tujuan:Penelitian ini bertujuan untuk mengkaji efektivitas jus herbal yang disimpan 50 hari dan 100 hari pada tikus yang diinduksi PTU dan pakan tinggi lemak.Metode:Pengujian ini menggunakan 6 kelompok hewan perlakuan yang terdiri dari kelompok I (NaCMC 0,5%/kontrol negatif), kelompok II (jus herbal segar), kelompok III (jus herbal yang disimpan 50 hari suhu kamar), kelompok IV (jus herbal yang disimpan 50 hari suhu dingin), kelompok V (jus herbal yang disimpan 100 hari suhu kamar), dan kelompok VI (jus herbal yang disimpan 100 hari suhu dingin). Dosis sediaan uji 5,4 ml/kgbb yang diberikan satu kali sehari selama 10 hari. Induksi dilakukan dengan pemberian PTU ad libitum dan pakan tinggi lemak 2x sehari selama 10 hari. Pengukuran kadar kolesterol total serum dilakukan pada hari ke-0 dan ke-11 dengan metode CHOD-PAP.Hasil:Kelompok II dan IV dapat menurunkan kolesterol secara signifikan dibandingkan kelompok kontrol negatif (p&amp;lt;0,05), sementara kelompok lain mengalami peningkatan kadar kolesterol darah.Kesimpulan: Jus herbal menunjukkan efektivitas sebagai antihiperkolesterolemia pada tikus putih jantan setelah disimpan selama 50 hari dan 100 hari. Masa simpan dan suhu tidak mengurangi aktivitasnya.Kata kunci :antihiperkolesterolemia, jus herbal, masa simpan, suhu</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21461</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art5</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 37-43</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21461/12135</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21462</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Sub chronic toxicity effect of combination of herbal juice on the function and 2 histopathology feature of male Wistar rat liver</dc:title>
	<dc:creator>Rasyad, Ade Arinia</dc:creator>
	<dc:creator>Aisah, Aisah</dc:creator>
	<dc:creator>Lidia, Lidia</dc:creator>
	<dc:creator>Meisyayati, Sari</dc:creator>
	<dc:description xml:lang="id-ID">Abstract Background: Previously, the activity test of the combination herbal juice of garlic, rosella flower, red ginger, lime, apple cider vinegar, and honey, combined herbal juice can lower blood sugar [1] and can reduce total cholesterol levels [11]. In the use of traditional medicine and its effectiveness, its safety must also be proven before herbal juices are circulated in the communityObjective: This study was to determine the subacute hepatotoxic effect of the combination herbal juiceMethod: This research is an experimental study using 24 rats divided into four groups. Namely, the control group was given distilled water, and the group was given the combination herbal juice at a dose of 28, 14, and 7 mg/kg BW/day for 28 days. The measurement parameters were the increased activity of SGOT and SGPT and histopathological features of liver cells. The data were statistically analyzed with one-way ANOVA analysisResults: The administration of combination herbal juice for 28 days at a dose of 28, 14, and 7 mg/kg BW/day did not increase SGOT activity but caused a significant decrease in SGPT levels, namely by 20.34%, 19.39%, and 15.30%. From the histopathological picture of liver cells, at a dose of 28 mg/kg BW/day, there was no histopathological damage to liver cellsConclusion: Subacute administration of combined herbal juice did not cause hepatotoxicity in Wistar male white ratsKeywords: Combination herbal juice, subacute toxicity, histopathology, SGOT, and SGPT Intisari Latar belakang: Telah dilakukan sebelumnya uji aktivitas dari jus herbal kombinasi bawang putih, bunga rosella, jahe merah, jeruk nipis cuka apel dan madu,  jus herbal kombinasi dapat menurunkan gula darah  [1] dan dapat menurunkan kadar kolesterol total [11]. Dalam penggunaan obat tradisional, selain efektifitasnya, keamanannya pun harus dibuktikan sebelum jus herbal beredar dimasyarakatTujuan: Penelitian ini untuk mengetahui efek hepatotoksik sub akut dari jus herbal kombinasiMetode: Penelitian ini bersifat eksperimental menggunakan 24 ekor tikus yang terbagi dalam 4 kelompok. yaitu kelompok kontrol yang diberi akuades dan kelompok yang diberi jus herbal kombinasi dengan dosis 28, 14 dan 7 mg/kgBB/hari selama 28 hari. Parameter pengukuran adalah peningkatan aktivitas SGOT dan SGPT serta gambaran histopatologi sel hati. Data dianalisa secara statistik dengan  analisa ANOVA satu arahHasil: Pemberian jus herbal kombinasi selama 28 hari dengan dosis 28, 14 dan 7 mg/kgBB/hari tidak menyebabkan peningkatan aktifitas SGOT  tetapi menyebabkan penurunan kadar SGPT secara signifikan yaitu sebesar 20,34 %, 19,39 % dan 15,30 %. Dari gambaran histopatologi sel  hati, dosis 28 mg/kggBB/hari tidak ditemukan kerusakan histopatologi sel hatiKesimpulan: Pemberian subakut jus herbal kombinasi tidak menyebabkan hepatotoksik pada  tikus putih jantan galur wistarKata kunci : Jus herbal kombinasi, toksisitas subakut, histopatologi, SGOT, dan SGPT</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21462</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art14</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 121-127</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21462/12142</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21462/13434</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21474</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Lotion deodorant formulation of ethanolic extract of red betel leaf (Piper crocatum Ruiz &amp; Pav) with stearic acid as base</dc:title>
	<dc:creator>Lidia, Lidia</dc:creator>
	<dc:creator>Munarsih, Ensiwi</dc:creator>
	<dc:creator>Aprilianti, Dini</dc:creator>
	<dc:description xml:lang="id-ID">Abstract Background: Red betel leaf (P. crocatum Ruiz &amp;amp; Pav) possesses antibacterial properties, so the prospect is to be developed as a deodorant in lotion dosage forms.Objective: This study was conducted with the intention to prepare, evaluate, and investigate the stability of deodorant lotion preparations from the ethanolic extract of red betel leaf (P. crocatum Ruiz &amp;amp; Pav) based on stearic acid.Methods: The maceration method used 70% ethanol as solvent to obtain red betel leaf extract. Furthermore, the concentrated extract was formulated as a deodorant lotion formula into three formulas, FI, FII, and FIII, with varying concentrations of stearic acid 2, 4, and 6%, respectively. All the deodorant lotion formulas were evaluated, their characteristics and stability of organoleptic, pH, homogeneity, viscosity, spreadability, adhesion, and irritation properties. The physical stability test was done by cycling test. The storage stability test was evaluated for 28 days.Results: Evaluation of physical properties for 28 days showed that deodorant lotion was homogeneous and pH in the range of 5.5-6.4; viscosity, spreadability, and adhesion tests gave good results and stability.  In the irritation test, all formulas showed no irritation. Statistical test paired T-test on stability testing during storage and cycling test showed that the best and most stable formula was F3 with 6% stearic acid concentration.Conclusion: Ethanolic extract of red betel leaf (P. crocatum Ruiz &amp;amp; Pav) can be formulated into a deodorant lotion preparation that is stable and good during storage.Keywords: deodorant lotion, Piper crocatum Ruiz &amp;amp; Pav, stearic acid Intisari Latar belakang: Daun sirih merah (Dasimer) (P. crocatum Ruiz &amp;amp; Pav) berkhasiat sebagai antibakteri, sehingga prospek untuk dikembangkan sebagai deodorant dalam bentuk sediaan losion.Tujuan: Penelitian ini dilakukan dengan tujuan untuk membuat, mengevaluasi dan melakukan uji stabilitas sediaan losion deodoran dari ekstrak etanol Dasimer (P. crocatum Ruiz &amp;amp; Pav) dengan variasi basis asam sterat.Metode:  Ekstrak Dasimer diekstraksi menggunakan metode maserasi dengan etanol 70% sebagai pelarut. Ekstrak kental etanol yang diperoleh diformulasikann menjadi 3 formula losion yaitu FI, FII dan FIII dengan variasi asam stearate 2, 4 dan 6 %. Formula losion deodoran, dievaluasi karakteristik dan stabilitasnya meliputi organoleptis, homogenitas, pH, viskositas, daya sebar, daya lekat dan iritasi. Uji stabilitas fisik dilakukan dengan cycling test. Uji stabilitas dalam penyimpanan dievaluasi selama 28 hari.Hasil: Evaluasi sifat fisik selama 28 hari menunjukkan bahwa deodoran losion homogen dan pH dalam rentang yang baik yakni 5,5-6,4. Pengujian viskositas, daya sebar dan daya lekat juga memberikan hasil yang baik dan stabil. Pada pengujian iritasi, semua formula menunjukkan tidak terjadi iritasi. Uji statitistik T-test berpasangan pada pengujian stabilitas selama penyimpanan dan cycling test, menunjukkan bahwa formula yang paling baik dan stabil yaitu F3 dengan konsentrasi asam stearat 6 %.Kesimpulan:  Ekstrak etanol Dasimer (P. crocatum Ruiz &amp;amp; Pav) dapat dibuat menjadi sediaan deodoran losion yang stabil dan baik pada saat penyimpanan.Kata Kunci: losion deodoran, Piper crocatum Ruiz &amp;amp; Pav, asam stearat</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21474</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art18</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 159-168</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21474/12164</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21479</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Antioxidant activity, total flavonoid, and total tannin content of ethanol extract of avocado peel (Persea americana Mill.)</dc:title>
	<dc:creator>Isromarina, Rini</dc:creator>
	<dc:creator>Rusli, Doddy</dc:creator>
	<dc:creator>Sari, Deva Ulan</dc:creator>
	<dc:description xml:lang="id-ID">Background: Avocado is a plant that can grow in tropical climates. In general, people only consume the fruit while the skin and seeds are not used. Avocado fruit, skin and seeds contain secondary metabolites such as flavonoids and tannins which have antioxidant activity. Objective: To determine antioxidant activity, total flavonoid, and total tannin content of the ethanol extract of avocado peel. Methods: P. americana Mill. was collected from Lubuk Linggau, South Sumatra. The ethanol extract of P. americana Mill.  peel obtained by maceration with ethanol. Qualitative analysis of flavonoids using Mg and HCl while tannins using FeCl3. Determination of total flavonoid content was carried out with AlCl3 reagent and Folin-Ciocalteu reagent to determine the total tannin content and was measured by a UV-Vis Spectrophotometer. Determination of antioxidant activity using the DPPH method.Result: The results of the qualitative analysis showed that ethanol extract of avocado peel contained flavonoids and tannins. It also had antioxidant activity with IC50 of 41,93 µg/mL. The total flavonoid and tannin content of it were 125,01 mgQE/g extract and 53,82 mgTAE/g extract respectively. Conclusion: Ethanol extract of avocado peel had antioxidant activity, while the total flavonoid compounds was higher than the total tannins.Keywords: antioxidant, DPPH, total flavonoid, total tannins Intisari Latar Belakang: Buah, kulit dan biji alpukat mengandung metabolit sekunder seperti flavonoid dan tanin yang memiliki aktivitas antioksidan. Namun, penelitian terkait kulit alpukat sebagai antioksidan belum banyak dilakukan.Tujuan: Mengetahui aktivitas antioksidan total flavonoid, total tanin ekstrak etanol kulit alpukat.Metode: Buah alpukat yang diperoleh dari Lubuk Linggau, Sumatra Selatan diekstraksi dengan cara maserasi dengan pelarut etanol. Ekstrak kemudian dianalisis kualitatif untuk mengetahui kandungan flavonoid menggunakan Mg dan HCl dan tanin menggunakan FeCl3. Penentuan aktivitas antioksidan ekstrak dilakukan dengan metode DPPH, sedangkan penentuan flavonoid total menggunakan AICI3 serta tanin total menggunakan reagen folin ciocelteu yang diukur menggunakan spektrofotometer UV-VIS. Hasil:  Hasil analisis kualitatif memperlihatkan bahwa ekstrak etanol kulit alpukat mengandung flavonoid dan tanin. Esktrak etanol kulit alpukat memiliki aktivitas antioksidan kuat dengan IC50 41,93 µg/mL. Kandungan flavonoid total dan tanin total ekstrak etanol kulit alpukat masing-masing adalah 125,01 mgQE/g ekstrak dan 53,82 mgTAE/g ekstrak.Kesimpulan: Ekstrak etanol kulit alpukat memiliki aktivitas antioksidan  dengan kandungan flavonoid yang lebih tinggi dibandingkan tanin.Katakunci: antioksidan, DPPH, flavonoid total, tanin total</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21479</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art19</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 169-174</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21479/12150</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21496</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The risk of  Angiotensin Converting Enzyme Inhibitor (ACEI) and Calcium Channel Blocker (CCB) used on Obstructive Sleep Apnea (OSA) incidence in hypertension patients</dc:title>
	<dc:creator>Cesa, Fibe Yulinda</dc:creator>
	<dc:creator>Aditya, Martanty</dc:creator>
	<dc:creator>Sitepu, Rehmadanta</dc:creator>
	<dc:creator>Notario, Dion</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: The administration of angiotensin-converting enzyme inhibitor (ACEI) and calcium channel blocker (CCB) therapy is known to have a side effect of a dry cough that would trigger OSA. Further research is needed to compare the effect of these two drugs on the side effects of OSA, which could trigger high-risk patient conditions.       Objective: To determine the risk of using ACE and CCB on the incidence of OSA using a case-control study method at Dau Primary Health Center.Methods: Demographic data were collected on 207 respondents aged 40-60 years by collecting Data Collection Sheets and Berlin questionnaires to determine the risk of OSA in respondents. Then, statistical analysis was carried out by determining the odds ratio (OR).Results: The results showed that one of the factors BMI (obese BMI; OR=1.33; 95% CI=0.11-15.70) induces OSA with the highest OR value compared to other factors.Conclusion: Obese patient has a 1.33 times greater risk of OSA with ACEI and CCB therapy than non-obese. It is necessary to conduct further research with a larger sample size related to OSA’s assessment associated with this therapy to improve patients’ quality of life.Keywords: Obstructive sleep apnea, ACE inhibitors, calcium channel blockers, hypertension IntisariLatar belakang: Obtructive Sleep Apnea (OSA) yang terjadi pada pasien hipertensi dapat disebabkan karena efek samping dari penggunaan antihipertensi angiotensin converting enzyme inhibitor (ACEI) dan calcium channel blocker (CCB), namun analisis hubungan keduanya belum diketahui dengan pasti.Tujuan: Penelitian ini bertujuan untuk mengetahui risiko penggunaan ACE dan CCB terhadap kejadian OSA dengan metode case control study di Puskesmas Dau.Metode: Pengambilan data demografi pada 207 responden usia 40-60 tahun dilakukan dengan mengumpulkan Lembar Pengumpul Data (LPD) dan kuesioner Berlin untuk mengetahui risiko OSA pada responden kemudian dilakukan analisis statistik dengan penentuan odds ratio (OR).Hasil: Hasil penelitian menunjukkan bahwa pasien yang menjalani pengobatan dengan antihipertensi ACEI dan obesitas memiliki risiko lebih besar mengalami OSA (OR=1,33; CI 95%=0,11-15,70)  yaitu 1,33 kali dibandingkan pada pasien yang tidak obesitas.Kesimpulan: Obesitas menjadi factor risiko terhadap kejadian OSA pada pasien hipertensi yang mendapatkan antihipertensi golongan ACEI dan CCB.Kata kunci: Obstructive sleep apnea, ACE inhibitor, calcium channel blocker, hipertensi</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21496</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art1</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 1-10</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21496/12152</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21496/13435</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21505</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Total phenolic and flavonoid contents of n-hexane fraction in binjai leaves (Mangifera caesia Jack. ex. Wall)</dc:title>
	<dc:creator>Yuliani, Cahaya Rahayu</dc:creator>
	<dc:creator>Ramadhan, Hafiz</dc:creator>
	<dc:creator>Sayakti, Putri Indah</dc:creator>
	<dc:creator>Torizellia, Cast</dc:creator>
	<dc:description xml:lang="id-ID">AbstractBackground: Binjai leaves (Mangifera caesia Jack. ex. Wall) or M. caesia contain phenolic and flavonoid compounds important in medicinal plants development. The solvent difference and fractionation will give various active substance concentrations.Objective: To evaluate the phenolic and flavonoid content qualitatively and quantitatively from the n-hexane fraction of binjai leaves methanol extract.Methods: The soxhletation method with methanol was used to extract binjai leaves followed by fractionation. Thin Layer Chromatography (TLC) followed by spraying reagents were used to test phenols and flavonoids compounds. Folin-Ciocalteu reagents were used to analyzed total phenolics, while AlCl3 reagents were used to quantify the total flavonoid content.Result: This study gave positive results on the qualitative test of phenolics and flavonoids. Meanwhile, the fraction assay results showed total phenolic levels of 45.19 µgGAE/mg and total flavonoid levels of 165.06 µgQE/mg.Conclusion: The n-hexane fraction of M. caesia leaves methanol extracts contains phenols and flavonoid content so that it has the potential as a medicinal plant.Keywords: Binjai leaves, methanol extracts, n-hexane fraction, phenol, flavonoid. IntisariLatar belakang: Daun binjai (Mangifera caesia Jack. ex. Wall) memiliki senyawa fenolik dan flavonoid yang penting dalam pengembangan tanaman obat. Perbedaan pelarut dan fraksinasi akan memberikan kadar senyawa aktif yang berbeda.Tujuan: Penelitian ini bertujuan untuk mengetahui secara kualitatif dan kuantitatif senyawa fenolik dan flavonoid dari fraksi n-heksan ekstrak metanol daun binjai.Metode: Metode soxhletasi dengan pelarut metanol digunakan untuk mengekstraksi daun binjai yang dilanjutikan dengan fraksinasi. Kromatografi Lapis Tipis (KLT) yang dilanjutkan dengan reagen semprot digunakan untuk menguji senyawa fenolik dan flavonoid. Reagen Folin-Ciocalteu digunakan untuk menetapkan kadar total fenolik, sedangkan pereaksi AlCl3untuk menetapkan kadar total flavonoid.Hasil: Penelitian ini memberikan hasil positif pada uji kualitatif fenolik dan flavonoid, sedangkan hasil penetapan kadar fraksi memberikan hasil total fenolik sebesar 45,19 µgGAE/mg dan kadar total flavonoid 165,06 µgQE/mg.Kesimpulan: Fraksi n-heksana ekstrak metanol daun M. caesia memiliki kandungan fenolik dan flavonoid sehingga berpotensi untuk dikembangkan sebagai tanaman obat,Kata Kunci: Daun binjai, ekstrak metanol, fraksi n-heksan, fenolik, flavonoid.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21505</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art2</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 11-19</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21505/12161</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21505/13436</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21505/13499</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21506</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The effect of drug information service using leaflet media and medication reminder chart on adherence and blood pressure of hypertensive patients in primary health care</dc:title>
	<dc:creator>Rikmasari, Yopi</dc:creator>
	<dc:description xml:lang="id-ID">Abstract Background: Treatment adherence is an important factor affecting blood pressure control in hypertensive patients. Intervention in pharmacy service can improve medication adherence and lower blood pressure.Objective: This study aimed to evaluate the effect of drug information service using leaflets and MRC on the level of patient compliance and lowering blood pressure.Method: The research design was a quasi-experimental pre-and post-design with control, the intervention group (n=20), and the control group (n=20). The patient adherence was measured using the MGLS questionnaire at the beginning and the end of the study. The intervention was performed by distributing a drug information leaflet and medication reminder chart (MRC). The differences of adherence pre and post-intervention were analyzed using paired t-test, while the differences in adherence and blood pressure between the control and the intervention group were analyzed using the Mann-Whitney test.Results: The results showed that there was a significant difference in adherence between pre and post-intervention (p&amp;lt;0.001). A significant difference was also found in the level of adherence between the control group and the intervention group (p&amp;lt;0.001). Whereas the decrease of systolic (p=0.396) and diastolic (p=0.564) blood pressure in the intervention group and control group was not different significantly.Conclusion: Drug information services using leaflets and MRCs affected patient adherence to medication, but did not interfere with the decrease of systolic and diastolic blood pressure.Keywords: leaflets, medication reminder chart, adherence, blood pressureIntisari Latar belakang: Kepatuhan pengobatan merupakan faktor penting yang mempengaruhi pengendalian tekanan darah pada pasien hipertensi. Intervensi dalam pelayanan kefarmasian diketahui dapat meningkatkan kepatuhan pengobatan dan menurunkan tekanan darah.Tujuan: Penelitian ini bertujuan untuk mengetahui pengaruh PIO (PIO) menggunakan media leaflet disertai pemberian MRC terhadap tingkat kepatuhan pasien dan penurunan tekanan darah.Metode: Desain penelitian berupa quasi-experimental dengan pre-test dan post-test design with control group. Subjek penelitian pada tiap kelompok intervensi (n=20) dan kelompok kontrol (n=20). Kepatuhan pasien diukur menggunakan kuesioner MGLS pada awal penelitian dan empat minggu setelah intervensi. Uji-t berpasangan digunakan untuk menganalisis perbedaan kepatuhan sebelum dan sesudah intervensi, sedangkan perbedaan kepatuhan dan perubahan tekanan darah antara kelompok intervensi dan kontrol dianalisis dengan uji mann-whitney.Hasil: Hasil penelitian memperlihatkan ada perbedaan kepatuhan yang signifikan antara sebelum dan sesudah mendapatkan intervensi (p&amp;lt;0,001). Selain itu, tingkat kepatuhan minum obat antara kelompok kontrol dan kelompok intervensi juga berbeda signifikan (p&amp;lt;0,001), sedangkan penurunan tekanan darah sistolik (p=0,396) dan tekanan darah diastolik (p=0,564) pada kelompok intervensi dan kelompok kontrol tidak terdapat perbedaan yang signifikan.  Kesimpulan: PIO menggunakan media leaflet disertai pemberian MRC mempengaruhi tingkat kepatuhan minum obat pasien, namun tidak memberikan pengaruh terhadap penurunan tekanan darah sistolik dan diastolik.Kata kunci: leaflet, medication reminder chart, kepatuhan, tekanan darah</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21506</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art6</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 44-53</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21506/12136</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21513</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Isolation of endophytic fungi from benalu batu (Begonia medicinalis) and their toxicity on Artemia Salina</dc:title>
	<dc:creator>Anam, Syariful</dc:creator>
	<dc:creator>Syamsidi, Armini</dc:creator>
	<dc:creator>Musyahidah, Musyahidah</dc:creator>
	<dc:creator>Ambianti, Nurul</dc:creator>
	<dc:creator>Widodo, Agustinus</dc:creator>
	<dc:creator>Zubair, Muhammad Sulaiman</dc:creator>
	<dc:description xml:lang="id-ID">Abstract   Background: Endophytic fungi are microorganisms found in plant tissues that are mutually beneficial to the host plant. They are known as sources of bioactive metabolites which possess various biological activities such as antimicrobial, anticancer, antiviral, antifungal, and antioxidant.  Benalu batu (Begonia medicinalis) has been used empirically as a medicinal plant and has shown anticancer activity in breast cancer cells (T47D cells) and cervical cancer cells (HeLa cells).Objective: This study aimed to isolate the endophytic fungi from benalu batu and determine the toxicity activity and Lethal Concentration 50% (LC50) value of isolated endophytic fungi using shrimp larvae (Artemia salina). Method: Endophytic fungi were isolated from fresh parts; leaves, stems, roots of Benalu Batu. The selected parts were sterilized with ethanol 70% and sodium hypochlorite 1% subsequently placed into Potato Dextrose Agar Chloramphenicol (PDAC) then incubated at 28°C for 7 days. Isolated endophytic fungi were extracted by sonication method using ethyl acetate. The toxicity activity of isolated endophytic fungi was determined using the Brine Shrimp Lethality Test (BSLT).Results: Isolation of the endophytic fungi from benalu batu obtained 10 isolates, which the leaves part obtained 6 isolates, the stem obtained 3 isolates and the root obtained 1 isolate. The results of screening for toxicity test of 10 isolates at concentrations of 500 µg/mL shown that isolate D3, D5, and D6 gave 100% mortality. The LC50 values of isolate D3, D5, and D6 were obtained respectively in 448.03, 8.784, and 9.13 µg/mL.Conclusion: These results indicated that isolate D5 exhibits the greatest toxicity and needs to be investigated the activity for testing on cancer cells.Keywords: endophytic fungi, Begonia medicinalis, toxicity, Artemia salina Intisari  Latar belakang: Jamur endofit merupakan mikroorganisme yang terdapat dalam jaringan tumbuhan yang bersifat mutualisme terhadap tumbuhan inang. Jamur endofit telah diketahui sebagai sumber metabolit yang memiliki beberapa aktivitas biologi seperti antimikroba, antikanker, antivirus, antijamur, dan antioksidan. Tumbuhan benalu batu (B. medicinalis) telah digunakan secara empiris dan terbukti memiliki aktivitas antikanker pada sel kanker payudara (Sel T47D) dan sel kanker leher rahim (Sel HeLa). Tujuan: Studi ini bertujuan untuk melakukan isolasi jamur endofit dari benalu batu dan mengetahui toksisitas isolat jamur endofit serta menentukan nilai Lethal Concentration 50% (LC50) terhadap larva udang (Artemia salina)Metode: Jamur endofit diisolasi dari bagian segar; daun, batang, akar benalu batu. Bagian-bagian tersebut disterilisasi dengan etanol 70% dan natrium hipoklorit 1% selanjutnya diletakkan pada media Potato Dextrose Agar Chloramphenicol (PDAC) kemudian diinkubasi pada suhu 28°C selama 7 hari. Isolat jamur endofit diekstraksi dengan metode sonikasi menggunakan etil asetat. Aktivitas toksisitas isolat jamur endofit ditentukan menggunakan metode Brine Shrimp Lethality Test (BSLT).Hasil: Isolasi jamur endofit dari benalu batu diperoleh 10 isolat, bagian daun diperoleh 6 isolat, bagian batang diperoleh 3 isolat dan bagian akar diperoleh 1 isolat. Hasil penapisan uji toksisitas 10 isolat pada konsentrasi 500 µg/mL menunjukkan bahwa isolat D3, D5, dan D6 memberikan persentase mortalitas sebesar 100%. Nilai LC50 isolat D3, D5, dan D6 diperoleh masing-masing sebesar 448,03, 8,784, dan 9,13 µg/mL.Kesimpulan: Hasil ini menunjukkan isolat D5 memiliki toksisitas paling besar dan perlu dilanjutkan untuk pengujian pada sel kanker.Kata kunci : jamur endofit, Begonia medicinalis, toksisitas, Artemia salina</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21513</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art3</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 20-30</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21513/12139</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21540</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Evaluation of pharmaceutical services, the level of satisfaction and waiting time at Betung City Primary Health Care, Banyuasin Regency</dc:title>
	<dc:creator>Sriwijaya, Reza Agung</dc:creator>
	<dc:description xml:lang="id-ID">Background: Pharmaceutical services play an important role in the success of patient treatment in health centers, therefore it is necessary to evaluate the management of pharmaceutical preparations and clinical pharmacy services and see the level of patient satisfaction and waiting time for prescriptions in health centers by comparing those stipulated in the regulation of the minister of health no 74 of 2016 and no 129 year 2008Objective: The purpose of this study was to evaluate the management of Consumable Medical Materials (BMHP) services, clinical pharmacy services based on Minister of Health Regulation No. 74 /2016 and Permenkes no 129/2008.Methods : This research is an observational, experimental, quantitative descriptive, cross-sectional study with prospective data collection, survey methods and interviews. Measuring instrument research, questionnaire sheet, which has been validated. Inclusion criteria are pharmacy staff who are responsible for pharmacy services at Betung Public Health Center, Banyuasin Regency. The data obtained in the form of qualitative and quantitative descriptive data.Result : The results of the study obtained services according to Permenkes No. 74 of 2016 management of pharmaceutical preparations and medical consumables of 88.26% (good) and clinical pharmacy services 26.2% (less) especially in Drug Information Services (PIO), Monitoring of Side Effects Drugs (MESO), and Drug Therapy Monitoring (PTO), the visits have not been carried out, patients are very satisfied with the services of the Betung Health Center and the average waiting time for prescription services is 4 minutes 13 seconds according to the Regulation of the Minister of Health No. 129 Year 2008.Conclusion : Pharmaceutical services that are in accordance with Permenkes No.74 of 2016 on the management of pharmaceutical preparations and BMHP are in accordance with 88.26% but clinical pharmacy services are not in accordance with Permenkes 74/2016 by 21.3% (less category), especially in clinical pharmacy services which What has not been implemented is drug information service (PIO) by 33.05% and what has not been implemented, namely monitoring of drug side effects (MESO) and monitoring of drug therapy (PTO), Visit by 0%. The level of patient satisfaction is very satisfied with the puskesmas services with a percentage of 81.3% seen from the 5 dimensions, the average value of waiting time for prescription services is 4 minutes 13 seconds according to the Ministry of Health no. 129 in 2008.Keywords: puskesmas, pharmaceutical services, Permenkes IntisariLatar belakang: Pelayanan kefarmasian memegang peranan penting dalam keberhasilan pengobatan pasien di puskesmas. Dengan demikian, perlu dilakukan evaluasi pada pengelolaan sediaan farmasi dan pelayanan farmasi klinik serta melihat tingkat kepuasan pasien dan waktu tunggu resep di Puskesmas.Tujuan: Penelitian ini bertujuan untuk mengevaluasi pengelolaan pelayanan Bahan Medis Habis Pakai (BMHP), pelayanan farmasi klinik berdasarkan Peraturan Menteri Kesehatan (Permenkes) No. 74/2016 dan Keputusan Menteri Kesehatan (Kepmenkes) nomor 129/2008.Metode: Rancangan penelitian ini adalah potong lintang dengan metode survei dan observasional. Pengumpulan data secara prospektif, dengan pembagian kuesioner yang telah valid dan wawancara. Jumlah responden adalah 80 pasien dan satu tenaga kefarmasian yang bertanggung jawab atas pelayanan kefarmasian di Puskesmas Betung Kabupaten Banyuasin. Data yang diperoleh dianalisis secara deskriptif.Hasil: Hasil penelitian menunjukkan pengelolaan sediaan farmasi dan BMHP di sebesar 88,26% (kategori baik) dan pelayanan farmasi klinik 26,2% (kategori kurang) khususnya kegiatan Pelayanan Informasi Obat (PIO), Monitoring Efek Samping Obat (MESO), dan Pemantauan Terapi Obat (PTO), visite belum dilakukan. Pasiensangat puas (81,3%) terhadap pelayanan Puskesmas Betung dan rata-rata waktu tunggu pelayanan resep adalah 4 menit 13 detik sesuai Kepmenkes No. 129/2008.Kesimpulan: Pelayanan kefarmasian yang telah sesuai dengan Permenkes No.74 Tahun 2016 yaitu tentang Pengelolaan Sediaan Farmasi dan BMHP, sedangkan pelayanan farmasi klinik belum sesuai. Sebagian besar telah merasa puas terhadap pelayanan kefarmasian di Puskemas Betung dan waktu tunggu telah sesuai dengan persyaratan.Kata kunci: puskesmas, pelayanan kefarmasian, waktu tunggu, kepuasan</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21540</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art7</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 54 - 59</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21540/12138</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21562</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Antioxidant activity of methanol extract of cassava leaves (Manihot esculenta Crantz) using CUPRAC method</dc:title>
	<dc:creator>Sayakti, Putri Indah</dc:creator>
	<dc:creator>Anisa, Norma</dc:creator>
	<dc:creator>Ramadhan, Hafiz</dc:creator>
	<dc:description xml:lang="id-ID">Background: Antioxidants are a group of organic molecules and enzymes that work synergistically to enhance cellular defenses and combat oxidative stress. Antioxidants can come from plants because they contain many groups of phytochemical compounds and vitamins. One of the plants that has compounds with antioxidant activity is cassava.Objective: To measure the antioxidant activity of methanol extract of cassava leaves using the CUPRAC method.Methods: Cassava leaves were extracted by maceration using methanol as a solvent with the addition of 5% H2SO4. Phytochemical screening of flavonoids with Mg and HCl, while phenol with the addition of FeCl3. The antioxidant activity based on the reaction of the test solution with CUPRAC reagent. Antioxidant activity can be determined by IC50 value by using x value as concentration and y value as absorbance.Results: The results of phytochemical screening showed that the methanol extract of cassava leaves contained flavonoids and phenolic groups. The antioxidant capacity of the methanol extract of cassava leaves obtained an IC50 value of 156.03 ppm, while quercetin has a very strong capacity as an antioxidant with an IC50 of 9.83 ppm.Conclusion: The methanol extract of cassava leaves has a weak antioxidant capacity in reducing metal ions. Keywords: Cassava leaves, Manihot esculenta Crantz, methanol extract, antioxidants, CUPRAC.IntisariPendahuluan: Antioksidan adalah kelompok molekul organik dan enzim yang bekerja secara sinergis untuk meningkatkan pertahanan seluler dan memerangi stres oksidatif. Antioksidan dapat berasal dari tanaman karena banyak mengandung golongan senyawa fitokimia dan vitamin. Salah satu tanaman yang memiliki kandungan metabolit sekunder berupa flavonoid dan fenol yang berfungsi sebagai antioksidan adalah Singkong (Manihot esculenta Crantz).Tujuan: Penelitian ini bertujuan untuk mengukur kapasitas antioksidan dari ekstrak metanol daun Singkong menggunakan metode CUPRAC (Cupric Ion Reducing Antioxidant Capacity).Metode: Daun Singkong diekstraksi secara maserasi menggunakan pelarut metanol dengan penambahan H2SO4 5%. Skrining fitokimia flavonoid dengan Mg dan HCl, sedangkan fenol dengan penambahan FeCl3. Kapasitas antioksidan berdasarkan reaksi larutan uji dengan reagen CUPRAC yang diukur menggunakan spektrofotometer UV-Vis.Hasil: Hasil skrining fitokimia menunjukkan ekstrak metanol daun Singkong mengandung golongan flavonoid dan fenolik. Kapasitas antioksidan dari ekstrak metanol daun Singkong didapatkan nilai IC50 sebesar 156,03 ppm, sedangkan quersetin memiliki kapasitas yang sangat kuat sebagai antioksidan dengan IC50 sebesar 9,83 ppm.Kesimpulan: Berdasarkan hasil tersebut, dapat disimpulkan bahwa ekstrak metanol daun Singkong memiliki kapasitas antioksidan yang lemah dalam mereduksi ion logam.Kata kunci: Daun Singkong (Manihot esculenta Crantz), Ekstrak Metanol, Antioksidan, CUPRAC.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21562</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art12</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 97-106</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21562/12128</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21562/13438</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21570</identifier>
				<datestamp>2023-01-01T15:25:25Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Evaluation of single and combination chemotherapy agents in patients with metastatic breast cancer</dc:title>
	<dc:creator>Aditya, Martanty </dc:creator>
	<dc:creator>Hendra, Godeliva Adriani</dc:creator>
	<dc:creator>Gustyas, Suhul Raos Kumawula Ing </dc:creator>
	<dc:subject xml:lang="en-US">Metastatic breast cancer</dc:subject>
	<dc:subject xml:lang="en-US">CEA</dc:subject>
	<dc:subject xml:lang="en-US">CA15-3</dc:subject>
	<dc:subject xml:lang="en-US">chemotherapy agents</dc:subject>
	<dc:description xml:lang="en-US">Background: There are several ways to treat breast cancer, one of which is administering chemotherapy agents. Chemotherapy agents have activity in inhibiting the cell cycle. That will affect the effectiveness of therapy and the side effects of chemotherapy agents.
Objective: This study aimed to evaluate single and combination chemotherapy agent therapeutic efficacy and side effects
Method: The design of this study used an observational cohort study with retrospective data collection from January to December 2019. Patients obtained from medical records were diagnosed with metastatic stage of breast cancer at Panti Nirmala Hospital, Malang. The effectiveness of the chemotherapy agent was seen from the carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3), which were carried out in the first and third cycles, then analyzed using the Wilcoxon and U-Mann Whitney tests. Side effects of chemotherapy agents were analyzed descriptively.
Results: Analysis of the Wilcoxon test showed differences between the two groups of chemotherapeutic agents in CEA and CA15-3 (p&amp;lt;0.05). U-Mann Whitney test analysis showed no difference after administration of the two groups of chemotherapy agents at CEA (p&amp;gt;0.05). However, there was a difference in CA15-3 (p&amp;lt;0.05). Both chemotherapy agents showed most common side effects such as pain, nausea,  vomiting, and alopecia.
Conclusion: Patients who received a combination of chemotherapy agents had lower CA15-3 levels than single chemotherapy agents.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21570</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art14</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 145-152</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21570/14532</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21582</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Flavonoid compounds of tapak liman plant (Elephantopus scaber) as antihyperuricemia</dc:title>
	<dc:creator>Gunarti, Neni Sri</dc:creator>
	<dc:creator>Hidayah, Himyatul</dc:creator>
	<dc:description xml:lang="id-ID">Abstract   Background: Hyperuricemia is a condition where uric acid levels in the blood increase more than 6 mg/dL. Tapak liman (Elephantopus scaber) contains flavonoid compounds that are reported to inhibit the activity of the xanthine oxidase enzyme that causes hyperuricemia. Several Asteraceae tribes have activity as antihyperuricemia, one of which is the tapak liman plant (E. scaber) because of the compounds contained in the flavonoid group which has a working mechanism as an inhibitor of the xanthine oxidase enzyme.Objective: To determine the types of flavonoid compounds in tapak liman (E. scaber) plants that have antihyperuricemic activity.Method: This research is qualitative research using Literature Review Article (LRA) using Google Scholar, PubMed, ResearchGate, and Science direct databases with keywords related to the research topic, namely &quot;Elephantopus scaber, antihyperuricemia, tapak liman, xanthine oxidase, flavonoids&quot;.Results: Compounds from the flavonoid group in tapak liman that have the potential as antihyperuricemia are luteolin compounds, luteolin-7-glucoside, quercetin, and rutin with the mechanism of inhibiting the activity of the xanthine oxidase enzyme.Conclusion: compounds from the flavonoid group in tapak liman that have the potential as antihyperuricemic compounds are luteolin, luteolin-7-glucoside, quercetin, and rutin.Keywords: Elephantopus scaber, antihyperuricemia, tapak liman, xanthine oxidase, flavonoids Intisari  Latar belakang: Hiperurisemia merupakan suatu kondisi terjadinya peningkatan kadar asam urat dalam darah lebih dari 6 mg/dL. Tapak liman (E. scaber) mengandung  senyawa flavonoid yang dilaporkan dapat menghambat aktivitas enzim xantin oksidase penyebab hiperurisemia. Beberapa suku Asteraceae memiliki aktivitas sebagai antihiperurisemia, salah satunya adalah tanaman tapak liman (E. scaber) karena adanya senyawa yang terkandung yaitu golongan flavonoid yang memiliki mekanisme kerja sebagai inhibitor enzim xanthin oksidase.Tujuan: Mengetahui jenis-jenis senyawa flavonoid dalam tanaman tapak liman (E. scaber) yang memiliki aktifitas sebagai antihiperurisemia.Metode: Penelitian ini merupakan penelitian kualitatif menggunakan Literature Review Article (LRA) menggunakan database Google Scholar, PubMed, ResearchGate dan Science direct dengan kata kunci yang berkaitan dengan topik penelitian, yaitu “Elephantopus scaber, antihiperurisemia, tapak liman, xantin oksidase, flavonoid”.Hasil: Senyawa golongan flavonoid pada tapak liman yang berpotensi sebagai antihiperurisemia yaitu senyawa  luteolin, luteolin-7-glukosida, kuersetin, dan rutin dengan mekanisme menghambat aktivitas enzim xantin oksidase.Kesimpulan: Senyawa golongan flavonoid pada tapak liman yang berpotensi sebagai antihiperurisemia yaitu senyawa  luteolin, luteolin-7-glukosida, kuersetin, dan rutinKata kunci : Elephantopus scaber, antihyperuricemia, tapak liman, xanthine oxidase, flavonoid</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21582</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art4</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 31-36</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21582/12141</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21946</identifier>
				<datestamp>2021-11-29T03:37:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">CONCENTRATION OF DIAFILTRATE IN LOCAL GREEN TEA (Camellia  sinensis) WITH Arraca yabukita GRADE THROUGH NANOFILTRATION  MEMBRANE ANTI AS STRESS COMPOUND</dc:title>
	<dc:creator>Susilowati, Agustine</dc:creator>
	<dc:creator>Aspiyanto, Aspiyanto</dc:creator>
	<dc:description xml:lang="en-US">Proses pemekatan diafiltrat ieh hijau lokal (Camellia sinensis) grade Arraca yabukita merupakan rangkaian multifiltrasi untuk memisahkan dan memekatkan L-theanine dari komponen teh hijau lainnya yang didominasi oleh polyfeno!. L-theanine merupakan komponen yang berperan sebagai senyawa untuk relaksasi dan berpotensi untuk anti stres. Pemekatan dilakukan dengan menggunakan modul nanofiltrasi (NF) pad a tekanan proses 25 bar, kecepatan motor pompa 25 Hz, selama 0, 30, 60, 90, 120 dan 150 menit, dan pada suhu ruang (- 23 - 25°C). Hasil penelitian Menunjukkan bahwa sistem NF memisahkan L-theanine dengan sempurna dimana L-theanine lebih banyak tertahan pad a retentatlkonsentrat dari pada Lolos dalam permeat. Selektifitas membran nanofiltrasi terhadap L-theanine, protein terlarut,total polytenol dan total padatan tercapai masing-masing sebesar 97,92 %, 99,75 %, 10,38 % dan 99,78 %. Semakin lama proses NF akan meningkatkan L-theanine, total polytenol, protein terlarut dan total padatan dalam retentat,namun menurunkan nilai fluks permeat. Konsentrasi L-theanine tertinggi dicapai pada waktu pemekatan optimal 150 menit. Pad a kondisi ini menghasilkan nilai fluks sebesar 12,22 Liter/m2 .jam dengan kandungan L-theanine sebesar 7,2117 %, total polytenol 9,84 %, protein terlarut 2 mg/mL dan total padatan 1,2102 %. Permeat berpotensi sebagai minuman fungsional untuk relaksasi. Kata kunci: diafiltrat, L-theanine, teh hijau (Camellia sinensis), konsentrat, Nanofiltrasi (NF) </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-11-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21946</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 8 No. 2 (2011)</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21946/11786</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21947</identifier>
				<datestamp>2021-11-29T03:37:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">MIKROENKAPSULASi KAPTOPRIL DENGAN PENYALUT ETIL SELULOSA  MENGGUNAKAN METODA PENGUAPAN PELARUT</dc:title>
	<dc:creator>Rasyad, Ade Arinia</dc:creator>
	<dc:creator>Muslim, Deni Noviza</dc:creator>
	<dc:description xml:lang="en-US">Telah dilakukan penelitian untuk membuat suatu sediaan Ie pas lambat dengan cara mikroenkapsulasi menggunakan metoda penguapan pelarut. Bahan polimer yang digunakan untuk membentuk dinding mikrokapsul adalah etil selulosa dengan berbagai perbandingan (1:1; 1:1,25; 1: 1,5). Sediaan mikrokapsul yang terbentuk dievaluasi dengan distribusiukuran partikel, foto mikroskopis dan uji disolusi. Formula 3 mikrokapsul kaptopril dengan perbandingan 1: 1,5 memberikan hasil yang baik. Uji disolusi mikrokapsul menggunakan metode II (metode dayung) dengan medium dapar posfat pH 6,8 memenuhi persyaratan untuk sediaan lepas lambat, yaitu dalam waktu 6 jam persentase obat terdisolusi sebesar 55,76 %. Kata kunci: kaptopril, etilselullosa, mikroenkapsulasi, penguapan pelarut </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-11-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21947</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 8 No. 2 (2011)</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21947/11787</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21948</identifier>
				<datestamp>2021-11-29T03:37:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">PERKEMBANGAN PENELITIAN BENTUK SEDIAAN OBAT</dc:title>
	<dc:creator>Indrati, Oktavia</dc:creator>
	<dc:description xml:lang="en-US">Losartan merupakan suatu antagonis reseptor angiotensin II yang digunakan pada tempi hipertensi leru!arna untuk pasien yanq mengalarni efek sam ping berupa batuk akibat pemberian inhibitor angiotensin-converting enzyme (ACE) serta untuk mengurangi resiko stroke pada pasien denganhipertropi pad aventrikel kiri. L.osartan memiliki karakteristik-karakteristik berupa waktu paruh pendek, bioavailabilitas rendah serta bobot molekul yang keci!. Rendahnya bioavailabilitas tentu saja kurang disukai. Seiring dengan habisnya masa paten losartan pada tahun 2009 maka berbagai penelitian telah dilakukan untuk menghasilkan suatu formula dan bentuk sediaan yang baru dari zat aktif losartall. Pada review illi didiskusikan mengenai penelitian-penelitian yang telah dilakukan dalam mngka mengembangan bentuk sediaan farmasi dengan zat aktif losartan. Kata kunci: bentuk secliaan, losartan, peneli!ian, perkembangan  </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-11-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21948</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 8 No. 2 (2011)</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21948/11788</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21949</identifier>
				<datestamp>2021-11-29T03:37:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">KESESUAIAN PEMILIHAN OBAT PADA PASIEN SIROSIS HEPATIK</dc:title>
	<dc:creator>Ningrum, Vitarani Dwi Ananda</dc:creator>
	<dc:creator>Fitriyani, Laili</dc:creator>
	<dc:description xml:lang="en-US">Sirosis hati adalah penyakit menahun yang mengenai seluruh organ hati, ditandai dengan pembentukan jaringan ikat disertai nodul. Penyakit ini bersifat irreversible sehingga terapi yang digunakan adalah terapi simptomatis dan pengatasan komplikasi yang terjadi. Pemilihan obat yang tepat menjadi salah satu faktor yang harus dipertimbangkan dalam penatalaksanaan terapi pada pasien sirosis hepatik. Pemilihan obat yang tidak tepat dapat mengakibatkan kerusakan hati yang lebih parah. Tujuan dilakukan penelitian ini adalah untuk mengetahui profil terapi serta kesesuaian pemilihan obat yang digunakan. Pengambilan data dilakukan secara cross sectional terhadap data sekunder berupa data rekam medik pasien yang menjalani rawat inap dengan diagnosa primer maupun sekunder sirosis hepatik. Penilaian kesesuaian pemilihan obat berdasarkan referensi yang sesuai. Tujuh puluh delapan dari 155 pasien memenuhi kriteria inklusi. Hasil penelitian menunjukkan terapi obat yang digunakan terdiri dari terapi obat untuk penyakit komplikasi dan terapi obat untuk penyakit penyerta. Penyakit komplikasi yang terbanyak adalah varises esophagus dengan terapi obat terbanyak yaitu vitamin K (83,33 %). Penyakit penyerta terbanyak adalah stress ulkus dengan terapi obat terbanyak yaitu sukralfat (43,59 %). Sebanyak 21 pasien (26,92 %) mendapatkan jenis obat yang tidak sesuai. Kategori jenis obat yang tidak sesuai meliputi 25,64 % obat yang bersifat hepatotoksik, 1,28 % obat bersifat sedatif dan mempresipitasi ensefalopati hepatik. Kata kunci: kesesuaian pemilihan obat, rawat inap, sirosis hepatik </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-11-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21949</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 8 No. 2 (2011)</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21949/11789</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21950</identifier>
				<datestamp>2021-11-29T03:37:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">DRUG RELATED PROBLEMS PAOA PENATALAKSANAAN PASIEN  STROKE 01 INSTALASI RAWAT INAP RSAL OR RAMELAN SURABAYA  PERIOOE 1 SEPTEMBER m 31 OKTOBER 2006</dc:title>
	<dc:creator>Rahajeng, Bangunawati</dc:creator>
	<dc:creator>Widyati, Widyati</dc:creator>
	<dc:creator>Ikawati, Zullies</dc:creator>
	<dc:description xml:lang="en-US"> Stroke merupakan penyakit yang memerlukan perawatan jangka panjang sehingga untuk mendapatkan therapeutic outcome yang baik perlu kerjasama antara dokter, perawat, apoteker, pasien, dan keluarga pasien. Kejadian drug related problems sangat umum terjadi pada pasien rawat inap yang berisiko meningkatkan kesakitan, kematian, dan biaya. Penelitian ini bertujuan untuk menelusuri kejadian DRPs pada pasien stroke rawat inap dan untuk mengetahui apakah terjadi DRPs pada penatalaksanaan pasien stroke rawat inap di RSAL Dr Ramelan Surabaya periode 1 September - 31 Oktober 2006. Penelitian dilakukan dengan rancangan studi cross sectional yang dikerjakan secara prospektif terhadap suatu populasi terbatas, yaitu seluruh pasien stroke rawat inap di RSAL Dr. Ramelan Surabaya periode 1 September - 31 Oktober 2006. Data pasien stroke rawat inap didapat dari poli saraf dan UGo, kemudian dilakukan pencatatan status pasien dari rekam medik di bangsal rawat inap. Kekurangan rekam medik dilengkapi dengan melihat catatan perawat, melihat kondisi pasien langsung dengan mengikuti visite dokter, dan wawancara pasien atau keluarga pasien. Data yang diperoleh dilakukan kajian DRPs dengan acuan guidelines stroke yang ada, dihitung persentasenya. Sebanyak 102 dari 109 pasien memenuhi kriteria inklusi. Pad a 102 pasien didapat 67 pasien mengalami DRPs (65,69 %) dan 35 pasien tidak mengalami DRPs (34,31 %). Jenis DRPs yang terjadi adalah drug needed 27 pasien (22,50 %), wrong drug/innappropriate drug 32 pasien (26,67 %), wrong dose 26 pasien (21,67 %), adverse drug reaction 16 pasien (13,33 %), drug interaction 19 pasien (15,83 %). Kata kunci: drug related problems, stroke  </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-11-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21950</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 8 No. 2 (2011)</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21950/11790</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21951</identifier>
				<datestamp>2021-11-29T03:37:31Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">TINGKAT PERESEPAN ANTIBIOTIK DI PUSKESMAS KABUPATEN SLEMAN YOGYAKARTA SELAMA TAHUN 2004-2008</dc:title>
	<dc:creator>Saepudin, Saepudin</dc:creator>
	<dc:description xml:lang="en-US">ABSTRAKBeberapa hasil penelitian menunjukkan bahwa peresepan oba! di puskesmas cenderung berlebih, salah satunya adalah antibiotik. Permasalahan yang potensial terjadi akibat penggunaan antibiotik yang berlebihan adalah pesatnya pertumbuhan bakteri-bakteri yang resisten, di samping potensi terjadinya efek yang tidak dikehendaki dan bertambahnya beban biaya kesehatan yang harus ditanggung baik oleh pasien maupun pemerintah. Penelitian ini dilakukan dengan tujuan untuk mengetahui tingkat peresepan antibiotik di puskesmas yang berada di Kabupaten Sleman Provinsi Daerah Istimewa Yogyakarta selama tahun 2004 - 2008. Penelitian dilakukan dengan menggunakan data penggunaan antibiotik dari 5 (lima) puskesmas yang dipilih secara purposive sampling.Data penggunaan antibiotik setiap puskesmas untuk lima tahun selama tahun 2004 - 2008 diperoleh dari unit farmasi puskesmas, meliputi data jenis antibiotik, bentuk sediaan, serta jumlah penggunaan. Kuantitas penggunaan antibiotik selanjutnya dihitung dalam satuan DDD/1000 kunjungan pasien rawat jalan (DDD/1000KPRJ) berdasarkan metode ATC/DDD yang direkomendasikan WHO, dan selanjutnya dihitung persentase peresepan antibiotik berdasarkan persentase pasien rawat jalan yang mendapatkan resep antibiotik, menggunakan asumsi peresepan antibiotik untuk setiap pasien adalah 5 (lima) hari. Hasil penelitian menunjukkan bahwa penggunaan antibiotik di kelima puskesmas selama tahun 2004 - 2008 menunjukkan pola yang hampir seragam dalam hal jenis antibiotik dan kuantitas penggunaan untuk setiap jenis antibiotik. Namun demikian terdapat perbedaan yang signifikan dalam hal total kuantitas antibiotik yang digunakan selama tahun 2004 - 2008 dan juga rata-rata peresepan antibiotik. Selama tahun 2004 - 2008 rata-rata tingkat peresepan antibiotik di kelima puskesmas berkisar antara 13,6 % sampai 21,2 %, dan jenis antibiotik yang diresepkan relatif sama di antara kelima puskesmas tersebut. Kata kunci: antibiotik, ATC/DDD, DDD/1000KPRJ, puskesmas ABSTRACTAs bacterial resistance to antibiotics became a major public-health problem, antibiotic use is increasingly recognised as the main selective pressure driving this problem. Some researchs reported a high rates of antibitic prescription in primary care, espesially for respiratory tract infections. To combate antibiotic resistance, monitoring of antibiotic prescription should accompany other surveillance programmes. However, data for antibiotic prescriptions are often scarce and not freely available. This research was aimed to know antibiotic prescription rates at primary health center (PHC) in Sleman Yogyakarta during 2004 - 2008. Data of antibiotic use obtained from pharmacy unit of 5 PHCs in Sleman Yogyakarta, and the PHCs were selected purvosively based on data availabilty throughout the study periods. Antibioticutilization was retrieved including name, dosage form, and quantity of use. The quantity of antibiotics use finally expressed as the number of defined daily dose (DDD) per 1000 admissions based on 2003 ATC/DDD guideline released by WHO Collaborating Centre for Drug Statistics Methodology, and then antibiotic prescription rates for each PHC was calculated using the number of DDD per 1000 admissions based an assumption that at the PHCs systemic antibiotics were prescribed for 5 days. Antibiotic utilization for each PHC was compared for each year during 2004 - 2008 including total number of antibiotics agents used, total quantity of antibiotics used, and also antibiotics prescription rates. During 2004 - 2008, average of antibiotic prescription rates in the 5 PHCs range from 13.6 % to 21.2 %, and the item of used antibiotics were relatively same among the PHCs. Keywords: antibiotic, ATC/DDD, prescription, primay health center </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2021-11-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21951</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 8 No. 2 (2011)</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21951/11791</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21954</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Medication profile and potential drug interactions in diabetes mellitus with hypertension outpatient at RSUD dr. H. Andi Abdurrahman Noor</dc:title>
	<dc:creator>Rachmawati, Sinta</dc:creator>
	<dc:creator>Pratiwi, Fania</dc:creator>
	<dc:creator>Norcahyanti, Ika</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Background: Diabetes mellitus is a metabolic disease, characterized by hyperglycemia. It occurs due to impaired insulin secretion, insulin action, or both. Diabetes mellitus is a chronic disease that is often accompanied by complications, one of which is hypertension, so that drug interactions cannot be avoided.Objective: This study aimed to determine the medication profile and potential drug interactions in diabetes mellitus outpatient with hypertension at RSUD dr. H. Andi Abdurrahman Noor.Method: It was a descriptive study. The data was obtained from diabetes with hypertension outpatient in three months (October-December 2020). To analyze potential drug interaction, used drugs.com, Medscape and Stockley for literature.Results: The medication profile showed that insulin aspart (43.84%) and the combination of candesartan and amlodipine (52.05%) were the most used drugs. The most common potential drug interactions were found between insulin and candesartan (73.34%) with moderate severity.Conclusion: Insulin aspart was the most used of antidiabetic. Candesartan plus amlodipine was the most widely used antihypertensive. Both types of drugs (insulin and candesartan) have the potential for drug interactions.Keywords: antidiabetic, antihypertensive, drug interactionIntisari Latar belakang: Diabetes melitus merupakan penyakit metabolik yang ditandai dengan hiperglikemia yang disebabkan adanya gangguan sekresi insulin, kerja insulin, ataupun keduanya. Diabetes melitus merupakan penyakit kronis yang sering disertai komplikasi, salah satunya hipertensi, sehingga kejadian interaksi obat tidak dapat dielakkan.Tujuan: Penelitian ini bertujuan untuk mengetahui profil pengobatan dan potensi interaksi obat pada pasien rawat jalan yang didiagnosis diabetes melitus komplikasi hipertensi di RSUD dr. H. Andi Abdurrahman Noor.Metode: Penelitian ini bersifat deskriptif. Data diperoleh dari lembar resep pasien rawat jalan yang didiagnosis diabetes dengan komplikasi hipertensi selama 3 bulan (Oktober-Desember 2020). Analisis potensi interaksi obat menggunakan sumber drugs.com, Medscape dan Stockley sebagai rujukan.Hasil: Profil pengobatan menunjukkan insulin aspart (43,84%) serta kombinasi kandesartan dan amlodipin (52,05%) merupakan obat-obatan yang paling banyak digunakan. Potensi interaksi obat yang paling banyak ditemukan terjadi antara insulin dengan kandesartan sebesar 73,34% dengan tingkat keparahan sedang.Kesimpulan:Insulin aspart adalah antidiabetes yang paling banyak digunakan, sedangkan kandesartan yang dikombinasi dengan amlodipin merupakan antihipertensi yang paling banyak digunakan. Kedua jenis obat tersebut (insulin dan kandesartan) memiliki potensi interaksi obat.Kata kunci : antidiabetes, antihipertensi, interaksi obat</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21954</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art8</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 60-67</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21954/12137</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/21967</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antibacterial activity of the combination of Mentha spicata and Allium sativum extracts on the growth of  Mycobacterium tuberculosis clinical isolates</dc:title>
	<dc:creator>Jiwintarum, Yunan </dc:creator>
	<dc:creator>Diarti, Maruni Wiwin </dc:creator>
	<dc:creator>Adnyana, I Gede Angga </dc:creator>
	<dc:creator>Anshory, Hady</dc:creator>
	<dc:subject xml:lang="en-US">mint leaves </dc:subject>
	<dc:subject xml:lang="en-US">Mentha spicata</dc:subject>
	<dc:subject xml:lang="en-US">garlic</dc:subject>
	<dc:subject xml:lang="en-US">Allium sativum</dc:subject>
	<dc:subject xml:lang="en-US">Mycobacterium tuberculosis</dc:subject>
	<dc:subject xml:lang="en-US">multidrug-resistant (MDR)-Tuberculosis</dc:subject>
	<dc:description xml:lang="en-US">Background: Tuberculosis (TB) is a disease with a high mortality rate in the world, including in Indonesia. In addition, the problem of Mycobacterium tuberculosis resistance to antibiotics is getting higher. Mint leaves and garlic have been shown its the ability to kill M. tuberculosis. However, it has never been studied how the combined effect the M. tuberculosis growth.Objective: The major objective of this study was to investigate the anti-mycobacterial activity of mint leaves-garlic combination to growth inhibition of clinical culture M. tuberculosis.Method: Extraction of mint leaves and garlic was carried out by maceration using ethanol as a solvent. M. tuberculosis cultures were obtained from clinical samples of patients diagnosed with new tuberculosis (TBB) and MDR- tuberculosis (TBB). The growth inhibition activity test was carried out using the agar dilution method on Lowenstein Jensen (LJ) media.Results: Mint and garlic extracts, and their combination can inhibit the growth of M. tuberculosis clinical culture from TBB and TBM patients with minimal inhibitory concentration (MIC) of 3 mg/mL.Conclusion: Mint and garlic extracts, and their combination are effective in inhibiting the growth of M. tuberculosis clinical culture and can be used as an alternative treatment for tuberculosis disease.Keywords: mint leaves (Mentha spicata), garlic (Allium sativum), Mycobacterium tuberculosis, multidrug-resistant (MDR)-Tuberculosis
Intisari Latar belakang: Tuberkulosis (TBC) merupakan penyakit dengan tingkat kematian yang tinggi di dunia, termasuk Indonesia. Selain itu, masalah resistensi bakteri terhadap antibiotik semakin tinggi. Daun mint (Mentha spicata) dan bawang putih (Allium sativum) telah terbukti dapat membunuh bakteri M. tuberculosis. Namun belum pernah diteliti bagaimana efek kombinasi keduanya dalam membunuh atau menghambat pertumbuhan bakteri M. tuberculosis. Tujuan: Mengetahui aktivitas kombinasi ekstrak daun mint dan bawang putih dalam menghambat pertumbuhan bakteri M. tuberculosis isolat klinik.Metode: Ekstraksi daun mint dan bawang putih dilakukan secara maserasi menggunakan pelarut ethanol. Bakteri uji M. tuberculosis diperoleh dari sampel klinik pasien terdiagnosis tuberkulosis baru (TBB) dan tuberkulosis multidrug resistant (TBB). Uji aktivitas penghambatan pertumbuhan dilakukan menggunakan metode dilusi padat pada media Lowenstein Jensen (LJ).Hasil: Ekstrak daun mint dan bawang putih serta kombinasi keduanya dapat menghambat pertumbuhan bakteri M. tuberculosis isolat klinik dari pasien TBB maupun TBM dengan konsentrasi terkecil 3 mg/mL.Kesimpulan: Ekstrak daun mint dan bawang putih serta kombinasi keduanya efektif menghambat pertumbuhan bakteri M. tuberculosis isolat klinik dan berpotensi untuk digunakan sebagai alternatif pengobatan tuberkulosis.Kata kunci: daun mint (Mentha spicata), bawang putih (Allium sativum), Mycobacterium tuberculosis, multidrug-resistant (MDR)-TB</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/21967</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art10</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 101-109</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/21967/13887</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22035</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Formulation and evaluation of pumpkin fruit (Cucurbita maxima L.) emulgel</dc:title>
	<dc:creator>Erwiyani, Agitya Resti</dc:creator>
	<dc:creator>Ayu, Sri Mustika</dc:creator>
	<dc:creator>Ningtyas, Winda Ayu</dc:creator>
	<dc:creator>Vifta, Rissa Laila</dc:creator>
	<dc:description xml:lang="id-ID">Abstract  Background: The fruit of pumpkin (Cucurbita maxima D.), one of genus Cucurbita, family Cucurbitaceae, has antioxidant activity due to the content of metabolites including amino acids, fatty acids, alpha-tocopherol, beta-tocopherol, beta-carotene, beta-cryptoxanthin, and beta-sitosterol. The content of carotenoids and tocopherols in pumpkin has antioxidant activity, reduces skin damage due to sun exposure, and can slow down the aging process.Objective: The study aimed to formulate pumpkin fruit emulgel and evaluate its physical stability during storage Method: Emulgel contains pumpkin fruit extracts at a concentration of 0.5 – 1.5% w/v. Emulgel evaluations were organoleptic, homogeneity, pH, spreadability, adhesion, and viscosity at 2 - 8°C, room temperature, and 40 degree Celcius. The stability test observed the physical properties for 28 days.Results: Pumpkin fruit extracts contain flavonoids based on the TLC test. Emulgel showed organoleptic yellow color with pH in the range of 5, homogeneous, adhesion for more than 1 second, dispersion 5 – 7 cm, and viscosity 2000 – 4000 cP. Storage for 28 days did not show a significant difference at all storage temperatures and centrifugation tests.Conclusion Pumpkin fruit emulgel is stable at all storage temperatures 2 – 8 degree Celcius, 28 ± 2 degree Celcius, and 40 ± 2 degree Celcius.Keywords: emulgel, pumpkin, formulation, physical stabilityIntisari Latar belakang: Buahlabu kuning (C. maxima D.) yang termasuk dalam genus Cucurbita famili Cucurbitaceae memiliki aktivitas antioksidan karena kandungan metabolit diantaranya asam amino, asam lemak, alfa-tokoferol, beta-tokoferol, beta-karoten, beta-kriptoxantin, dan beta-sitosterol. Kandungan karotenoid dan tokoferol dalam labu kuning memiliki aktivitas antioksidan, menurunkan kerusakan kulit akibat paparan sinar matahari serta dapat memperlambat penuaan dini. Tujuan: Tujuan penelitian untuk memformulasikan emulgel daging buah labu kuning serta evaluasi stabilitas fisik selama penyimpananMetode: Emulgel mengandung ekstrak daging buah labu kuning pada konsentrasi 0,5 – 1,5 % b/v. Evaluasi emulgel meliputi organoleptis, homogentitas, pH, daya sebar, daya lekat, dan viskositas pada 2 - 8 derajat Celcius, suhu kamar dan 40 derajat Celcius. Uji stabilitas dilakukan dengan pengamatan sifat fisik selama 28 hari.  Hasil: Ekstrak daging buah labu kuning mengandung flavonoid berdasarkan uji KLT. Emulgel menunjukkan organoleptis berwarna kuning dengan pH berkisar 5, homogen, daya lekat lebih dari 1 detik, daya sebar 5 – 7 cm, dan viskositas 2000 – 4000 cP. Penyimpanan selama 28 hari tidak menunjukkan perbedaan yang signifikan pada semua suhu penyimpanan dan uji sentrifugasi. Kesimpulan: Emulgel daging buah labu kuning stabil pada semua suhu penyimpanan yaitu 2 – 8 derajat Celcius, 28 ± 2 derajat Celcius dan 40 ± 2 derajat Celcius.Kata kunci : emulgel, labu kuning, formulasi, stabilitas fisik</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22035</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art9</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 68-78</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22035/12153</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22441</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The pattern of vancomycin, gentamycin, and meropenem prescriptions for the inpatients of a regional public hospital in Yogyakarta, Indonesia</dc:title>
	<dc:creator>Herawati, Mutiara</dc:creator>
	<dc:creator>Kemila, Mir-a</dc:creator>
	<dc:creator>Anggriani, Putri</dc:creator>
	<dc:creator>Mardhiyah, Nur</dc:creator>
	<dc:creator>Maulida, Siti</dc:creator>
	<dc:description xml:lang="en-US">Background: The mechanism of action of gentamycin is inhibiting protein synthesis inside bacteria. Meropenem and vancomycin have the same mode of action that inhibit bacterial cell wall activity. Antibiotic resistance occurs when antibiotic use does not follow the guidelines. Therefore, this study aims to determine how vancomycin, gentamycin, and meropenem are prescribed in a regional public hospital. Objective: This study aimed to evaluate the prescription of vancomycin, gentamycin, and meropenem in Yogyakarta Regional Public Hospital in 2017. Methods: This research employed a descriptive analysis with a cross-sectional design. The study was conducted to describe the profiles of vancomycin, gentamycin, and meropenem utilization. Data collection was performed retrospectively using patients’ medical record data including the diagnosis, dosage, and duration of administration.Results: The study showed that the total number of patients who received aminoglycoside: meropenem: vancomycin antibiotics in 2017 and met the research criteria was 6:8:24. According to the diagnosis, gentamycin was used for post-operation (75%), then sepsis and encephalitis. Meropenem was used for sepsis with a percentage of 67% while vancomycin was for endocarditis, intraabdominal, MRSA, cellulitis, pneumonia, and sepsis. Based on the appropriate dosage in the guidelines, the prescribing of gentamycin and meropenem resulted in 100% properness and 69.23% for vancomycin. For the duration of appropriate utilization, it was found that the most prolonged use was in patients given meropenem for 29 days, and the fastest use was a day for patients using vancomycin. Conclusion:Vancomycin, gentamycin, and meropenem had the appropriate dosage. However, discrepancies were still found in the indication and duration of the treatment using these antibiotics.Keywords: Vancomycin, gentamycin, meropenem, antibiotics</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22441</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art16</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 136-146</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22441/12140</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22441/13495</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22475</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The phenolic compounds of ethanolic extract of date seed (Phoenix dactylifera L.) exert hepatoprotective activity on rat induced carragenan</dc:title>
	<dc:creator>Warsinah, Warsinah</dc:creator>
	<dc:creator>Utami, Esti Dyah</dc:creator>
	<dc:creator>Baroroh, Hanif Nasiatul</dc:creator>
	<dc:description xml:lang="en-US">Background: Hepatotoxic effects can occur with the use of toxic drugs or standard doses, but in the long term or chronic therapy. In addition to the drugs, carrageenan also causes hepatotoxic after 12 hours of induction intraperitoneally. The effect of liver cell repair is highly related to the antioxidant activity of phenolic compounds in date seeds.Objective: The present study determined the total phenolic levels and hepatoprotective activity of ethanol extracts of date palm seeds (EEBK) in carrageenan-induced rats.Method: Determination of total phenolics in palm ethanol extract samples was carried out with the Folin- Ciocalteu reagent. This study was the pre and post-test control group design. Examination of SGOT and SGPT levels was performed by the kinetic method based on IFCC. Data was analyzed using paired t-test and ANOVA test. Results: The total phenolic content of the ethanol extract of date seeds of Deglet Noor variety was 8.521% GAE. The ethanol extract of date seed (EEBK) with the dose of 150 mg/kg BW showed the highest reduction in SGOT levels (34.80 U / L). The highest average decrease in SGPT levels occurred at a therapeutic dose of 300 mg/kg BW was 16.20 U / L compared to doses of 150 and 600 mg/kg bb (11.60 and 15.60 U / L respectively).Conclusion: The ethanol extract of date seed (EEBK) with the doses of 150, 300, and 600 mg/kg BW   had hepatoprotective activity in carrageenan-induced rats as observed from a significant decreased in SGOT and SGPT levels (p &amp;lt;0.05). Key word: Date seed, phenolic total, extract, SGPT, SGOT </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22475</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art10</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 79-86</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22475/12122</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22475/13496</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22488</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The immunomodulatory activity of ethanol extract of attarasa bark and fruit (Litsea cubeba (lour.) pers.) toward carbon clearance of mice (Mus musculus)</dc:title>
	<dc:creator>Asfianti, Vivi</dc:creator>
	<dc:creator>Sapitri, Alfi</dc:creator>
	<dc:creator>Marbun, Eva Diansari</dc:creator>
	<dc:description xml:lang="en-US">Abstract Background: Attarasa (L.a cubeba (Lour.) Pers.) is a potential Indonesian medicinal plant that is used as a cold remedy, head ulcers, antimicrobials, antioxidants, and anticancer drugs. Objective: This research was conducted to analyze the immunomodulatory effect of bark (EEKBA) and fruit of attarasa ethanolic extract (EEBA) by detecting its phagocytosis activity in male mice using carbon clearance method.Method: Total of 24 male mice were divided into 6 groups. Extract was orally administered to mices for 7 days at the dose of 100 mg/kg BW, 200 mg/kg BW, and 400 mg/kg BW. Imboost® suspension at the dose of 32.5 mg/kg BW and CMC-Na 1 % suspension was orally administered in positive control, negative control and normal groups. On the 8th day, 0.1 ml carbon suspension was given through intravenous tail injection. The blood samples were withdrawn at 5, 10, 15, and 20 minutes after injection of carbon suspension to find out the carbon absorbance contained in the blood that was measured using spectrophotometer then the carbon elimination speed, phagocytic index, and the stimulation index has been calculatedResult: EEKBA and EEBA at the dose of 400 mg/kg BW induced the higher carbon elimination rate in mice compared to EEKBA and EEBA dose of 100 and 200 mg/kg BW. Phagocytic index of macrophage in mice given with EEKBA and EEBA at dose of 100, 200, dan 400 mg/kg BW were 3.429, 3.501, and 3.925 for EEKBA consecutively; 4.289, 4.375 and 4.732 for EEBA respectively. Stimulation index of macrophage in mice given with EEKBA and EEBA at dose of 100, 200, and 400 mg/kg BW were 1.00; 1.20, 1,02; 1,23, and 1,13; 1,33. Based on the results of statistical test, EEKBA and EEBA administration at the dose of 100, 200, and 400 mg/kg BW stimulate the phagocytosis activity of the macrophage of male mice and significantly has different result compared to normal control group (p &amp;lt; 0.05). Phagocytosis activity was best shown at the mice group that administered EEKBA and EEBA at dose of 400 mg/kg BW and was shown not significantly different compared to positive control group (p &amp;gt; 0.05).  Conclusion: EEKBA and EEBA have immunomodulatory effect by increasing the phagocytosis activity of mice.Keywords: immunomodulatory, Litsea cubeba, carbon clearance, phagocytosis activity Intisari Latar belakang: Attarasa (Litsea cubeba (Lour.) Pers.) merupakan tumbuhan obat potensial Indonesia yang digunakan sebagai obat flu, borok dikepala, antimikroba, antioksidan dan antikanker.Tujuan: Penelitian ini dilakukan untuk dapat mengamati efek imunomodulator Ekstrak Etanol Kulit Batang (EEKBA) dan Ekstrak Etanol Buah Attarasa (EEBA) terhadap aktivitas fagositosis pada mencit jantan dengan menggunakan metode carbon clearance.Metode: Sebanyak 24 ekor mencit jantan dibagi menjadi 6 kelompok. Ekstrak diberikan secara per oral selama 7 hari pada mencit jantan dengan dosis 100, 200, dan 400 mg/kg BB. Suspensi imboost® dengan dosis 32,5 mg/kg BB, suspensi CMC-Na 1% diberikan pada kelompok kontrol positif, negatif, dan normal. Pada hari ke-8 disuntikkan suspensi karbon 0,1 ml secara intravena di ekor mencit. Sampel darah dikumpulkan pada menit ke-5, 10, 15, dan 20 setelah diinjeksi dengan suspensi karbon untuk mengetahui absorbansi karbon dalam darah yang diukur menggunakan spektrofotometer kemudian dihitung kecepatan eliminasi karbon, indeks fagositosis, dan indeks stimulasinya.Hasil: EEKBA and EEBA dosis 400 mg/kg BB menghasilkan kecepatan eliminasi karbon yang paling tinggi dibandingkan dengan EEAB dan EEAF 100 dan 200 mg/kg BB. Indeks fagositosis yang dihasilkan dari pemejanan EEKBA and EEBA dosis 100, 200, dan 400 mg/kg BB terhadap hewan uji yaitu 3,429; 4,289; 3,501; 4,375 dan 3,925; 4,732. Indeks stimulasi makrofag yang diperoleh setelah hewan uji dipejani dengan EEKBA and EEBA dosis 100, 200, dan 400 mg/kg BB yaitu 1,00; 1,20, 1,02; 1,23, dan 1,13; 1,33. Berdasarkan hasil uji statistik, pemberian EEKBA and EEBA pada dosis 100, 200, dan 400 mg/kg BB dapat meningkatkan aktivitas fagositosis pada mencit jantan dan terdapat perbedaan yang signifikan dengan CMC-Na 1% dan kelompok normal (p&amp;lt;0,05). Aktivitas fagositosis yang paling baik ditemukan pada pemberian EEKBA and EEBA dengan dosis 400 mg/kg BB dengan perbedaan yang tidak signifikan terhadap kelompok hewan uji yang diberi Imboost® (p&amp;gt;0,05).Kesimpulan: EEKBA and EEBA mempunyai efek imunomodulator dengan meningkatkan aktivitas fagositosis pada mencit jantanKata kunci: imunomodulator, Litsea cubeba, carbon clearance, aktivitas  fagositosis.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/vnd.openxmlformats-officedocument.wordprocessingml.document</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22488</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art20</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 175-184</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22488/12165</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22488/13497</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22496</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">The profile of anxiety, stress, and depression among pharmacy students  in Universitas Islam Indonesia</dc:title>
	<dc:creator>Herawati, Mutiara</dc:creator>
	<dc:creator>Karinaningrum, Aldia Dwi</dc:creator>
	<dc:creator>Febrianti, Yosi</dc:creator>
	<dc:description xml:lang="id-ID">Abstract Background: Implementation of the new curriculum is tiresome for both lecturers and students. Students who are passive and have limited cognitive abilities will feel depressed. This condition can cause anxiety leading to stress and ultimately depression. The enhancement of graduation standards for apothecary students rises the depression risk factors, especially for retaker students (students who do not pass the Indonesian Pharmacist Competency Exam).Objective: This study aimed to identify the level of anxiety, stress, and depression among undergraduate pharmacy and pharmacist profession students.Method: This study was a cross-sectional design that employed the students of undergraduate and apothecary programs. Respondents involved in this study were undergraduate students in the 2nd, 3rd, and 4th year (n=451) and professional students from batches 35, 36, and 37 (n=271). The DASS 42 questionnaire (Depression Anxiety Stress Scale) was used to identify depression. The data were analyzed descriptively.Result: The number of respondents who met the inclusion criteria was 668. Most undergraduate students had moderate levels of anxiety, normal stress, and normal depression, while apothecary students had normal profiles for all parameters.Conclusion: The various activities and pressure during the learning process triggered psychological disorders for only 5% of respondents.Keywords: Anxiety, stress, depression, DASS-42 Intisari Latar belakang: Implementasi kurikulum baru sangat menguras pikiran dan tenaga, baik dosen maupun mahasiswa. Bagi mahasiswa yang pasif dan memiliki kemampuan kognitif terbatas akan merasakan kondisi tertekan. Kondisi tersebut dapat menyebabkan kecemasan yang meningkat menjadi stress dan pada akhirnya depresi. Peningkatan standar kelulusan mahasiswa apoteker berpotensi meningkatkan faktor risiko kejadian depresi, terutama bagi mahasiswa retaker (mahasiwa yang tidak lulus Ujian Kompetensi Apoteker Indonesia). Tujuan: Penelitian ini bertujuan untuk mengidentifikasi tingkat kecemasan, stress, dan depresi mahasiswa S1 farmasi dan profesi apoteker.Metode: Penelitian menggunakan rancangan cross-sectional kepada mahasiswa program studi farmasi dan profesi apoteker. Responden yang terlibat dalam penelitian ini adalah mahasiswa strata pertama pada tahun ke-2,3, dan 4 (n=451) serta mahasiswa profesi angkatan 35, 36, dan 37 (n=271). Alat yang digunakan untuk mengidentifikasi depresi adalah kuesioner DASS 42 (Depression Anxiety Stress Scale). Data yang diolah secara deskriptif.Hasil: Jumlah responden yang sesuai dengan kriteria inklusi sebanyak 668. Mayoritas mahasiswa S1 memiliki profil tingkat kecemasan sedang, stress normal, dan depresi normal, sedangkan pada mahasiswa profesi apoteker memiliki profil tingkat kecemasan, stress, dan depresi normal. increaseKesimpulan: Dengan berbagai aktivitas dan tekanan selama proses pembelajaran, mayoritas mahasiswa tidak mengalami gangguan psikis, meskipun 5% diantaranya menyatakan mengalami gangguan.Kata kunci : Kecemasan, stress, depresi, DASS-42</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22496</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art17</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 147-158</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22496/12131</dc:relation>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22496/13498</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22503</identifier>
				<datestamp>2022-03-19T07:53:44Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Assessment of prescribing pattern based on WHO indicators at “X” Primary Health Care in Sleman Regency</dc:title>
	<dc:creator>Wardhani, Kristy Tri</dc:creator>
	<dc:creator>Medisa, Dian</dc:creator>
	<dc:creator>Saepudin, Saepudin</dc:creator>
	<dc:creator>Ifada, Ifada</dc:creator>
	<dc:description xml:lang="id-ID">Abstract Background: Puskesmas is a primary level of health service facility that must implement rational drug use. A rational prescribing pattern will improve the quality of health services.Objective: The aim of this study was to know the prescribing pattern at the &quot;X&quot; Primary Health Care in Sleman Regency based on WHO indicators.Method: A retrospective observational study was conducted to assess the prescribing pattern. The sample was selected using simple random sampling and analyzed descriptively. The data was collected from prescriptions in Mei 2019.Result: The results of this study showed the average number of drugs per prescription was 2.66, drugs prescribed by generic name was 100%. The percentage of encounter in which injection and antibiotic was prescribed was 0% and 15.83% respectively. Most drugs (91.85%) were included in National Formulary.Conclusion: It can be concluded that the prescribing pattern at Puskesmas X is rational according to the target of the Ministry of Health and WHO, but it is necessary to carry out a continuous MTP (monitoring training planning) process involving related parties.Keywords: prescribing pattern, primary health care, Sleman, WHO indicatorsIntisari Latar belakang: Puskesmas adalah fasilitas pelayanan kesehatan tingkat I yang harus menerapkan penggunaan obat rasional. Pola peresepan yang rasional akan menghasilkan kualitas dalam pelayanan kesehatan masyarakat.Tujuan:  Penelitian ini bertujuan untuk mengetahui gambaran pola peresepan di Puskesmas “X” Kabupaten Sleman berdasarkan indikator peresepan WHO.Metode: Penelitian merupakan penelitian observasional secara retrospektif menggunakan resep bulan Mei 2019. Sampel resep diambil dengan metode random sampling dan data dianalisis secara deskriptif.Hasil: Hasil penelitian menunjukkan rata-rata jumlah obat per lembar resep adalah 2,66, tingkat peresepan obat dengan nama generik 100%, tingkat penggunaan antibiotik sebesar 15,83% dari total kasus, tingkat peresepan injeksi 0%, dan kesesuaian peresepan dengan Formularium Nasional 2017 sebesar 91,85%.Kesimpulan: Pola peresepan di Puskesmas X sudah rasional sesuai target Kementerian Kesehatan dan WHO, namun perlu dilakukan proses MTP (monitoring training planning) berkesinambungan melibatkan pihak terkait.Kata kunci: pola peresepan, puskesmas, Sleman, indikator WHO </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-01-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22503</dc:identifier>
	<dc:identifier>10.20885/jif.specialissue2022.art11</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; 2022: Special Issue; 87-96</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22503/12129</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22612</identifier>
				<datestamp>2023-07-31T16:54:14Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Isolation of antifungal bioactive compounds from an ethanolic extract of beluntas leaves (Pluchea indica) against Microsporum canis</dc:title>
	<dc:creator>Safitri, Devi</dc:creator>
	<dc:creator>Muhaimin</dc:creator>
	<dc:creator>Nelson</dc:creator>
	<dc:creator>Tarigan, Indra Lasmana</dc:creator>
	<dc:creator>Lizawati</dc:creator>
	<dc:creator>Latief, Madyawati</dc:creator>
	<dc:subject xml:lang="en-US">Pluchea indica</dc:subject>
	<dc:subject xml:lang="en-US">antifungal</dc:subject>
	<dc:subject xml:lang="en-US">Microsporum canis</dc:subject>
	<dc:subject xml:lang="en-US">isolation compound</dc:subject>
	<dc:description xml:lang="en-US">Abstract Background: Fungus prevalence in Indonesia is still relatively high. This happens because Indonesia has high temperatures and humidity. Beluntas (Pluchea indica) is a shrub native to Indonesia and widely distributed in most parts of the country. Pluchea indica is usually used by the community as a medicine for skin diseases. The bioactive content of P. indica leaves has potential as an antifungal agent. One of the fungi that is pathogenic to humans is Microsporum canis.Method: N-hexane, ethyl acetate, and ethanol served as the solvents for the graded maceration method of extraction over two 24-hour periods. Furthermore, using Vacuum Liquid Chromatography (VLC) and characterization with UV-Vis and FT-IR. Antifungal activity was performed by disc diffusion method.Results: Pluchea indica leaves have antifungal activity in the ethanol extract of 20.08 mm (very strong), the F5 fraction of 22.24 mm (very strong), and the F5 isolate of 6.3 mm (weak) at a concentration of 4%. Based on the UV-Vis and FT-IR data, the isolate had a wavelength of 267 nm with a functional group of -OH, C=C aromatic, C-H, and C-O.Conclusion: Isolate from the ethanol extract of Pluchea indica leaves has potential as an antifungal originating from the flavonoid group.Keywords: Pluchea indica, antifungal, Microsporum canis, isolation compound
Intisari Latar belakang: Prevalensi infeksi jamur di Indonesia masih terbilang tinggi. Hal ini terjadi karena Indonesia memiliki suhu dan kelembaban yang tinggi. Beluntas (Pluchea indica) merupakan tumbuhan semak asli Indonesia, tersebar luas hampir di sebagian besar wilayah Indonesia. Tumbuhan P. indica biasanya dimanfaatkan masyarakat sebagai obat penyakit kulit. Kandungan bioaktif yang dimiliki daun P. indica dapat berpotensi sebagai antijamur. Salah satu jamur yang bersifat patogen pada manusia adalah Microsporum canis.Tujuan: Mengetahui aktivitas antijamur dari ekstrak etanol daun P. indica dan mengkarakterisasi senyawa hasil isolasinya.Metode: Ekstraksi dilakukan dengan metode maserasi bertingkat selama 2 x 24 jam menggunakan pelarut n-heksan, etil asetat dan etanol. Selanjutnya identifikasi menggunakan Kromatografi Vakum Cair (KVC) dan karakterisasi dengan spektrofotometer UV-Vis dan FT-IR. Pengujian aktivitas antijmur dilakukan dengan metode difusi cakram.Hasil: Daun P. indica memiliki aktivitas sebagai antijamur pada ekstrak etanol sebesar 20,08 mm (sangat kuat), fraksi F5 22,24 mm (sangat kuat) dan isolat F5 6,30 mm (lemah) pada konsentrasi 4%. Berdasarkan data spektrofotometer UV-Vis dan FT-IR diperoleh isolat memiliki panjang gelombang sebesar 267 nm dengan gugus fungsi -OH, C=C cincin aromatik, C-H dan C-O.Kesimpulan: Isolat dari ekstrak etanol daun Pluchea indica memiliki potensi sebagai antijamur yang berasal dari golongan flavonoid.Kata kunci: Pluchea indica, antijamur, Microsporum canis, isolasi senyawa</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22612</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss1.art5</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 1 (2023): Jurnal Ilmiah Farmasi; 52-64</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol19.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22612/15446</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22679</identifier>
				<datestamp>2023-07-31T16:54:14Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The relationship between knowledge and community behavior in improving the immune system during the COVID-19 pandemic era in Barong Tongkok Village</dc:title>
	<dc:creator>Windi, Stevania</dc:creator>
	<dc:creator>Dewi, Lucia Vita Inandha</dc:creator>
	<dc:creator>Hanifah, Inaratul Rizkhy </dc:creator>
	<dc:subject xml:lang="en-US">Level of knowledge</dc:subject>
	<dc:subject xml:lang="en-US">behavior</dc:subject>
	<dc:subject xml:lang="en-US">immune system</dc:subject>
	<dc:subject xml:lang="en-US">COVID-19 pandemic</dc:subject>
	<dc:description xml:lang="en-US">Abstract Background: Within 2 years of the COVID-19 pandemic, stopping the spread of COVID-19 in the community can be done with adequate knowledge about immune system improvement behaviors and the use of health supplements to improve the body's immune system.Objective: This study aims to determine the relationship between the level of knowledge and community behavior in improving the immune system in Barong Tongkok Village in the era of the COVID-19 pandemic.Method: This study is a quantitative type with a cross-sectional method conducted in Barong Tongkok Village with a total sample of 356 respondents from 4,787 total populations. Analysis of results is carried out with univariate tests to concentrate and display data, while bivariate tests are statistical analyses of chi-square tests to see the relationship between two variables.Results: A univariate analysis revealed that the level of knowledge in the high category was 55.6% and the behavior of improving the immune system in the good category was 50.8%. The results of the bivariate test analysis with the chi-square test revealed a significant relationship between the level of knowledge and the behavior of improving the immune system (p = 0.000).Conclusion: There is a relationship between the level of knowledge and the behavior of improving the immune system in Barong Tongkok Village.Keywords: Level of knowledge, behavior, immune system, COVID-19 pandemic
Intisari Latar belakang: Dalam kurun waktu 2 tahun lamanya pandemi COVID-19 telah berlangsung, penghentian penyebaran COVID-19 di masyarakat bisa dilakukan dengan pengetahuan yang memadai tentang perilaku peningkatan sistem imun dan penggunaan suplemen kesehatan untuk memperbaiki sistem imun tubuh.Tujuan: Studi ini bertujuan untuk mengetahui hubungan antara tingkat pengetahuan, dengan perilaku masyarakat dalam peningkatan sistem imun di Kelurahan Barong Tongkok di era pandemi COVID-19. Metode: Penelitian ini termasuk jenis kuantitatif dengan metode cross-sectional dilakukan di Kelurahan Barong Tongkok dengan jumlah sampel 356 responden dari 4.787 populasi masyarakat, analisis hasil dilakukan dengan uji univariat untuk mempersentasekan dan menampilkan data, sedangkan uji bivariat yaitu analisis statistika uji chi-square untuk melihat hubungan antara dua variabel.Hasil: Analisis univariat diperoleh bahwa tingkat pengetahuan dengan kategori tinggi sebesar 55,6%, dan perilaku peningkatan sistem imun dengan kategori baik sebesar 50,8%. Hasil analisis uji bivariat dengan uji chi-square diperoleh hubungan yang signifikan antara tingkat pengetahuan dengan perilaku peningkatan sistem imun (p=0,000).Kesimpulan: Terdapat hubungan antara tingkat pengetahuan dengan perilaku peningkatan sistem imun di Kelurahan Barong Tongkok.Kata kunci: Tingkat pengetahuan, perilaku, sistem imun, pandemi COVID-19</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22679</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss1.art6</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 1 (2023): Jurnal Ilmiah Farmasi; 67-75</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol19.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22679/15447</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/22921</identifier>
				<datestamp>2025-06-14T03:45:15Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">A review of calophyllolide from Calophyllum inophyllum L.: isolation, quantification, analytical method, and burn wound healing potential</dc:title>
	<dc:title xml:lang="id-ID">Review: Isolasi, Peningkatan Kadar, dan Analisis Calophyllolide dalam Minyak Calophyllum inophyllum Linn. serta Potensinya untuk Terapi Luka Bakar</dc:title>
	<dc:creator>Herawati, Zainab</dc:creator>
	<dc:creator>Rakhmawati, Rita</dc:creator>
	<dc:subject xml:lang="en-US">Calophyllolide</dc:subject>
	<dc:subject xml:lang="en-US">Calophyllum inophyllum</dc:subject>
	<dc:subject xml:lang="en-US">isolation</dc:subject>
	<dc:subject xml:lang="en-US">quantification</dc:subject>
	<dc:subject xml:lang="en-US">burn wound healing</dc:subject>
	<dc:description xml:lang="en-US">Background: Calophyllolide is a dipyranocoumarin compound found in Calophyllum inophyllum L., known for its antimicrobial and anti-inflammatory properties, which are beneficial for burn wound healing. However, variability in its content and lack of standardized methods remain challenges.Objective: This review aims to present a literature study on calophyllolide, including its sources, isolation techniques, bioactive content optimization, analytical methods, and pharmacological potential in burn wound healing.Method: Data were retrieved from Scopus and PubMed using predefined keywords. Articles published in English between 2001 and 2021 and classified as original research were selected. Relevant studies were assessed for quality using the SYRCLE tool (animal studies) and the Young &amp;amp; Solomon checklist (non-clinical research).Results: Seeds harvested in September had the highest calophyllolide content (0.23%). Enhancement through tissue culture using 2 mg/L IBA yielded up to 45.23 mg/100 g callus. Among analytical techniques, a validated GC-MS method showed high precision and recovery. Pharmacological studies confirmed its activity against Staphylococcus aureus and its ability to modulate inflammatory responses.Conclusion: Calophyllolide shows strong potential as a natural agent for burn wound therapy. Standardized extraction, quantification, and production approaches are essential for further development.</dc:description>
	<dc:description xml:lang="id-ID">Background: Calophyllolide in C. inophyllum oil is reported to have antimicrobial and anti-inflammatory activity. This activity prompted the proposal of the compound as a burn therapy agent. In addition, several studies have reported on the isolation, content increase, and analysis of Calophyllolide.Objective: This review aims to present a literature study related to the isolation, content increase, and analysis of Calopyllolide in C. inophyllum oil and its potential as a burn therapy agent.Method: The data comes from Scopus and PubMed with the inclusion criteria of English articles, original research type of study, and published in 2001-2021. Appropriate articles were assessed for quality by SYRCLE and Young &amp;amp; Solomon Questions.Results: In this review, 10 scientific articles are used as data sources.Conclusion: Isolation by column chromatography followed by Sephadex LH-20 ethanol extract of C. inophyllum seeds harvested in September showed the highest calophyllolide content. Callus culture method with the addition of phytohormones, elicitors, and modification of the medium can increase the levels of Calophyllolide. The validated method can be used for Calophyllolide analysis. Based on its antimicrobial and anti-inflammatory activity, Calophyllolide can be proposed as a burn therapy agent.Keywords: analysis, burns, calophyllolide, content, isolation</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2025-05-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/22921</dc:identifier>
	<dc:identifier>10.20885/jif.vol21.iss1.art10</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 21 No. 1 (2025): Jurnal Ilmiah Farmasi; 105-119</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/22921/18371</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/23258</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The relationship of empirical antibiotic appropriateness based on ATS/IDSA  with clinical outcome and LOS for sepsis pneumonia patients in ICU</dc:title>
	<dc:title xml:lang="id-ID">Relationship Between Appropriateness of Empirical Antibiotics Based on ATS/IDSA with Clinical Outcome and Length of Stay in ICU (Intensive Care Unit) Patient with Sepsis Pneumonia</dc:title>
	<dc:creator>Aziz, Muhammad Luthfi</dc:creator>
	<dc:creator>Sari, Ika Puspita</dc:creator>
	<dc:creator>Asdie, Rizka Humardewayanti</dc:creator>
	<dc:subject xml:lang="en-US">sepsis pneumonia</dc:subject>
	<dc:subject xml:lang="en-US">antibiotic empiric</dc:subject>
	<dc:subject xml:lang="en-US">clinical outcome</dc:subject>
	<dc:subject xml:lang="en-US">LOS</dc:subject>
	<dc:description xml:lang="en-US">Background: In ICU (Intensive Care Unit), sepsis is the most common cause of death, with pneumonia being the most common source of infection. The management of sepsis pneumonia is determined by the therapy used. One of the supporting aspects in the successful treatment of sepsis pneumonia is appropriate empiric antibiotic therapy.Objective: Determine the relationship between the appropriateness of empirical antibiotics based on ATS/IDSA (American Thoracic Society/ The Infectious Disease Society of America) with clinical outcome and LOS (Length Of Stay) in ICU patients with sepsis pneumonia.Method: An observational study with a retrospective cohort design in ICU patients with sepsis pneumonia from January 2019-December 2020 at RS X Jakarta. The study involved 99 patients who were divided into two groups based on appropriate and inappropriate with ATS/IDSA. Data were analyzed using bivariate and multivariate for reducing the confounding factor.Results: The appropriateness of empirical antibiotics was found to be appropriate in 48.48% (48 patients), while 51.52% (51 patients) were inappropriate with ATS/IDSA. There was a relationship between empirical antibiotic appropriateness and clinical outcome (p=0.042; RR=1.430; 95%CI=1.039-1.969) based on the chi-square test, but no relationship with LOS (p=0.629) based on the Mann Whitney test. The multivariate analysis showed that there were no confounding factors affecting the clinical outcome (p&amp;gt;0.05).Conclusion: There is a relationship between empirical antibiotic appropriateness based on ATS/IDSA with clinical outcomes but not related to the length of stay in sepsis pneumonia patients in the ICU.Keywords: sepsis pneumonia, antibiotic empiric, clinical outcome, LOS
IntisariLatar belakang: Sepsis merupakan penyebab kematian terbanyak di ICU (Intensive Care Unit), dengan sumber infeksi tertinggi adalah pneumonia. Keberhasilan pengobatan sepsis pneumonia bergantung pada terapi yang diberikan. Pemberian terapi antibiotik empirik yang sesuai merupakan salah satu faktor penunjang keberhasilan pengobatan sepsis pneumonia.Tujuan: Mengetahui hubungan kesesuaian antibiotik empirik berdasarkan ATS/IDSA (American Thoracic Society/ The Infectious Disease Society of America) dengan outcome klinik dan lama waktu rawat pasien sepsis pneumonia di ICU.Metode: Penelitian observasional dengan rancangan kohort retrospektif pada pasien ICU dengan diagnosis sepsis pneumonia periode 1 Januari 2019-31 Desember 2020 di RS X Jakarta. Penelitian melibatkan 99 pasien yang terbagi dalam kelompok sesuai dan tidak sesuai ATS/IDSA. Data dianalisis dengan uji bivariat serta multivariat untuk mereduksi variabel pengganggu.Hasil: Kesesuaian antibiotik empirik diperoleh sebesar 48,48% (48 pasien) telah sesuai dan 51,52% (51 pasien) tidak sesuai ATS/IDSA. Berdasarkan hasil uji chi-square terdapat hubungan kesesuaian antibiotik empirik dengan outcome klinik (p=0,042; RR=1,430; 95%CI=1,039-1,969) dan berdasarkan uji mann whitney tidak terdapat hubungan antara kesesuaian antibiotik empirik dengan lama waktu rawat (p=0,629). Hasil analisis multivariat menunjukkan tidak ada faktor pengganggu yang mempengaruhi outcome klinik (p&amp;gt;0,05).Kesimpulan: Kesesuaian antibiotik empirik berdasarkan ATS/IDSA pada pasien sepsis pneumonia di ICU memiliki hubungan dengan outcome klinik namun tidak berhubungan dengan lama waktu rawat.Kata kunci: sepsis pneumonia, antibiotik empirik, outcome klinik, lama waktu rawat</dc:description>
	<dc:description xml:lang="id-ID">Abstract Background: In ICU (Intensive Care Unit), sepsis is the most common cause of death, with pneumonia being the most common source of infection. The management of sepsis pneumonia is determined on the therapy used. One of the supporting aspects in the successful treatment of sepsis pneumonia is appropriate empiric antibiotic therapy.Objective: Determine the relationship between appropriateness of empirical antibiotics based on ATS/IDSA (American Thoracic Society/ The Infectious Disease Society of America) with clinical outcome and LOS (Length Of Stay) in ICU patient with sepsis pneumonia.Method: An observational study with a retrospective cohort design in ICU patients with sepsis pneumonia from January 2019-Desember 2020 at RS X Jakarta. The study involved 99 patients who were divided into two groups based on appropriate and inappropriate with ATS/IDSA. Data were analyzed using bivariate and multivariate for reducing the confounding factor.Results: The appropriateness of empirical antibiotics was found to be appropriate in 48.48% (48 patients), while 51.52% (51 patients) inappropriate with ATS/IDSA. There was a relationship between empirical antibiotic appropriateness and clinical outcome (p=0.042; RR=1.430; 95%CI=1.039-1.969) based on the chi-square test, but no relationship with LOS (p=0.629) based on the Mann Whitney test. The multivariate analysis showed that there were no confounding factors affecting the clinical outcome (p&amp;gt;0.05).Conclusion: In patients with sepsis pneumonia in the ICU, the appropriateness of empirical antibiotics based on ATS/IDSA has a relationship with clinical outcomes but not with LOS.Keywords: sepsis pneumonia, antibiotic empiric, clinical outcome, LOS Intisari Latar belakang: Sepsis merupakan penyebab kematian terbanyak di ICU (Intensive Care Unit), dengan sumber infeksi tertinggi adalah pneumonia. Keberhasilan pengobatan sepsis pneumonia bergantung pada terapi yang diberikan. Pemberian terapi antibiotik empirik yang sesuai merupakan salah satu faktor penunjang keberhasilan pengobatan sepsis pneumonia.Tujuan: Mengetahui hubungan kesesuaian antibiotik empirik berdasarkan ATS/IDSA (American Thoracic Society/ The Infectious Disease Society of America) dengan outcome klinik dan lama waktu rawat pasien sepsis pneumonia di ICU.Metode: Penelitian observasional dengan rancangan kohort retrospektif pada pasien ICU dengan diagnosis sepsis pneumonia periode 1 Januari 2019-31 Desember 2020 di RS X Jakarta. Penelitian melibatkan 99 pasien yang terbagi dalam kelompok sesuai dan tidak sesuai ATS/IDSA. Data dianalisis dengan uji bivariat serta multivariat untuk mereduksi variabel pengganggu.Hasil: Kesesuaian antibiotik empirik diperoleh sebesar 48,48% (48 pasien) telah sesuai dan 51,52% (51 pasien) tidak sesuai ATS/IDSA. Berdasarkan hasil uji chi-square terdapat hubungan kesesuaian antibiotik empirik dengan outcome klinik (p=0,042; RR=1,430; 95%CI=1,039-1,969) dan berdasarkan uji mann whitney tidak terdapat hubungan antara kesesuaian antibiotik empirik dengan lama waktu rawat (p=0,629). Hasil analisis multivariat menunjukkan tidak ada faktor pengganggu yang mempengaruhi outcome klinik (p&amp;gt;0,05).Kesimpulan: Kesesuaian antibiotik empirik berdasarkan ATS/IDSA pada pasien sepsis pneumonia di ICU memiliki hubungan dengan outcome klinik namun tidak berhubungan dengan lama waktu rawat.Kata kunci: sepsis pneumonia, antibiotik empirik, outcome klinik, lama waktu rawat</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/23258</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art9</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 88-100</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/23258/13881</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Jurnal Ilmiah Farmasi</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/23467</identifier>
				<datestamp>2023-01-02T06:10:28Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Mechanism and immunomodulator bioactive compounds of Phyllanthus niruri (Meniran) </dc:title>
	<dc:title xml:lang="id-ID">Phyllanthus niruri (Meniran) Sebagai Imunomodulator: Mekanisme aksi dan senyawa bioaktif </dc:title>
	<dc:creator>Hikmah, Uzulul </dc:creator>
	<dc:creator>Triastuti, Asih</dc:creator>
	<dc:subject xml:lang="en-US">Phyllanthus niruri</dc:subject>
	<dc:subject xml:lang="en-US">immunomodulator</dc:subject>
	<dc:subject xml:lang="en-US">immunostimulant</dc:subject>
	<dc:description xml:lang="en-US">Background: Phyllanthus niruri (meniran) is a medicinal plant with antimicrobial, antioxidant, anticancer, anti-inflammatory, antiplasmodial, antiviral, hepatoprotective diuretic, and immunomodulator properties.
Objective: This review examined the activity, mode of action, and active compounds of P. niruri as an immunomodulator in various preclinical and clinical studies, along with the bioactive compounds and their mechanism.
Results: Flavonoids, lignans, terpenoids, and alkaloids, among other phytochemicals found in P. niruri, play an essential part in the pharmacological activity of the plant. The immunomodulation activity of P. niruri has been extensively researched in preclinical (in silico, in vitro, and in vivo) and clinical trials. A study in silico revealed the potential of P. niruri as an immunomodulator in Covid-19 infection by inhibiting the COVID-19 target receptors spike glycoprotein (6LZG) and major protease (5R7Y and Mpro). In addition, P. niruri boosted macrophage phagocytic activity, increased antibody total, and reduced inflammation in vitro and in vivo experiments. P. niruri also showed immunomodulatory effects in both healthy subjects and patients. 
Conclusion: P. niruri exhibits pharmacological potential as an immunomodulator in preclinical and clinical trials, according to the findings of various investigations.
Keywords: Phyllanthus niruri, immunomodulator, immunostimulant
Intisari 
Latar belakang: Phyllanthus niruri merupakan tanaman obat yang memiliki beberapa aktivitas farmakologi seperti antimikroba, antioksidan, antikanker, antiinflamasi, antiplasmodium, antivirus, diuretik, hepatoprotektif, dan sebagai imunomodulator. 
Tujuan: Melakukan tinjauan analisis mengenai aktivitas, mekanisme, dan senyawa aktif P. niruri sebagai imunomodulator pada uji preklinis maupun uji klinis.
Hasil: Kandungan kimia P. niruri seperti flavonoid, lignan, terpenoid, dan alkaloid berperan penting pada aktivitas farmakologi P. niruri sebagai imunomodulator.  Uji in silico menunjukkan potensi P. niruri sebagai imunomodulator pada infeksi Covid-19 dengan berikatan pada protein spike dan protease yang bertanggungjawab pada replikasi dan pematangan virus. Uji in vitro dan in vivo menunjukkan bahwa P. niruri mampu meningkatkan aktivitas fagositosis dari makrofag, meningkatkan antibodi serum total, dan mengurangi inflamasi. Pengujian klinis membuktikan bahwa P. niruri memiliki aktivitas imunomodulator baik pada subjek uji sehat maupun pada pasien. 
Kesimpulan: P. niruri memiliki aktivitas sebagai imunomodulator baik pada pengujian preklinis maupun klinis. 
Kata kunci : P. niruri, imunomodulator, imunostimulan</dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Phyllanthus niruri merupakan tanaman obat yang memiliki beberapa aktivitas farmakologi seperti antimikroba, antioksidan, antikanker, antiinflamasi, antiplasmodium, antivirus, diuretik, hepatoprotektif, dan sebagai imunomodulator.
Tujuan: Melakukan tinjauan analisis mengenai efektivitas P. niruri) sebagai imunomodulator pada uji preklinis maupun uji klinis.
Hasil: Kandungan kimia P. niruri seperti flavonoid, lignan, terpenoid, dan alkaloid berperan penting pada aktivitas farmakologi P. niruri sebagai imunomodulator. &amp;nbsp;Uji in silico menunjukkan potensi P. niruri sebagai imunomodulator pada infeksi Covid-19 dengan berikatan pada protein spike dan protease yang bertanggungjawab pada replikasi dan pematangan virus. Uji in vitro dan in vivo menunjukkan bahwa P. niruri mampu meningkatkan aktivitas fagositosis dari makrofag, meningkatkan antibodi serum total, dan mengurangi inflamasi. Pengujian klinis membuktikan bahwa P. niruri memiliki aktivitas imunomodulator baik pada subjek uji sehat maupun pada pasien.
Kesimpulan: Phyllanthus niruri memiliki aktivitas sebagai imunomodulator baik pada pengujian preklinis maupun klinis.
Kata kunci : Phyllanthus niruri, Imunomodulator, Imunostimulan, Metabolit sekunder</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-12-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/23467</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss2.art19</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi; 205-218</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/23467/14537</dc:relation>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/23531</identifier>
				<datestamp>2023-07-31T16:54:14Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">In Silico Study of Monascus sp. Pigment Derivatives as Anticardiovascular Candidate</dc:title>
	<dc:creator>Nuryadin Zain, Dichy</dc:creator>
	<dc:creator>Yuliana, Anna</dc:creator>
	<dc:subject xml:lang="en-US">Monascus sp. Pigment</dc:subject>
	<dc:subject xml:lang="en-US">Anticardiovascular</dc:subject>
	<dc:subject xml:lang="en-US"> In silico</dc:subject>
	<dc:subject xml:lang="en-US">PAK1</dc:subject>
	<dc:subject xml:lang="en-US">ADME  </dc:subject>
	<dc:subject xml:lang="en-US">Toxicity</dc:subject>
	<dc:description xml:lang="en-US">Abstract Background: Cardiovascular disease is the leading cause of death in the world. The therapeutic activity of Monascus sp. pigment can act as an anticardiovascular agent. Research on Monascus sp. pigment is rapidly developing, including the discovery of new pigments, the methods used, and their identification. Currently, there are 57 dyestuff compounds that have been successfully isolated from Monascus molds. So, researchers conducted an in-silico study of Monascus sp.Objective: To determine whether it can have better interactions and activities as an anticardiovascular medicine candidate.Method: PAK1 is used as a receptor for anticardiovascular drugs. 57 test compounds were carried out for ligand preparation and application of Lipinski's rule of five by using MarvinSketch software, ADME prediction and toxicity testing using PreADMET, the docking process using Autodock tools, and visualization using Discovery Studio.Results: The results of the docking analysis are seen from the values of binding affinity consecutively. compound R3 (-8.74 kcal/mol), red shandong (-8.16 kcal/mol), and monaphilol (-8.14 kcal/mol) are lower than the comparison compound bisoprolol (-6.44 kcal/mol), which shows that the three compounds have better interactions than the comparison compounds. Conclusion: Derivative compounds from Monascus sp. Pigment are predicted to have better interactions and can be used as anticardiovascular medicine candidates.Keywords: Monascus sp., pigment, anticardiovascular, in silico, PAK1, ADME, and toxicity</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-03-03</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/23531</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss1.art1</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 1 (2023): Jurnal Ilmiah Farmasi; 1-14</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol19.iss1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/23531/14903</dc:relation>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/23768</identifier>
				<datestamp>2023-12-31T09:55:59Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The level of knowledge, attitude, and community behavior about halal cosmetics in Makasar District, DKI Jakarta</dc:title>
	<dc:title xml:lang="id-ID">The level of knowledge, attitude, community behavior about halal cosmetics in Makasar District DKI Jakarta</dc:title>
	<dc:creator>Nugrahaeni, Fitria</dc:creator>
	<dc:creator>Wiyati, Tuti </dc:creator>
	<dc:creator>Wulandari, Nora </dc:creator>
	<dc:creator>Utami, Meidi Sari Putri </dc:creator>
	<dc:subject xml:lang="en-US">Knowledge</dc:subject>
	<dc:subject xml:lang="en-US">attitude</dc:subject>
	<dc:subject xml:lang="en-US">behavior</dc:subject>
	<dc:subject xml:lang="en-US">halal cosmetics</dc:subject>
	<dc:description xml:lang="en-US">Background: Halal is essential for a Muslim, particularly while using cosmetics. Halal cosmetics are those whose ingredients do not originate from non-halal sources. The choice to purchase cosmetics with a halal label falls into the low group, indicating that the halal label has little impact on a consumer's interest in a cosmetic product.Objective: This study aims to discover the knowledge, attitudes, and behavior of the people of Makasar District towards halal cosmetics. Method: This research is a cross-sectional observational study undertaken between November 2021 - March 2022. The questionnaire used in the study assesses knowledge, attitudes, and behavior and has been validated for validity. The study includes a total of 519 respondents.Results: The results showed that 92.9% of respondents had good knowledge, 98.5% had positive attitudes, and 93.2% had good behavior towards halal cosmetics. There is a significant relationship between knowledge and behavior (p&amp;lt;0.05) (r=0.166), as well as attitudes and behavior (p&amp;lt;0.05; r=0.215). Meanwhile, there is no correlation between knowledge and attitudes (p&amp;gt;0.05; r=0.086).Conclusion: There is a considerable association between knowledge and conduct, but no relationship between knowledge and attitude. The link between attitude and conduct is crucial. Keywords: Knowledge, attitudes, behavior, halal cosmetics
Intisari Latar belakang: Bagi seorang Muslim, sangat penting bahwa kosmetik apa pun yang mereka gunakan benar-benar halal. Kosmetik dianggap halal jika komponen dasarnya semua diizinkan dalam Islam. Niat beli tidak dipengaruhi secara signifikan oleh pelabelan halal pada kosmetik, seperti yang terlihat dari penempatannya dalam kategori rendah.Tujuan: Penelitian ini bertujuan untuk menyelidiki tingkat pengetahuan, sikap, dan perilaku tentang kosmetik halal di kalangan penduduk Kabupaten Makassar. Metode: Penelitian ini dilakukan antara November 2021 hingga Maret 2022 dan dirancang sebagai penelitian observasional cross-sectional. Tes validitas dengan 519 peserta mengkonfirmasi keakuratan kuesioner pengetahuan, sikap, dan perilaku yang digunakan dalam penelitian ini.Hasil: Temuan mengungkapkan bahwa 92,9% responden berpengetahuan luas, 98,5% baik, dan 93,2% berperilaku baik berkaitan dengan kosmetik halal. Terdapat hubungan yang signifikan antara tingkat pengetahuan dan perilaku (p&amp;lt;0,05; r=0,166); sikap dan perilaku (p&amp;lt;0,05; r=0,215). Sementara itu antara tingkat pengetahuan dan sikap tidak terdapat hubungan (p&amp;gt;0,05; r=0,086). Kesimpulan: Tingkat pengetahuan berhubungan signifikan terhadap perilaku, namun tidak berhubungan terhadap sikap. Terdapat hubungan signifikan terhadap sikap dan perilaku. Kata kunci: Tingkat pengetahuan, sikap, perilaku, kosmetik halal</dc:description>
	<dc:description xml:lang="id-ID">Background: Halal is important for a Muslim, especially in the use of cosmetics. Halal cosmetics are those whose raw materials are not derived from non-halal materials.
Objective: This study aims to find out the knowledge, attitudes, and behavior of the people of Makasar District towards Halal cosmetics.
Method: This research is an observational study with a cross-sectional design which will be conducted from November 2021 to March 2022. The research instrument uses a questionnaire of the knowledge, attitudes, and behavior that has been tested for validity and total of respondents is 519 respondents.
Results: The results showed that 92.9% of respondents had good knowledge, 98.5% had positive attitudes, and 93.2% had good behavior towards halal cosmetics. There is a significant relationship between the knowledge and behavior (P&amp;lt;0.05) (r=0.166); attitudes and behavior (P&amp;lt;0.05) (r=0.215). Meanwhile, there is no relationship between the knowledge and attitudes (P&amp;gt;0.05) (r=0.086).
Conclusion: Knowledge has a significant relationship with behavior, but there is no relationship with attitude. There is a significant relationship between attitude and behavior. High levels of knowledge, attitude, and behavior will increase people’s interest in choosing Halal cosmetics.
Keywords: Knowledge, Attitudes, Behavior, Halal cosmetics</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/23768</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss2.art9</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 2 (2023): Jurnal Ilmiah Farmasi; 97-112</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/jif.vol19.iss2</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/23768/16056</dc:relation>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/23855</identifier>
				<datestamp>2022-07-31T16:47:53Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The influencing factors in knowledge of DAGUSIBU drug management in a rural area</dc:title>
	<dc:title xml:lang="id-ID">¬¬Faktor-faktor yang Memengaruhi  Tingkat Pengetahuan DAGUSIBU pada Masyarakat Desa </dc:title>
	<dc:creator>Yulianto</dc:creator>
	<dc:creator>Alfiana, Mega</dc:creator>
	<dc:creator>Ningrum, Vitarani D.A</dc:creator>
	<dc:subject xml:lang="en-US">DAGUSIBU</dc:subject>
	<dc:subject xml:lang="en-US">knowledge</dc:subject>
	<dc:subject xml:lang="en-US">village community</dc:subject>
	<dc:subject xml:lang="en-US">influencing factors</dc:subject>
	<dc:description xml:lang="en-US">Background: As RISKESDAS findings indicate that most families obtain drugs from prescription or self-medication. A good understanding of drug management is needed to minimize the risks of inappropriate drug use, counterfeit drugs, and other negative impacts. GKSO (The Family Drug Awareness) with the DAGUSIBU slogan (Obtain, Use, Store, Dispose) is an Indonesian Pharmacist Association’s program to raise awareness of exemplary behavior toward family drug management. Objective: This study analyzed the factors influencing DAGUSIBU knowledge among the people in Sekarbagus Village of Lamongan Regency. Methods: A cross-sectional survey study was conducted from March-May 2021 with the levels of DAGUSIBU knowledge assessed using a validated questionnaire. Data analysis used the chi-square in SPSS 21. Results: The results from 113 respondents indicated that the majority of the community had poor knowledge of using and disposing of medications with 57.52% and 87.61%, respectively. Compared to other knowledge, storing medications had the largest proportion (14,16%). There were no respondents with good knowledge of obtaining medications. This study also found that educational level and types of occupations correlated with levels of knowledge (p &amp;lt; 0.05). Conclusion: With more than a third of the population having poor knowledge, pharmacists are expected to educate the community to improve their knowledge and good practice of DAGUSIBU.Keywords: DAGUSIBU, knowledge, village community, influencing factors
IntisariLatar belakang: Seiring dengan hasil RISKESDAS terkait mayoritas keluarga memiliki persediaan obat yang diperoleh melalui peresepan maupun layanan swamedikasi. Pemahaman yang baik tentang pengelolaan obat diperlukan untuk meminimalkan risiko ketidaktepatan penggunaan, pemalsuan obat, dan dampak negatif lainnya. Gerakan Keluarga Sadar Obat (GKSO) dengan slogan DAGUSIBU (Dapatkan, Gunakan, Simpan, Buang obat) merupakan program Ikatan Apoteker Indonesia untuk meningkatkan kesadaran berprilaku benar tentang pengelolaan obat keluarga. Tujuan: Penelitian ini menganalisis faktor-faktor yang memengaruhi tingkat pengetahuan masyarakat desa Sekarbagus Kecamatan Sugio Kabupaten Lamongan tentang DAGUSIBU. Metode: Penelitian berdesain cross-sectional survey dilakukan selama bulan Maret-Mei 2021 dengan penilaian tingkat pengetahuan DAGUSIBU menggunakan kuesioner yang telah divalidasi. Analisis data menggunakan uji chi-square dengan SPSS versi 21. Hasil: Hasil penelitian pada 113 responden menunjukkan masyarakat berpengetahuan rendah mayoritas pada aspek dapatkan dan buang obat yakni masing-masing sebanyak 57,52% dan 87,61%, berturutan. Dibandingkan lainnya, pengetahuan simpan obat menunjukkan proporsi tertinggi berpengetahuan baik (14,16%). Tidak ditemukan responden dengan pengetahuan kategori baik pada aspek dapatkan. Studi ini juga menemukan tingkat pendidikan dan jenis pekerjaan berkorelasi dengan tingkat pengetahuan masyarakat (p &amp;lt;0,05). Kesimpulan: Temuan masyarakat berpengetahuan kurang pada semua aspek DAGUSIBU sebanyak lebih dari sepertiga populasi menghendaki edukasi apoteker untuk meningkatkan pengetahuan dan kesadaran praktek pengelolaan obat di masyarakat pedesaan. Kata Kunci: DAGUSIBU, pengetahuan, masyarakat desa, faktor yang memengaruhi</dc:description>
	<dc:description xml:lang="id-ID">Intisari
Latar belakang: Seiring dengan hasil RISKESDAS terkait mayoritas keluarga memiliki persediaan obat yang diperoleh melalui peresepan maupun layanan swamedikasi, perlu ada pemahaman yang baik tentang pengelolaan obat untuk meminimalkan risiko ketidaktepatan penggunaan, pemalsuan obat dan dampak negatif lainnya. Gerakan Keluarga Sadar Obat (GKSO) dengan slogan DAGUSIBU (Dapatkan, Gunakan, Simpan, Buang obat) merupakan program Ikatan Apoteker Indonesia untuk meningkatkan kesadaran berprilaku benar tentang pengelolaan obat keluarga.
Tujuan: Penelitian ini menganalisis faktor-faktor yang memengaruhi tingkat pengetahuan masyarakat desa Sekarbagus kecamatan Sugio kabupaten Lamongan tentang DAGUSIBU.
Metode: Penelitian berdesain cross-sectional dilakukan selama bulan Maret-Mei 2021 dengan penilaian tingkat pengetahuan DAGUSIBU menggunakan kuesioner yang telah divalidasi. Analisis data menggunakan uji chi-square dengan SPSS versi 21.
Hasil: Hasil penelitian pada 113 responden menunjukkan masyarakat berpengetahuan rendah mayoritas pada aspek dapatkan dan buang obat yakni masing-masing sebanyak 57,52% dan 87,61%, berturutan. Dibandingkan lainnya, pengetahuan simpan obat menunjukkan proporsi tertinggi berpengetahuan baik (14,16%). Tidak ditemukan responden dengan pengetahuan kategori baik pada aspek dapatkan. Studi ini juga menemukan tingkat pendidikan dan jenis pekerjaan berkorelasi dengan tingkat pengetahuan masyarakat (p &amp;lt;0,05).
Kesimpulan: Temuan masyarakat berpengetahuan kurang pada semua aspek DAGUSIBU sebanyak lebih dari sepertiga populasi menghendaki edukasi apoteker untuk meningkatkan pengetahuan dan kesadaran praktek pengelolaan obat di masyarakat pedesaan.
Kata Kunci: DAGUSIBU, Pengetahuan, Masyarakat Desa­­­, Faktor yang Memengaruhi</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2022-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/23855</dc:identifier>
	<dc:identifier>10.20885/jif.vol18.iss1.art8</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 18 No. 1 (2022): Jurnal Ilmiah Farmasi ; 73-87</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol18.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/23855/13880</dc:relation>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.jurnal.uii.ac.id:article/23980</identifier>
				<datestamp>2023-08-01T08:11:06Z</datestamp>
				<setSpec>JIF:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Quality and Antioxidant Activity of Faloak (Sterculia quardifida R.Br) Extract Syrup with Variations in Addition of Ginger (Zingiber officinale Roscoe)</dc:title>
	<dc:title xml:lang="id-ID">Kajian Kualitas Dan Aktivitas Antioksidan Sediaan Sirup Ekstrak Faloak (Sterculia quardifida R.Br) Dengan Variasi Penambahan Jahe (Zingiber officinale Roscoe) </dc:title>
	<dc:creator>Tenda, Priska Ernestina</dc:creator>
	<dc:creator>Kapitan, Lely A. V. </dc:creator>
	<dc:creator>Indrawati, Maria I. M. </dc:creator>
	<dc:creator>Soeharto, Faizal R. </dc:creator>
	<dc:subject xml:lang="en-US">Faloak</dc:subject>
	<dc:subject xml:lang="en-US">syrup</dc:subject>
	<dc:subject xml:lang="en-US">antioxidant</dc:subject>
	<dc:subject xml:lang="en-US">DPPH</dc:subject>
	<dc:description xml:lang="en-US">AbstractBackground: Faloak is known to contain flavonoids, terpenoids, phenols, and tannins, all of which have antioxidant activity. The preparation of faloak in the dosage form of syrup has been completed, but the suboptimal extraction of the active ingredient reduces the antioxidant activity of the syrup. In this study, the syrup was created by macerating extracts of faloak and red ginger, which contain active substances. The quality of the syrup is further evaluated for its antioxidant activity.Objective: To determine the characteristics of the extract, the quality of the syrup, and the antioxidant activity of the syrup.Method: During extraction using the maceration technique, both specific and non-specific characteristics of the extract are evaluated. The 2,2-diphenyl-1-picrilhydrazyl (DPPH) method was used to measure antioxidant activity.Results: The results of testing particular properties revealed that faloak and red ginger extracts contained flavonoids, triterpenoids, phenols, and tannins. The faloak and red ginger extracts had a water content of 5.926 ± 0.116 and 4.270 ± 0.121, respectively, and a total ash content of 2.430 ± 0.160 and 3.570 ± 0.140, according to non-specific analyses of the extract. The IC50 values for the antioxidant activity of formula 1 and formula 2 syrups were 114.002 ± 0.174 and 107.888 ± 0.115 ppm, respectively. Conclusion: The addition of red ginger to Faloak syrup increases its antioxidant activity compared to that of the syrup without the addition of red ginger, although both syrups have moderate antioxidant activity.Keywords: Faloak, syrup, antioxidant, DPPH
Intisari Latar belakang: Faloak diketahui memiliki kandungan flavonoid, terpenoid, fenol dan tanin yang diketahui memiliki aktivitas antioksidan. Penyiapan faloak dalam bentuk sediaan sirup telah dilakukan namun proses penarikan zat aktif yang kurang optimal menurunkan aktivitas antioksidan sirup. Pada penelitian ini sirup diformulasikan dari ekstrak faloak dan jahe merah yang merupakan hasil penarikan zat aktif secara maserasi. Sirup selanjutnya dilakukan uji kualitatif dan aktivitas antioksidannya. Tujuan: Mengetahui karakteristik ekstrak, kualitas sirup dan aktivitas antioksidannya.Metode: Ekstraksi menggunakan metode maserasi, dilanjutkan dengan karakterisasi ekstrak yang dinilai dari aspek spesifik dan non spesifik. Aktivitas antioksidan diukur menggunakan metode 2,2-difenil-1-pikrilhidrazil (DPPH). Hasil: Hasil pengujian karakteristik spesifik menunjukkan ekstrak faloak dan jahe merah mengandung flavonoid, triterpenoid, fenol dan tanin. Uji non spesifik ekstrak menunjukkan kadar air ekstrak faloak dan jahe merah berturut-turut sebesar 5,926 ± 0,116 dan 4,270 ± 0,121 % b/b, sedangkan kadar abu total sebesar 2,430 ± 0,160 dan 3,570 ± 0,140 % b/b. Aktivitas antioksidan sirup formula 1 dan formula 2 diperoleh nilai IC50 berturut-turut sebesar 114,002 ± 0,174 dan 107,888 ± 0,115 ppm. Kesimpulan: Sirup faloak dengan penambahan jahe merah memiliki aktivitas antioksidan lebih tinggi dibandingkan dengan tanpa penambahan jahe merah meskipun sama-sama berada dalam kisaran aktivitas sedang.Kata kunci : Faloak, sirup, antioksidan, DPPH
 </dc:description>
	<dc:description xml:lang="id-ID">Latar belakang: Faloak diketahui memiliki kandungan flavonoid, terpenoid, fenol dan tanin yang diketahui memiliki aktivitas antioksidan. Penyiapan faloak dalam bentuk sediaan sirup telah dilakukan namun&amp;nbsp; proses penarikan zat aktif yang kurang optimal menurunkan aktivitas antioksidan sirup. Pada penelitian ini sirup diformulasikan dari ekstrak faloak dan jahe merah yang merupakan hasil penarikan zat aktif&amp;nbsp; secara maserasi. Sirup selanjutnya dilakukan uji kualitatif dan aktivitas antioksidannya.
Tujuan: Untuk mengetahui karakteristik ekstrak, kualitas sirup dan aktivitas antioksidannya
Metode: Ekstraksi menggunakan metode maserasi, karakteristik ekstrak dinilai dari aspek spesifik dan non spesifik.&amp;nbsp; Aktivitas antioksidan diukur menggunakan metode 2,2-difenil-1-pikrilhidrazil (DPPH).
Hasil: Hasil pengujian karakteristik spesifik menunjukkan ekstrak faloak dan jahe merah mengandung&amp;nbsp; flavonoid, triterpenoid, fenol dan tanin. Uji non spesifik ekstrak menunjukkan kadar air ekstrak faloak dan jahe merah berturut-turut&amp;nbsp; sebesar 5,926 ± 0,116 dan 4,270 ± 0,121 sedangkan kadar abu total sebesar 2,430 ± 0,160 dan 3,570 ± 0,140. Aktivitas antioksidan sirup formula 1 dan formula 2 diperoleh nilai IC50 berturut-turut sebesar 114,002 ± 0,174 ppm dan 107,888 ± 0,115 ppm.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
Kesimpulan: Sirup faloak dengan penambahan jahe merah memiliki aktivitas antioksidan lebih tinggi dibandingkan dengan tanpa penambahan jahe merah meskipun sama-sama berada dalam kisaran aktivitas sedang.
Kata kunci : Faloak, sirup, antioksidan, DPPH</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Islam Indonesia</dc:publisher>
	<dc:date>2023-07-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uii.ac.id/JIF/article/view/23980</dc:identifier>
	<dc:identifier>10.20885/jif.vol19.iss1.art2</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Farmasi; Vol. 19 No. 1 (2023): Jurnal Ilmiah Farmasi; 15-30</dc:source>
	<dc:source>2657-1420</dc:source>
	<dc:source>1693-8666</dc:source>
	<dc:source>10.20885/10.20885/jif.vol19.iss1</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://journal.uii.ac.id/JIF/article/view/23980/15442</dc:relation>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<resumptionToken expirationDate="2026-05-27T18:18:43Z"
			completeListSize="158"
			cursor="0">276a563eccac11ca8ed8c2b323053f38</resumptionToken>
	</ListRecords>
</OAI-PMH>
